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5 Summary 
Summary 
Infection with human papillomavirus type 16 (HPV16) is the leading cause for cervical cancer. 
For infection of host cells, the virus requires to deliver its genome to the site of replication by a 
process called virus entry. HPV16 enters the cells by a novel endocytic pathway. For endocytic 
uptake after initial structural modification, HPV16 engages with an elusive secondary receptor for 
internalization. Intriguingly, infectious internalization occurs in a slow and asynchronous manner 
over a protracted period of time with half times of 10-12 h, which is atypical for viruses that have 
evolved to quickly take over control of their host cells. 
The central question of this work was the underlying reason for the asynchronous and protracted 
residence on the cell surface. There, structural modifications occur on both structural proteins of 
HPV particles, L1 and L2. They start with binding to heparan sulfate proteoglycans (HSPGs) and 
subsequent L1 cleavage by the protease kallikrein-8 (KLK8) to open up the outer shell. This 
allows for the exposure of the L2 N-terminus by cyclophilins and its proteolytic cleavage by 
furin.  
To investigate whether structural changes contributed to the unusual, slow internalization 
kinetics, preprocessed, structural variants of the virus were used to address the role of both 
cyclophilins and furin. After assessing correct particle assembly and uptake by the same endocytic 
pathway of furin-precleaved HPV16 (FPC-HPV16) particles, uptake kinetics were determined. 
The structurally primed particles showed that structural modifications by cyclophilins and furin 
accounted for about a third of the slow and asynchronous internalization kinetics, whereas 
previous steps of HSPG binding and KLK8 cleavage did not.  
Natural infection with HPV16 occurs in differentiating epithelial tissues. We addressed whether 
HPV16 particles derived from differentiating tissues were similarly preprocessed or whether 
further processing steps occurred. Thus, we set up an organotypic raft culture system resembling 
natural environment during HPV infection more closely, from which we extracted and purified 
raft-derived HPV16 particles. These particles and the tissue model will both help to better 
understand structural processing and entry of HPV16, by comparing this system to monolayer 
cell culture.  
A further cause for the slow uptake kinetics could be a protracted engagement of the secondary 
receptor. A number of candidates have been proposed, so that internalization receptor candidates 
were initially verified for their requirement for infection using RNA interference. The confirmed 
receptor candidates CD151 and EGFR were additionally analyzed for their availability and 
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engagement during HPV16 endocytosis by immunofluorescence microscopy and super-
resolution microscopy, which showed only a low incidence of co-localization. Moreover, HPV 
interacted with low affinity with the secondary receptor, irrespective of structural priming. This 
may be due to a proposed function of receptor candidates as a complex, which may limit their 
availability. Hence, the interaction of HPV16 with this complex may be another rate-limiting 
factor during virus entry. 
In conclusion, structural modifications by cyclophilins and furin only partially contributed to the 
slow and asynchronous endocytosis of HPV16. Future research will be directed towards the 
interactions with the internalization receptor and potential causes for the limited internalization 
receptor availability.  
These results extend our understanding of the initial steps of HPV16 entry. Identification of the 
cellular receptor involved will help to identify the cellular function of the endocytic pathway. It 
will also broaden the knowledge on the processes and requirements during HPV infection within 
differentiating host tissues. 
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Zusammenfassung 
Eine Infektion mit dem humanen Papillomvirus 16 (HPV16) zählt zu den Hauptursachen für die 
Entwicklung von Gebärmutterhalskarzinomen. Eine effiziente Infektion von Wirtszellen 
erfordert das Einbringen des viralen Erbguts in den Zellkern im Rahmen des sog. Viruseintritts. 
Im Zellkern findet die Replikation des viralen Erbguts statt. HPV16 nutzt einen neuartigen 
Endozytoseweg für den Eintritt in Wirtszellen. Dafür ist es essentiell, dass HPV16 zunächst 
Strukturveränderungen in der Virushülle erfährt. Diese ermöglichen die anschließende 
Interaktion mit einem Sekundärrezeptor, welcher zur Aufnahme in die Zelle führt. Im Vergleich 
mit anderen Viren verläuft die Endozytose von HPV16 mit Halbwertszeiten von 10-12 Stunden 
in die Wirtszellen außerordentlich langsam und asynchron.  
Die Hauptfrage dieser Arbeit beschäftigte sich mit den Gründen für die lange und asynchrone 
Verweildauer auf der Zelloberfläche. Die strukturellen Veränderungen von HPV16 Partikeln 
geschehen durch Modifikation beider viraler Strukturproteine, L1 und L2, auf der Zelloberfläche. 
Die schrittweise Öffnung des Viruspartikels beginnt mit dem Binden an Heparansulfat 
Proteoglykane (HSPG) und einer darauf folgenden Spaltung des L1 Proteins durch die Protease 
Kallikrein-8 (KLK8). Dies ermöglicht die Präsentation des äußersten N-Terminus des L2 
Proteins auf der Kapsidoberfläche mit Hilfe von Cyclophilinen und dessen anschließende 
proteolytische Abspaltung durch die Protease Furin. 
Um zu untersuchen, ob diese strukturellen Veränderungen zu der ungewöhnlich langsamen und 
asynchronen Aufnahme in die Wirtszelle führen, wurden strukturveränderte Viruspartikel 
eingesetzt, welche die Rolle von Cyclophilinen und Furin aufklären sollten. Die Furin-
behandelten Partikel zeigten einen korrekten Aufbau und die Aufnahme durch den HPV 
Endozytoseweg. Anschließend wurden diese Partikel für die Betrachtung von 
Zelleintrittskinetiken verwendet. Mit Hilfe der strukturveränderten Viruspartikel konnte gezeigt 
werden, dass etwa ein Drittel der langsamen und asynchronen Aufnahme durch Cyclophiline und 
Furin verursacht wurden. Die Bindung von HSPG und die Prozessierung durch KLK8 hatten 
jedoch keinen Einfluss auf die Kinetik. 
Der natürliche Infektionsweg basiert auf der Infektion von differenzierten Epithelien. Daher 
wurde untersucht ob Viruspartikel, die aus differentierten Epithelien stammen, auf dieselbe 
Weise strukturell prozessiert werden wie rekombinant hergestellte Partikel oder ob weitere 
Prozessierungsschritte notwendig sind. Um die natürliche Situation nachzuahmen, wurde eine 
organotypische Gewebekultur etabliert, die zur Extraktion von „raft-derived HPV“ genutzt 
wurde. Die anschließend aufgereinigten Partikel und das Gewebekulturmodell werden in 
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zukünftigen, vergleichenden Studien zu einem verbesserten Verständnis der viralen 
Strukturveränderungen und des Zelleintritts von HPV16 führen. 
Eine verzögerte Interaktion mit dem Sekundärrezeptor könnte ein weiterer Grund für den 
langsamen Zelleintritt von HPV16 sein. Da bereits einige Rezeptorkandidaten in der Literatur 
bekannt waren, wurden diese zunächst mittels RNA-Interferenz auf ihre Relevanz während der 
HPV16 Infektion überprüft. Die hierdurch bestätigten Rezeptorkandidaten CD151 und EGFR 
wurden des Weiteren auf ihre zelluläre Verfügbarkeit und ihre Interaktion mit HPV16 durch 
Immunofluoreszenzmikroskopie und Höchstauflösungs-Mikroskopie untersucht. Diese 
Experimente zeigten, dass eine Kolokalisierung von Rezeptorkandidaten mit HPV16 nur sehr 
selten vorkam. Des Weiteren war die Bindungsaffinität von sowohl unprozessiertem als auch 
strukturell modifiziertem HPV16 zum Sekundärrezeptor grundsätzlich sehr niedrig.  Dies deutete 
darauf hin, dass der Sekundärrezeptor möglicherweise als funktioneller Komplex vorliegen 
musste, was seine Verfügbarkeit einschränken würde. Daher könnte die Interaktion von HPV16 
mit diesem Rezeptorkomplex ein weiterer geschwindigkeitsbestimmender Schritt beim Zelleintritt 
sein. 
Zusammengefasst waren die Strukturveränderungen durch Cyclophiline und Furin nur für einen 
Teil der langsamen und asynchronen Endozytose von HPV16 verantwortlich. Weitere Studien 
werden die Rolle der Interaktionen von HPV16 mit dem Sekundärrezeptor und dessen potentiell 
eingeschränkte Verfügbarkeit untersuchen. 
Diese Erkenntnisse erweitern unser Verständnis der frühen Schritte des Zelleintritts von HPV16. 
Die Aufklärung der Identität des Sekundärrezeptors wird dabei helfen die zelluläre Aufgabe des 
HPV16 Endozytosewegs zu verstehen. Diese Arbeit trägt dazu bei die Prozesse während der 
HPV16 Infektion eines differenzierten Epithels zu entschlüsseln. 
 
  
9 Introduction 
1 Introduction 
1.1 Viruses 
Viruses are intracellular parasites, which are dependent on their host cell for their replication. To 
ensure their own „survival“, they evolved strategies to reprogram the host cells after successful 
initial infection. Due to this reprogramming, viruses are causative agents of many diseases.  
Virus particles are composed of a viral genome of either ribonucleic acid (RNA) or 
deoxyribonucleic acid (DNA) and a protective protein shell, called capsid. Virus capsids self-
assemble from viral structural proteins upon replication within the host cell. Certain virus 
families, e.g. herpesviridae or orthomyxoviridae, are in addition enveloped by a lipid bilayer 
containing viral envelope proteins. Virus capsids have icosahedral (adenoviridae), bullet-like 
(rhabdoviridae) or filamentous (filoviridae) shapes with diameters ranging from 26 nm for 
parvoviridae to about 500 nm for the amoeba-infecting mimiviridae (Prasad and Schmid, 2012; 
Xiao et al., 2005; Huang et al., 2014; Berns and Parrish, 2007). 
Viruses infect all kinds of cellular organisms, including animals, plants, bacteria and fungi 
((Koonin et al., 2006; Fields et al., 2007). Depending on the adaptation to the host, the disease 
caused by virus infection can vary in its severity. As viruses are dependent on infection of host 
cells, adaptation and asymptomatic infections are beneficial for extended shedding of progeny 
virus or to establish viral reservoirs. In addition to economic losses upon infection of plants and 
cattle, viruses similarly affect the human health. Whereas some virus infections cause outbreaks 
of mild disease, others can lead to development of severe and contagious disease. Infection with 
rhinoviruses leads to the development of the common cold, which is unpleasant but mostly mild, 
whereas infection with Ebola almost always leads to life threatening conditions with very high 
mortality (Goeijenbier et al., 2014). Other viruses like herpesviruses establish persistent infection 
with recurring development of blisters but can cause severe disease upon immunosuppression 
(Nicoll et al., 2012). Importantly, the development of certain cancers is attributed to virus 
infection. Human papillomaviruses (HPVs), for instance, infect skin and mucosal tissues 
(Doorbar et al., 2012). In most cases, they remain asymptomatic or lead to development of 
benign warts. Upon inefficient immune clearance of infected cells, however, HPVs can persist in 
dividing stem cells and benign lesions can develop into cancers (Doorbar et al., 2012). Efficient 
treatment of viral diseases is an important humanitarian and economic task, for which 
understanding of the basic mechanisms underlying virus infections is essential.  
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1.2 Virus entry 
As efficient uptake into host cells is essential for every virus to establish infection, the 
understanding of virus entry is critical for the development of anti-viral therapies. Virus entry 
into host cells is a multi-step process, during which the virus is transported from the extracellular 
space to its site of replication.  
1.2.1 Binding 
In order to be taken up, viruses have to attach to the host cell surface. Primary binding often 
occurs to so-called attachment factors, which can serve as universal receptors and help to tether 
and concentrate virus particles in close proximity to the plasma membrane (Jolly and Sattentau, 
2006; Marsh and Helenius, 2006). Most prominent attachment factors are glycosaminoglycans, 
e.g. plasma membrane-bound heparan sulfate proteoglycans or sialylated glycoproteins 
(Marsh&Helenius, 2006). In addition to attachment factors, viruses interact with (entry) 
receptors, which actively promote virus entry by initiation of structural changes in the virus 
 
Figure I Virus entry into host cells 
Virus entry is a multistep process, which leads to the delivery of the viral genome to its site of replication within 
the host cell. A prototypical virus entry is depicted above. In brief, viruses bind to cell surface receptors, followed 
by a phase of lateral diffusion and signaling, which leads to internalization of the virus particle by endocytosis. The 
viruses are trafficked in endocytic vesicles until they escape by penetration of the limiting vesicle membrane. A 
subviral complex may then be transported through the cytosol to reach the site of replication, which is most cases 
is the nucleus. Adapted from (Marsh and Helenius, 2006). 
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capsid and/or activation of signaling and thereby trigger internalization of the virus. Entry 
receptor interactions are rather specific; therefore, their expression pattern also determines host 
specificity of viruses (Grove and Marsh, 2011). 
Heparan sulfate based receptors are used by, for example, herpes simplex virus (HSV-1) for 
enhanced membrane fusion (Jolly and Sattentau, 2006; WuDunn and Spear, 1989) and Vaccinia 
virus (Chung et al., 1998). Polyoma viruses like Simian Virus 40 (SV40) and human BK virus bind 
to gangliosides, which are glycosphingolipid containing sialic acid residues within the glycan chain 
(Tsai et al., 2003; Low et al., 2006). Prominent sialic acid dependent viruses are influenza A 
viruses (IAV) (Rogers et al., 1983b; a). Hemagglutinin (HA) proteins of IAV interact with 
multiple sialic acid residues providing high avidity for the cell surface. The specificity of IAV HA 
proteins for different sialic acid linkages thereby determines the host and species tropism of IAV 
stains (Air, 2014; Stencel-Baerenwald et al., 2014). Polioviruses exemplify viruses, which only 
require interaction with a single host cell protein for efficient internalization. Here, only the first 
Ig-like domain of CD155 binds within a cavity in the poliovirus capsid (He et al., 2000). 
Some viruses also require interaction with more than one receptor for host cell entry. For 
example, binding of adenoviruses to Coxsackievirus and Adenovirus receptors (CAR) is not 
sufficient for infection. Receptor-mediated endocytosis only occurs upon interaction with an 
integrin αv co-receptor (Wickham et al., 1993). Hepatitis C virus (HCV) even requires the 
involvement of minimally four distinct membrane proteins for efficient entry (Lindenbach and 
Rice, 2013; Ploss and Evans, 2012). After interaction with GAGs, HCV requires engagement 
with low density lipoprotein receptor (LDLR) and high density lipoprotein receptor scavenger 
receptor class B type I (SR-BI) as well as tight junction proteins claudin-1 (CLDN1) and 
occluding (OCLN) on the targeted hepatocytes (Lindenbach and Rice, 2013; Ploss and Evans, 
2012), which exemplifies the range of complexity during host cell binding. 
Even though virus receptors have been studied extensively and multiple receptor engagements 
have been found to be essential for many viruses, there is little knowledge about dynamic and 
transient processes occurring after initial cell surface binding and before internalization (Marsh 
and Helenius, 2006). Binding to attachment factors like HSPGs is considered to be unspecific 
and of low affinity to mediate rapid concentration of particles on the cell surface and allow for 
subsequent engagement of specific internalization receptors (Grove and Marsh, 2011). Several 
models aim to explain how initial receptor binding leads to induction of endocytic uptake 
(reviewed in (Boulant et al., 2015)): Incoming virus particles may bind to their cell confined 
surface receptor and induce signaling directly or indirectly until they are endocytosed (stick 
mechanism). Viruses may bind to a receptor and experience a phase of lateral movement to 
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cluster with further receptor molecules. The resulting confined complex may then signal and be 
endocytosed (seek mechanism). Further, viruses may bind to a receptor structure, with which 
they move laterally until they encounter a preformed endocytic structure for immediate 
internalization (preformed mechanism). Lastly, viruses may bind to an initial receptor, which 
induces signaling and lateral movement aiming to engage a secondary receptor structure. This 
may then be used as a hub for immediate internalization (stick and seek mechanism). However, 
none of these models explains conclusively how viruses transfer from primary receptors to 
internalization receptors. 
1.2.2 Internalization 
Whereas some enveloped viruses like retroviruses directly fuse with the plasma membrane, most 
viruses are taken up by endocytosis. Endocytosis is a cellular mechanism to import selected 
molecules and proteins (cargos) over the plasma membrane, which represents the main barrier to 
the extracellular space (Doherty and McMahon, 2009). In general, extracellular cargo is taken up 
into plasma membrane-derived vesicles, which are released from the plasma membrane by 
scission. Several endocytic pathways were initially characterized by the transported cargo and 
cellular factors required. Macropinocytosis (Swanson and Watts, 1995), clathrin-mediated 
endocytosis (CME) (McMahon and Boucrot, 2011), caveolin-mediated/lipid-raft-dependent 
endocytosis (Rothberg et al., 1992), and phagocytosis are well studied among the known 
pathways. Phagocytosis is the general mechanism by which specialized immune cells internalize 
large particles, bacteria and cellular debris and is restricted to these cells (Flannagan et al., 2012). 
Additionally, further endocytic pathways have been described recently, but are not as well 
characterized yet (Mercer et al., 2010). These pathways include the IL-2 endocytic pathway (Subtil 
et al., 1994), the clathrin-independent carrier/GPI-AP-enriched early endosomal compartment 
(CLIC/GEEC) pathway (Sabharanjak et al., 2002), the flotillin-mediated endocytosis (Frick et al., 
2007; Glebov et al., 2006), and the Arf6 pathway (Naslavsky, 2003, 2004). Viruses hijack most of 
these cellular pathways, which evolved to easily bypass natural barriers like plasma membrane, the 
actin cortex, and the crowded cytoplasm (Mercer et al., 2010). Interestingly, some viruses, like 
human papillomavirus 16 (HPV16) and lymphocytic choriomeningitis virus (LCMV), use novel 
endocytic pathways (Schelhaas et al., 2012; Quirin et al., 2008; Rojek et al., 2008). These pathways 
require sets of cellular factors, which differ from previously described canonical pathways. 
Therefore, viruses can be used as a tool to study and characterize cellular functions such as 
endocytic pathways (Schelhaas, 2010). 
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1.2.3 Intracellular trafficking, membrane penetration and viral uncoating 
After endocytic uptake, virus particles reside in primary vesicles, which can allow for a safe 
passage through the crowded cytoplasm. Endocytic vesicles usually fuse with early endosomes 
(EE) (Jovic et al., 2010; Mayor et al., 1993). However, other vesicles like macropinosomes 
undergo maturation and fuse with late endosomes/lysosomes (Racoosin and Swanson, 1993). 
EEs are large vacuoles that function as key sorting stations in the cell (Gruenberg et al., 1989; 
Jovic et al., 2010). Early endosomes have a slightly acidic pH (6.8-6.1), and are generally 
characterized by an enrichment of phosphatidylinositol-3-phosphate (PI3P) in the limiting 
membrane and the presence of the tethering factor early endosome antigen 1 (EEA1) and the 
small GTPase Rab5 (Maxfield and Yamashiro, 1987; Huotari and Helenius, 2011). Rab proteins 
mediate fusion and fission events in the endo-lysosomal system by switching between an active 
GTP-bound form and an inactive GDP-bound form, which enables them to dynamically interact 
with different effectors. Early endosomes sort cargo back to the plasma membrane via the 
recycling endosome (RE) or towards late endosomes (LE) and lysosomes for degradation. En 
route to the LE, vesicles detach from the EE, undergo maturation and eventually fuse with the 
LE. Maturation and fusion depends on the small GTPase Rab7a (Rink et al., 2005; Vonderheit 
and Helenius, 2005). Membrane receptors e.g. mannose-6-phosphate receptor, have to escape 
from the degradative pathway and are recycled back to the trans-Golgi network. This usually 
occurs from early endosomes by the retromer complex or from LE by Rab9 and Rab7b 
dependent trafficking (Lombardi et al., 1993; Arighi et al., 2004; Progida et al., 2010). The 
retromer complex is composed of five proteins, which recognize cargo in the endosomes and 
coat and deform membranes to mediate formation of vesicles, which then travel to the TGN 
(Trousdale and Kim, 2015). 
Endosomal compartments are trafficked by motor-proteins from the cell periphery to the 
perinuclear area through the cytosol (Brown et al., 2005; Huotari and Helenius, 2011). However, 
their progressive fusion with protease containing vesicles ensures that late endosomes and 
lysosomes become a strongly degradative environment. The provided changes in the pH and 
increasing protease activity makes the endo-lysosomal system the preferred place for viral 
uncoating. Depending on the compartment they escape from, viruses can be classified in early – 
and late-penetrating viruses (Lozach et al., 2011). Early-penetrating viruses, like semliki forest 
virus (SFV) and vesicular stomatitis virus (VSV), escape from early endosomal compartments 
into the cytosol (Marsh et al., 1983; Johannsdottir et al., 2009). Late-penetrating viruses travel to 
LE and lysosomes until they escape to the cytosol, e.g. reoviruses (Mainou and Dermody, 2012). 
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Viruses also use other organelles to escape into the cytoplasm, as polyomavirus escape occurs 
from the ER (Kartenbeck et al., 1989). 
During host cell entry, viruses have to rid themselves of the shielding protein capsids to make the 
viral genome accessible for replication in a processes called uncoating. Incoming viruses 
dynamically react to cellular cues, which are receptor interactions, enzymes or chemical 
environments (reviewed in (Yamauchi and Greber, 2016)). For example, many viruses require the 
acidic environment within the endosomal compartments to mediate membrane fusion, like 
influenza A viruses, which release their genomes by fusion with late endosomal membranes 
(White et al., 1982). Reoviruses require proteolytic cleavage of the capsid proteins in the lysosome 
before a subviral complex can escape into the cytosol (Ebert et al., 2002). 
The ability of viruses to overcome membrane barrier at plasma membrane or endosomal 
membranes is tightly linked to the aforementioned cellular cues (Yamauchi and Greber, 2016). 
Most non-enveloped viruses possess proteins with specific functions aiding in membrane 
penetration. These functions include pore formation or lysis of the membrane. Adenoviruses 
proteins mediate membrane lysis by insertion of hydrophobic domains, which leads to disruption 
of the endosomal membrane and the release of the partially uncoated capsid into the cytoplasm 
(Wiethoff et al., 2005). Polioviruses, however, are able to form a small pore upon receptor 
mediated conformational changes and thereby release only their genome into the cytoplasm 
(Tosteson and Chow, 1997).  
1.2.4 Nuclear import 
For replication within the nucleus, viral genomes have to gain access to the nuclear space after 
penetration into the cytosol. There are different ways of nuclear delivery exploited by viruses 
(Cohen et al., 2011). Direct nuclear import of virus particles is rarely observed due to the limited 
diameter of the nuclear pore complexes (NPCs), which have a diameter of maximally 39 nm 
(Panté and Kann, 2002). However, hepadnavirus particles associate with the NPCs, where the 
capsid is arrested in the nuclear basket and the DNA is released into the nucleus (Kann et al., 
1999; Schmitz et al., 2010). Similarly, adenoviruses and large viruses like herpesviruses associate 
with the cytoplasmic site of the NPCs, where they open up and deliver their genome through the 
nuclear pore (Newcomb et al., 2007). Influenza A viruses release the viral genome segments (viral 
ribonucleoproteins, vRNPs) upon fusion with the endosomal membrane directly into the 
cytoplasm (Doms et al., 1985; Carr and Kim, 1993). The associated viral NP protein has a nuclear 
localization signal (NLS) by which the vRNPs are bound by cellular importins and imported into 
the nucleus (Babcock et al., 2004; Martin and Helenius, 1991). Parvoviruses have a diameter of 
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only 26 nm, which enables them to pass through NPCs, likely via NLS and importins (Berns and 
Parrish, 2007). Intact particles have been found within the nucleus. Interestingly, parvoviral 
capsid protein VP1 has phospholipase A2 activity, which enables it to escape from endosome by 
formation of membrane pores (Porwal et al., 2013). It is still under debate whether this 
mechanism is also used to perturb the nuclear membrane (Farr et al., 2005; Porwal et al., 2013). 
All mechanisms above, which rely on transport through NPCs, allow for infection of non-
dividing cells. Interestingly, human papillomaviruses (HPVs) only infect mitotically active cells 
(Pyeon et al., 2009). A subviral complex of HPVs only enters the nucleus upon nuclear envelope 
breakdown (NEBD) during mitosis (Aydin et al., 2014).  Moreover, some retroviruses like murine 
leukemia virus (MLV) depend on mitosis for nuclear import, as the MLV pre-integration 
complex (PIC) is too large to be transported through the NPCs (Roe et al., 1993). 
1.2.5 Kinetics of virus entry 
Several viruses enter host cells by rapid uptake. Vesicular stomatitis virus (VSV) enters the cell by 
clathrin-mediated endocytosis (CME) and shows a half-time of infectious internalization of about 
3 min after binding (Johannsdottir et al., 2009). Similarly, dengue virus is rapidly internalized by 
CME about 1 min post binding to the cell surface (Van Der Schaar et al., 2008). Herpes simplex 
virus 1 (HSV-1) is a large enveloped virus and fuses within minutes with the plasma membrane 
(Fuller and Spear, 1987; Nicola et al., 2003; Sodeik et al., 1997) or is taken up by 
macropinocytosis with a half time of 8-9 min depending on the cell type (Nicola and Straus, 
2004). However, not all viruses enter their host cells that fast. Simian virus 40 (SV40) has a half 
time of 1 h for internalization through caveolar endocytosis (Pelkmans et al., 2001). Intriguingly, 
HPVs enter cells by a novel endocytic pathway and exhibit very slow and particularly 
asynchronous uptake, which will be discussed in more detail below (Giroglou et al., 2001; Selinka 
et al., 2003; Buck et al., 2006; Smith et al., 2007; Selinka et al., 2007; Schelhaas et al., 2012; 
Cerqueira et al., 2013). 
1.3 Human papillomaviruses 
Papillomaviridae are a large family of animal viruses of, to date, about 200 described members 
((Doorbar et al., 2012; Van Doorslaer et al., 2013); PaVE Database, https://pave.niaid.nih.gov). 
Human papillomaviruses are important human pathogens, of which more than 150 types have 
been sequenced (Doorbar et al., 2012). Based on their sequence homology, HPVs are divided 
into five genera (alpha, beta, gamma, mu and nu), which exhibit different disease association and 
life-cycle characteristics (De Villiers et al., 2004). HPV types are classified into high-risk and low-
risk types depending on their ability to cause cancers (De Villiers et al., 2004; Bernard et al., 
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2010). The alpha type viruses infect cutaneous and mucosal tissues. Both high-risk mucosal types 
associated with the development of cervical and anogenital cancers as well as low-risk types 
causing benign lesions or skin warts are found among the alpha-HPVs. The other genera include 
mainly cutaneous viruses of which only certain high-risk beta-HPVs are associated with 
squamous cell carcinoma (Doorbar et al., 2012). About 70-80% of all invasive cervical cancers are 
caused by the high-risk alpha-types HPV16 and HPV18 (Doorbar, 2006; Muñoz et al., 2004) and 
in total 5% of all human cancers are related to HPV infection (Parkin, 2006). 
1.3.1 The HPV life cycle 
HPVs have circular, double stranded DNA genomes with a size of about 8 kbp, which is 
incorporated into a capsid with a diameter of 55 nm (Howley and Lowy, 2007). The capsid is 
assembled from the two structural proteins, the major capsid protein L1 and the minor protein 
L2, and will be discussed in more detail below. In addition to the structural proteins, the viral 
genome encodes for six early virus proteins E1, E2, and E4-E7 (Howley and Lowy, 2007). The 
early proteins are expressed upon infection of the host cell and regulate viral replication and cell 
proliferation. HPVs exhibit a strong tropism for epithelial tissues (Doorbar et al., 2015) and the 
viral life cycle is tightly linked to differentiation of the tissue. To maintain a pool of infected cells, 
HPVs depend on infection of dividing basal stem cells within the tissue. For initial infection, 
HPVs access basal stem cells probably through microwounds in the epithelium. In addition, entry 
may occur in single cell layered epithelia in the ectocervix (Doorbar et al., 2012). The viral 
genome is maintained as an episome in low copy number within the basal layers of the tissue. 
The early viral proteins E1 and E2 regulate genome replication and transcriptional activity (Mohr 
et al., 1990; Ustav and Stenlund, 1991; Ustav et al., 1991). Upon differentiation of the infected 
cell, changed promoter activities lead to increased expression of E6 and E7, which stimulate cell 
proliferation and further amplification of infected cells (Doorbar, 2005; Valencia et al., 2008). 
Within the suprabasal granular layer, expression of the late structural proteins occurs and leads to 
assembly of progeny virus. Eventually, due to the changing redox environment in terminally 
differentiating cells, progeny HPV particles mature by disulfide bond formation (Conway and 
Meyers, 2009). Mature particles are shed from the cornified layers of the differentiated epithelium 
(desquamation) (Bryan and Brown, 2001). 
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The E2 protein is the major transcriptional regulator of HPVs (Spalholz et al., 1985, 1987). E2 
thereby regulates abundance of E6 and E7, which directly regulate proliferation of infected cells 
(Nishimura et al., 2000). In many HPV-positive cancers, one or more copies of the viral genome 
is integrated at random locations in the host cell genome. Frequently, integration disrupts the 
expression of regulatory proteins E1 or E2, which leads to dysregulation of E6 and E7 
expression, hyperproliferation, and genomic instability resulting in cancer development 
(Romanczuk and Howley, 1992; Williams et al., 2011). 
1.3.2 Virus particles in HPV research 
As HPV replication is tightly linked to tissue differentiation, the virus is not easily grown in cell 
culture. Different cell culture systems were set up for efficient production of virus particles. To 
date, most research on virus entry relies on recombinant particles, which are extracted from 
monolayer producer cells without the need for tissue differentiation. Producer cells are 
transfected with expression plasmids encoding for the structural proteins of HPV. Three types of 
virus particles are produced with this system: virus-like particles (VLP) (Zhou et al., 1991; 
Kirnbauer et al., 1992; Hagensee et al., 1993), pseudovirus particles (PsV) (Buck et al., 2005b; a; 
Pyeon et al., 2005) and quasiviruses (QV) (Culp et al., 2006c). Recombinant particles rely on the 
self-assembly of virus capsids from L1 only or L1 and L2 proteins. VLPs do not contain a 
genome and are composed of L1 or L1/L2. QV particles incorporate the viral genome, whereas 
PsVs harbor a reporter plasmid expressing fluorescent proteins (e.g. green-fluorescent protein, 
GFP) (Buck and Thompson, 2007), secreted alkaline phosphatase (SEAP) (Pastrana et al., 2004) 
or luciferase (Johnson et al., 2009), which serves as readout for efficient genome delivery. Mature 
 
Figure II The HPV life cycle depends on tissue differentiation 
HPV infection and viral gene expression is tightly linked to the differentiation of epithelial tissues. Progeny virus 
particles are shed from the cornified layers of the tissue. Adapted from (Moody and Laimins, 2010).  
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virus particles are separated from the cell lysates by density gradient centrifugation (Buck et al., 
2004, 2005b). With this system, virus particles can be produced in high quantity and purity. 
Organotypic raft culture represents a means for production of virus within differentiating tissues 
derived from HPV-positive cells (Meyers et al., 1992; McLaughlin-Drubin et al., 2004). In 
principle, HPV-transduced keratinocytes are grown on a collagen-fibroblast support matrix at the 
air-liquid interphase for 10-20 days to allow for tissue differentiation and virus maturation. 
Harvesting and homogenization of the tissues yields low amounts of so-called raft-derived HPV 
(also called authentic virus or native virus). Raft-derived HPV particles likely mirror virus 
maturation in host tissues, however, the setup of this system is complex, time consuming and 
costly (Meyers et al., 1992; McLaughlin-Drubin and Meyers, 2005; Biryukov et al., 2015). 
Importantly, in contrast to the production of recombinant virus particles, raft-derived HPVs are 
usually not purified and therefore come in crude suspension containing large amounts of cellular 
material (Biryukov et al., 2015; Biryukov and Meyers, 2015).  
1.3.3 Structure 
Human papillomavirus capsids are formed from two structural proteins, L1 and L2. 360 
molecules of the major capsid protein L1 assemble into 72 pentamers (also called capsomers) and 
form the outer shell of the icosahedral capsid (T=7) (Klug, 1965; Finch and Klug, 1965). Within 
the capsid arrangement, 12 pentameres are surrounded by 5 capsomers (pentavalent) and 60 
surrounded by 6 capsomers (hexavalent) (Baker et al., 1991; Finch and Klug, 1965; Klug, 1965). 
The L1 monomers have a “jelly roll” beta sandwich fold and assemble into a ring with a central 
channel (Chen et al., 2000). The strands of the beta sheet are connected by large surface loops 
(BC, DE, EF, FG, HI), which are intertwined with loops of the neighboring surface loops (Chen 
et al., 2000; Bishop et al., 2007). The capsomers are interconnected by intercapsomeric disulfide 
bonds, which form between a cysteine within the C-terminal invading arm from each L1 of the 
pentamer and a surface exposed cysteine in the neighboring pentamer (Modis et al., 2002; Wolf et 
al., 2010). Formation of these disulfide bonds requires an oxidizing environment, which is likely 
supplied during tissue differentiation and therefore allows for virus maturation (Buck et al., 
2005b; Cardone et al., 2014; Conway et al., 2009b). As this is not efficient during in vitro virus 
production in producer cells, the oxidation-dependent maturation is supplied by extended 
incubation after cell lysis (Buck et al., 2005b; Cardone et al., 2014). 
In addition to the L1 protein, which self-assembles into capsids as described above, a number of 
L2 proteins are incorporated into HPV particles. Cryo-EM analyses of L1/L2 VLPs versus L1 
only VLPs revealed that L2 is located underneath the cavity at the base of each pentamer (Buck 
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et al., 2008; Buck and Trus, 2012). Consequently, maximally 72 L2 proteins can be incorporated, 
however, lower amounts have been described, which might reflect the natural packaging 
efficiency or represent an average value from complete versus empty capsids (Buck and Trus, 
2012). The presence of L2 is important for efficient DNA encapsidation and also impacts the L1 
capsid structure (Kirnbauer et al., 1993; Chen et al., 2011; Zhao et al., 1998). In mature virions 
most part of the L2 protein is buried inside the particle, however, the N-terminus is exposed 
upon structural changes of the capsids (Day et al., 2008a; Kines et al., 2009). In addition to its 
role in particle assembly, L2 is a multifunctional protein and involved in many interactions with 
cellular proteins. Consequently, many protein interaction domains have been described, which 
implicate multiple functions upon virus entry and uncoating (Wang and Roden, 2013). 
1.4 Host cell entry of Human Papillomaviruses 
1.4.1 Primary binding 
Primary binding of HPVs to host cells occurs by attachment to heparan sulfate proteoglycans 
(HSPG) in the plasma membrane (Joyce et al., 1999; Giroglou et al., 2001). HPVs interact with 
glucosaminoglycan (GAG) chains without the requirement of a specific core protein as syndecan-
1, syndecan-4 and glypican-1 can serve as primary receptors (Shafti-Keramat et al., 2003). 
Moreover, the sulfation pattern is important for infection, as O-sulfation and N-sulfation are 
essential for infection and high degree of sulfation facilitates binding to cells (Shafti-Keramat et 
al., 2003; Selinka et al., 2003; Cerqueira et al., 2013). To date, four distinct heparan sulfate binding 
sites have been described for HPV (Knappe et al., 2007; Dasgupta et al., 2011; Richards et al., 
2013). These binding sites are located at surface-exposed lysine residues (Dasgupta et al., 2011; 
Richards et al., 2013). Mutagenesis studies suggest that only one site (Lys-278/-361) on top of the 
pentamer was vital for efficient binding to cells, whereas the other sites (Lys-54/356 and Asn-57, 
Lys-59/-442/-443) were vital for efficient infectious uptake but did not affect binding (Richards 
et al., 2013). 
Alternatively, HPVs can bind to laminin-332 and HSPGs in the extracellular matrix (ECM). 
Transient binding to laminin-332 likely serves as an attachment factor to concentrate virus and 
allow interaction with HSPGs on the cell surface or within the ECM (Culp et al., 2006b; a). 
1.4.2 Structural modifications 
Several extracellular structural modifications have been described to occur after primary binding 
of HPV16. HSPGs serve as a primary attachment factor (Joyce et al., 1999; Giroglou et al., 2001; 
Shafti-Keramat et al., 2003; Knappe et al., 2007). However, multiple binding sites have been 
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described (Dasgupta et al., 2011; Richards et al., 2013). The interaction of HPV16 with HSPGs 
leads to a change in exposure of surface epitopes, eventually resulting in a reduced affinity to 
HSPGs (Selinka et al., 2003, 2007; Cerqueira et al., 2013). This loss of affinity to HSPGs is 
required for a receptor transfer to an internalization receptor required for infectious 
internalization (Selinka et al., 2007; Richards et al., 2013). Extracellular structural changes are 
considered to be the first steps of HPV uncoating during entry. Of the many proteolytic 
cleavages required during uncoating is the extracellular cleavage by the secreted protease 
kallikrein-8 (KLK8), which is enhanced by prior interaction with heparin (Cerqueira et al., 2015). 
RNAi knock down and antibody-based depletion experiments show that KLK8-mediated L1 
cleavage is essential for internalization of HPV (Cerqueira et al., 2015).  
Importantly, structural changes lead to the exposure of an important cross-neutralizing epitope of 
the L2 protein, called RG-1 epitope (Gambhira et al., 2007). This epitope is only accessible for 
neutralizing antibodies upon N-terminal cleavage of the L2 at a highly conserved furin cleavage 
site at amino acids 9-12 and is required for infection (Richards et al., 2006). As L2 lies buried 
within mature virions, interaction with HSPGs and L1 cleavage by KLK8 likely facilitate 
accessibility of the L2 N-terminus (Cerqueira et al., 2015). Activity of cyclophilins, which are 
peptidyl-prolyl cis/trans isomerases, mediates the L2 conformational change. This leads to 
exposure of the L2 N-terminus (Bienkowska-Haba et al., 2009, 2012). Interaction of cyclophilins 
most occurs within a conserved prolin-rich binding site in the L2 protein (HPV16: 97-
PVGPLDP-103). Mutation of this binding site (L2-GP-N mutant) resulted in CyP-independent 
exposure of the RG-1 epitope and internalization, likely due to an increased flexibility within the 
L2 (Bienkowska-Haba et al., 2009). In contrast to that, a recent study attributes only little 
relevance to cyclophilins for efficient furin cleavage (Bronnimann et al., 2016). This result could 
either hint at a different, cyclophilin-independent mechanism for L2 N-terminal exposure or 
indicate that modification of the L2 N-terminus causes a different mode of exposure as the study 
relies on tagged L2 proteins. This will have to be clarified in future studies. However, cyclophilins 
are also required for further uncoating after internalization, as infection with the L2-GP-N 
mutant was still sensitive to CyP inhibition by cyclosporine B (Bienkowska-Haba et al., 2009, 
2012). This study showed that during uncoating within the endosomal system, cyclophilins 
facilitate the separation of the L1 protein targeted for degradation from the L2/DNA subviral 
complex, which travels to the nucleus. 
The indicated structural changes result in cleavage by furin and eventually yield terminally 
restructured particles that according to the current understanding are ready to be internalized 
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(Selinka et al., 2003, 2007; Sapp and Bienkowska-Haba, 2009; Richards et al., 2013; Day and 
Schelhaas, 2014). 
To bypass the requirement of extracellular structural changes, recombinant HPV pseudovirus 
particles have been produced by exposure to furin during maturation to result in furin-precleaved 
HPV (FPC-HPV) (Day et al., 2008b; Wang et al., 2014). Depending on the production method, 
different levels of in-vitro furin cleavage are observed (Day et al., 2008b; Wang et al., 2014). FPC-
HPV particles infect independently from HSPGs and active furin, both in vitro and in vivo. FPC-
HPV particles are immediately sensitive to an RG-1 neutralizing antibody (Day et al., 2008a; 
Kines et al., 2009; Wang et al., 2014). The FPC-HPV16 is therefore considered to be a valuable 
tool to study entry steps downstream of structural priming. 
Studies on binding and infection are also performed in vivo using a murine vaginal challenge 
model, which is based on infection upon mechanical or chemical disruption of the vaginal tissue 
(Roberts et al., 2007; Johnson et al., 2009). HPVs bind in vivo to HSPGs and laminin-332 in the 
basement membrane (BM). Here, initial structural changes occur before the virus is transferred to 
the cell, which migrates into the wounded area (Johnson et al., 2009; Kines et al., 2009). 
In contrast to research using HPV16 pseudovirus, experiments with raft-derived HPV provided 
some contradictory findings. Raft-derived and recombinant HPV particles are recognized by 
similar neutralizing antibodies and are therefore considered immunologically indistinct (White et 
al., 1999; McLaughlin-Drubin et al., 2004; Day et al., 2007). One study reports that raft-derived 
HPV31b does not require heparin sulfates for infection (Patterson et al., 2005), whereas Cruz and 
colleagues suggest that only HPV16 infection is GAG-independent, and HPV18 particles, and 
HPV31 and HPV45 depend completely and partially, respectively, on GAG interaction (Cruz and 
Meyers, 2013). Moreover, recent reports suggested that raft-derived HPV16 and HPV45 infect 
cells independently from active furin and that raft-derived HPV16 particles, but not HPV18 and 
31, contain furin-precleaved L2 proteins (Cruz et al., 2015). Furthermore, raft-derived HPV16 
particles are neutralized upon incubation with RG-1 antibody during infection (Conway et al., 
2009b). These results may suggest that tissue-derived virus particles could be structurally 
preprocessed, and that they represent terminally restructured particles, which are ready for 
infection as they are shed from the tissue. However, more detailed biochemical and functional 
analyses are still required. 
1.4.3 Secondary receptor interaction 
After initial binding and proteolytic cleavage, HPVs are transferred from the HSPGs to a putative 
secondary receptor, which is essential for infectious internalization (Selinka et al., 2007; Day et al., 
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2008a; b). To date, several receptors candidates have been proposed. Their role during 
internalization and functional interplay is still under debate (Raff et al., 2013; Day and Schelhaas, 
2014).  
Laminin-binding integrin α6 was the first receptor candidate, which is reportedly essential for 
HPV internalization (Evander et al., 1997; Yoon et al., 2001). HPV infection correlates with the 
expression levels of integrin α6, as infection is reduced in ITGα6 null cells or after siRNA knock 
down (Abban and Meneses, 2010; Scheffer et al., 2013; Aksoy et al., 2014). Virus binding triggers 
integrin-induced signaling via PI3K and FAK, which may be involved in endocytic signaling for 
HPV16 (Fothergill and McMillan, 2006; Abban and Meneses, 2010). However, reports using 
virus particles of different PV types show that binding and internalization can occur in an 
integrin α6-independent manner (Giroglou et al., 2001; Shafti-Keramat et al., 2003; Sibbet et al., 
2000). This notion is supported by in vivo data, which show reporter gene expression in integrin 
α6 negative cells (Huang and Lambert, 2012). This leaves the role of integrin α6 as a receptor 
during HPV entry unclear. 
Signaling of the epidermal growth factor receptor (EGFR) is required for HPV16 host cell entry, 
as infection is perturbed in presence of receptor tyrosine kinase (RTK) inhibitors or EGFR 
inhibitors (Schelhaas et al., 2012).  
An alternative model for HPV attachment and uptake includes EGFR as a secondary receptor 
for HPV16 (Surviladze et al., 2012). Here, HPVs initially attach to HSPGs on the cell surface or 
ECM, which are associated with growth factors (GF). The resulting HPV-HSPG-GF-complex is 
subsequently shed from the cell surface or ECM by the action of matrix metalloproteinases 
(MMP). Subsequent association with EGFR via GF binding then induces signaling and 
internalization of EGFRs together with HPV (Surviladze et al., 2012). However, it appears 
unfavorable for a virus to lose the connection to the cell again after initial binding, as this is an 
unnecessary limitation of infection. 
Further studies suggest that Annexin A2 heterotetramer (A2t) to regulate internalization of 
HPV16 (Woodham et al., 2012; Dziduszko and Ozbun, 2013; Woodham et al., 2015). Annexins 
are Ca2+-dependent phospholipid binding proteins, which are therefore involved in many 
processes that involve membrane remodeling, e.g. exocytosis, endocytosis, intracellular trafficking 
(Gerke et al., 2005; Rescher and Gerke, 2008). Annexin A2 forms a heterotetrameric complex 
with S100A10 (A2t) and localizes in the plasma membrane and early endosomes (Rescher and 
Gerke, 2008; Grieve et al., 2012; Bharadwaj et al., 2013). The HPV-related function involves 
extracellular activity of A2t (Dziduszko and Ozbun, 2013; Woodham et al., 2012), which is 
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mediated by interaction of an HPV16 L2 with the S100A10 subunit (Woodham et al., 2012). 
Extracellular A2t has been implicated previously but is under debate within the field as the 
mechanism of translocation is completely unknown (review in (Rescher and Gerke, 2008; 
Bharadwaj et al., 2013)). 
Moreover, HPVs co-localize with tetraspanin CD151 and infection depends on the protein 
expression level as well as accessibility, as analyzed in RNAi experiments and antibody blocking 
assays, respectively (Spoden et al., 2008; Scheffer et al., 2013). CD151 is an integral membrane 
protein with four membrane-spanning domains (Hemler, 2005). Tetraspanins interact with other 
tetraspanins and other membrane proteins, like HSPGs, integrins, and GFRs, to form so-called 
tetraspanin-enriched microdomains (TEMs), which are involved in membrane 
compartmentalization and organization (Sterk et al., 2002; Hemler, 2003; Levy and Shoham, 
2005; Scheffer et al., 2014). Furthermore, CD151 is expressed in cervical tissues and involved in 
the formation of hemidesmosomal structures with the basement membrane in epithelial tissues 
(Scheffer et al., 2014; Sterk et al., 2000; Margadant et al., 2008). Due to these features, CD151 
may form an entry platform during HPV16 host cell entry (Scheffer et al., 2013; Raff et al., 2013).  
Due to the number and functions of the proposed receptor candidates, it was hypothesized that 
HPV entry occurs via interaction with an internalization receptor complex rather than a single 
receptor interaction (Raff et al., 2013; Scheffer et al., 2014). 
1.4.4 Internalization and signaling  
Early reports described endocytosis of different HPV types to occur by clathrin-mediated 
endocytosis or caveolar endocytosis (Smith et al., 2007; Day et al., 2003). Due to divergent results 
obtained with different virus particle preparations, the involvement of key factors in endocytosis 
has been systematically analyzed using small compound inhibitors, dominant-active and -negative 
mutants and RNAi (Schelhaas et al., 2012). In conclusion, HPV16 uses a novel endocytic 
pathway, which has similarities with macropinocytosis like the requirement of actin, H+/Na+-
exchangers, and specific kinases, but is distinct in other factors as well as its kinetics and 
phenotype. The novel pathway of HPV endocytosis is clathrin-, caveolin-, lipid raft-, and 
dynamin-independent but actin-dependent (Schelhaas et al., 2012). HPV particles are taken up 
into tight inward-budding membrane invaginations, which have a size of 65-120 nm and harbor 
mostly a single virus particle. Scission of these vesicles is likely mediated by actin polymerization 
(Schelhaas et al., 2012). 
To date, signaling pathways involved in HPV16 endocytosis are not clearly delineated. HPV16 
endocytosis depends on signaling by RTKs, EGFR, PLC, PI3K, and PAK1 (Schelhaas et al., 
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2012). Another study shows an early activation of focal adhesion kinase (FAK) upon HPV16 
binding (Abban and Meneses, 2010). In a previous study, rapid activation of PI3K signaling and 
its downstream effector AKT was connected to binding of different HPV types (Fothergill and 
McMillan, 2006). Downstream effects of AKT signaling were associated to an mTOR-mediated 
suppression of autophagy upon HPV16 infection, which may be the induction of a cellular 
mechanism to restrict infection (Surviladze et al., 2012). However, most of the described 
signaling pathways were activated rapidly after virus binding, which does not match with the 
prolonged and asynchronous internalization of HPV16 (Giroglou et al., 2001; Selinka et al., 2003; 
Buck et al., 2006; Smith et al., 2007; Selinka et al., 2007; Schelhaas et al., 2012; Cerqueira et al., 
2013). This suggests that initial virus binding induces a general activation of several signaling 
cascades for unknown functional reasons and may locally and asynchronously activate signaling, 
which allows for endocytic uptake (Day and Schelhaas, 2014). 
1.4.5 Endosomal trafficking and nuclear import 
After internalization, HPVs reside in endocytic vesicles and require acidification of endosomes 
for efficient infection (Selinka et al., 2002; Spoden et al., 2008; Schelhaas et al., 2012; Smith et al., 
2008; Day et al., 2003). Rab GTPases are involved in endosomal trafficking and are markers for 
different endosomal compartments (Zerial and McBride, 2001; Rink et al., 2005). HPV16 likely 
localizes to early endosomes (EE) as it co-localizes briefly with Rab5 in an early endosome or 
macropinosome-like organelle and depends on its function for infection (Schelhaas et al., 2012). 
However, no significant co-localization with the early endosomal antigen (EEA1) can be 
detected, which may be due to asynchronous internalization of virus particles and only very 
transient passage through this compartment (Schelhaas et al., 2012). Trafficking does not depend 
on late endosomes marked by Rab7 (Schelhaas et al., 2012; Day et al., 2013), which is a main 
regulator of endosomal maturation and of endosomal trafficking to late endosomes (LE) (Rink et 
al., 2005; Vonderheit and Helenius, 2005). This is surprising as virus particles end up in late 
endosomes or lysosomes as they co-localized with LAMP1 (Schelhaas et al., 2012; Day et al., 
2013; Smith et al., 2008). Thus, this suggests that the virus traffics to the LE by a non-canonical, 
Rab7-independent route.  
As mentioned above, the viral capsid is uncoated during trafficking to the late compartment. 
Separation of the L1 shell from the viral genomes and L2 (subviral complex) is mediated by 
cyclophilins to allow for its transport to the trans-Golgi network (Bienkowska-Haba et al., 2012; 
Day et al., 2013). Trafficking to the trans-Golgi has been suggested to occur by either 
Rab7b/Rab9 from the LE (Day et al., 2013) or by the retromer from the EE (Lipovsky et al., 
2013). According to our data, trafficking by Rab7b/Rab9 from the LE is more likely as co-
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localization data with LAMP1 is observed and LE are viable compartments for infection 
(Schelhaas et al., 2012).  
So far, it is still unknown how the subviral complex translocates into the cytosol. Sorting nexin 17 
(SNX17) interacts with L2 of several HPV types (Bergant and Banks, 2012). Sorting nexins 
mediate endosomal sorting of several cargos and thereby prevent their routing to degradative 
compartments (Day and Schelhaas, 2014; Gallon and Cullen, 2015). The HPV L2 protein has a 
central SNX17 interaction domain that may be involved in sorting by an unknown mechanism 
(Bergant Marušič et al., 2012). Moreover, L2 possesses a C-terminal membrane-penetration 
domain, which may insert into the limiting membrane and mediate efficient escape of the subviral 
complex into the cytosol (Kämper et al., 2006; Bronnimann et al., 2013). It has been recently 
proposed that HPVs enter the nucleus by a unique strategy, which relies on the transport of 
vesicles containing the subviral complex into the nucleus. This strategy requires membrane 
insertion of L2 (DiGiuseppe et al., 2016). 
Even though the membrane penetration step during HPV entry is unknown, it is clear that HPVs 
enter the nucleus during mitosis (Pyeon et al., 2009). Upon entry into mitosis, nuclear envelope 
breakdown (NEBD) occurs and allows for exchange of factors with the cytosol. The HPV 
subviral complex is imported after NEBD and associated to metaphase chromosomes (Aydin et 
al., 2014). Thereby, the viral genome automatically distributes into the daughter cells, where it is 
found together with L2 in nuclear bodies termed nuclear domain 10 (ND10) or promyelocytic 
leukemia protein (PML) nuclear bodies (Day et al., 2004). 
1.4.6 Internalization kinetics 
A unique feature of HPV endocytosis is that its internalization occurs over a protracted period of 
time in an asynchronous manner (Giroglou et al., 2001; Selinka et al., 2003; Buck et al., 2006; 
Smith et al., 2007; Selinka et al., 2007; Schelhaas et al., 2012; Cerqueira et al., 2013). Analyses of 
internalization kinetics have been performed with different virus types and particles and yielded 
different half times of infectious internalization. L1 or L1/L2 VLP of HPV33 or HPV16 have 
post attachment neutralization half times of 2-3 h (Selinka et al., 2003, 2007). In contrast, studies 
using HPV16 or HPV33 PsV or raft-derived HPV31 show longer half times of 7.5 h – 14 h for 
post attachment neutralization with heparin, neutralizing antibodies or carrageenan (Giroglou et 
al., 2001; Buck et al., 2006; Smith et al., 2007). However, neutralization experiments were 
performed with different neutralizing antibodies, which may act distinctly on virus particles and 
thereby cause variable neutralization times. Similar effects have been seen for HPV16 neutralizing 
antibodies H16.V5 and H16.U4, which exhibited different neutralizing effects on the virus (Day 
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et al., 2008a). Recent results rely on an experimental setup to determine internalization kinetics, 
scoring only infectiously internalized virus, as non-internalized virus particles were destabilized 
on the cell surface at different times (Schelhaas et al., 2012).  Experiments with HPV16 PsVs in 
HeLa or HaCaT cells corroborate slow internalization with half times of 10-12 h post binding 
(Schelhaas et al., 2012). Interestingly, infectious internalization of ECM-bound HPV16 PsVs is 
even slower than cell-bound virus with half times of 18 h (Cerqueira et al., 2013).  
To date, the underlying reason and function of the slow and asynchronous internalization 
behavior of HPV16 is still unknown. However, it may be due to the extended structural 
modifications of the virus capsid required upon binding. Alternatively or additionally, transfer of 
the rearranged virus to the internalization receptor may be limited and therefore slow down the 
internalization. Interestingly, infectious internalization exhibits a lag time of about 2 h (Schelhaas 
et al., 2012). Moreover, live cell imaging studies indicated that once virus particles are committed 
to endocytosis, the individual internalization events occur within seconds or minutes as for other 
endocytic mechanisms (Schelhaas et al., 2012). Therefore, it is reasonable to assume that the 
structural changes on the cell surface that prime the virus for secondary receptor engagement or 
that accessibility to the elusive secondary receptor are the underlying cause for the delay in 
internalization. 
  
 
Figure III Model of host cell entry of HPV16 
HPV16 host cell entry requires structural modifications upon binding to the cell surface or ECM. Endocytosis is 
mediated by an internalization receptor; intracellular trafficking occurs Rab5-dependent but Rab7 independently. The 
viral genome is accompanied by L2 and enters the nucleus upon nuclear envelope breakdown and co-localizes with 
ND10. Adapted from (Day and Schelhaas, 2014) 
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1.5 Model and Aims 
HPV16 host cell entry occurs by a novel endocytic pathway, which requires a unique set of 
cellular factors and shows extraordinarily slow internalization kinetics. Even though many of the 
steps during entry have been uncovered, the underlying reasons for the prolonged time the virus 
spends on the surface is still unknown. HPV entry begins with binding to HSPGs on the cell 
surface or to laminin-332 or HSPGs in the ECM. These primary interactions with HSPGs induce 
structural changes in the capsid, which finally lead to exposure and furin cleavage of the L2 N-
terminus. Terminally processed particles are then transferred to the internalization receptor 
complex and taken up by endocytosis. This structural processing involves several interactions 
with secreted cellular proteins. Each of these interactions may require its own processing time 
until a processing threshold for each particle is reached, which allows for infectious 
internalization. This would then result in an asynchronous uptake of processed virions. However, 
it is not clear whether all structural modification occur sequentially, how specific processing 
thresholds are defined and whether specific processing times are limited by the abundance of the 
secreted proteins.  
Due to the asynchronous internalization of HPVs, not much is known about interactions with 
the internalization receptor. Several receptor candidates have been put forward, however 
conclusive functions or functional connections were not dawn yet. Ligand binding to a receptor 
leads its internalization by a receptor-mediated endocytic pathway (Wileman et al., 1985). This 
implies that virus receptors target the virus into specific preexistent endocytic routes, which 
viruses have evolved to exploit. Hence, virus endocytosis can be used to identify and characterize 
preexistent endocytic pathways. Therefore, the identification of the HPV16 internalization 
receptor is essential to understand the cellular purpose of the HPV16 endocytic pathway. 
The aims of this study were 1) to establish the production and purification of raft-derived HPV16 
for future comparative studies, 2) to identify rate-limiting steps during structural processing and 
receptor interactions of HPV16 using structural variants, and 3) to analyze interaction of HPV16 
with secondary receptors. 
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Figure IV Structural changes after cell surface or ECM binding of HPV16 
HPV16 undergoes extensive structural modifications initiated by binding to heparin sulfate proteoglycans 
(HSPGs), and extended by L1 cleavage by kallikrein-8 (KLK8). The buried L2 N-terminus is exposed by 
cyclophilin activity and cleaved off by furin. Terminal restructured particles then interact with an internalization 
receptor and are taken up by a novel endocytic pathway. Modified from (Day and Schelhaas, 2014). 
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2 Materials and methods 
2.1 Material 
2.1.1 Cell lines 
Cell line Cell type Source Reference 
HaCaT human keratinocytes 
Dr. J.T. Schiller 
(NCI Bethesda, USA) 
(Boukamp, 1988) 
HeLa ATCC 
epithelial cells from 
cervical 
adenocarcinoma 
American Type Culture 
Collection (ATCC) 
(Scherer, 1953) 
HeLa Kyoto 
epithelia cells from 
cervical 
adenocarcinoma 
Dr. L. Pelkmans 
(ETH Zürich, Switzerland) 
(Landry et al., 2013) 
HEK293TT epithelial cells 
Dr. J.T. Schiller 
(NCI Bethesda, USA) 
(Buck et al., 2004) 
HEK293TTF 
epithelial cells 
overexpressing furin 
convertase 
Dr. R. Roden 
(JHU, Baltimore, USA) 
(Wang et al., 2014) 
HFK 
primary human 
foreskin keratinocytes 
Dr. C. Meyers 
(PSU, Hershey, USA) 
(McLaughlin-
Drubin and Meyers, 
2005) 
Chinese 
Hamster Ovary 
(CHO) cells 
ovary cells from 
chinese hamster 
Dr. JD Esko / Dr. Kay 
Grobe 
(WWU Münster, Germany) 
(Esko et al., 1985) 
pgsA-745 
xylosyltransferase-
deficient ovary cells 
from chinese hamster 
Dr. JD Esko / Dr. Kay 
Grobe 
(WWU Münster, Germany) 
(Esko et al., 1985) 
HPV16+ 114b 
WT3 
human keratinocytes 
transduced with 
HPV16 genome type 
114b 
Dr. C. Meyers 
(PSU, Hershey, USA) 
(McLaughlin-
Drubin and Meyers, 
2005) 
J2 3T3 mouse fibroblasts 
Dr. C. Meyers 
(PSU, Hershey, USA) 
(McLaughlin-
Drubin and Meyers, 
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Cell line Cell type Source Reference 
2005) 
CV1 
kidney epithelial cells 
from african green 
monkey 
Dr. J. Kartenbeck 
(DKFZ Heidelberg, 
Germany) 
(Pelkmans et al., 
2001) 
HeLa MK WT 
epithelial cells from 
cervical 
adenocarcinoma 
Dr. M. Kast 
(USC, Los Angeles, USA) 
(Woodham et al., 
2012) 
HeLa MK NT7 
epithelial cells from 
cervical 
adenocarcinoma with 
non-targeting shRNA, 
doxycycline inducible 
Dr. M. Kast 
(USC, Los Angeles, USA) 
HeLa MK 
Sh6/Sh11 
epithelial cells from 
cervical 
adenocarcinoma with 
ANXA2-targeting 
shRNA, doxycycline 
inducible 
Dr. M. Kast 
(USC, Los Angeles, USA) 
 
2.1.2 Growth media 
Cell line Growth medium 
HeLa ATCC/Kyoto, HaCaT, 
CV1 
DMEM high glucose, 10% FCS (Biochrom) 
293TT 
DMEM high glucose, 10% FCS (Biochrom), 400 mM 
hygromycin B 
293TTF 
DMEM high glucose, 10% FCS (Biochrom), 2.5 µg/ml 
Puromycin 
J2 3T3 Fibroblasts DMEM high glucose, 10% NCS (Life Technologies) 
HPV16+ 114b WT3 
keratinocytes 
E-Medium: 50% DMEM high glucose, 50% Ham’s F12, 
5% FCS supplemented with 5 µg/mL Insulin, 0.18 mM 
Adenine, 0.1 nM Choleratoxin, 5 µg/mL Transferrin, 0.02 
nM 3,3,5-triiodo-L-thyronine, 0.4 µg/mL Hydrocortisone, 
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Cell line Growth medium 
100 kU Nystatin, 100 kU Penicillin-Streptomycin 
CHO, pgsA Ham's F12, 1% L-glutamine, 10% FCS 
HeLa MK WT/NT7/Sh6/Sh11 
DMEM high glucose, 10% FCS (Biochrom), 2 µg/ml 
puromycin, doxycycline induction: 5 ng/mL for 7 days 
organotypic raft culture medium 
(HPV16 production) 
E-Medium + 10 µM 1,2-Dioctanoyl-sn-glycerol (C8) 
organotypic raft culture medium 
(primary keratinocytes) 
E-Medium + 5 µg/L EGF 
 
2.1.3 Specialized media 
Name Composition 
Freezing medium Growth medium with additional 10% FCS, 4% DMSO 
Infection medium for VSV RPMI, 30mM HEPES (pH 6.5) 
Infection medium for SV40 RPMI, 3%BSA, 10mM HEPES (pH 6.8) 
Imaging medium (live cell 
microscopy) 
DMEM without phenol red, 10% FCS, 1% Pen/Strep, 
1% Glutamine 
Mitomycin-treatment of J2 
fibroblasts 
DMEM high glucose + 10%NCS + 0.2 µg/mL 
mitomycin C 
Keratinocyte Growth Medium 2 with supplements (Promocell) 
 
2.1.4 Cell culture reagents 
Reagent Stock conc. Solvent Source 
Adenine 0.18 M sterile ddH2O 
Sigma-Aldrich 
(A8626) 
Brij-58 10% (w/V) HPV16 virion buffer 
Sigma-Aldrich 
(P5884) 
BSA 5 mg/mL sterile ddH2O VWR (62405-786) 
Choleratoxin 100 nM sterile ddH2O 
Sigma-Aldrich 
(C8052) 
1,2-Dioctanoyl-sn- 20 mM 100% EtOH Enzo Life Sciences 
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Reagent Stock conc. Solvent Source 
glycerol (C8) (BML-DG112-0020) 
DMEM high glucose -- -- 
Sigma-Aldrich 
(D5796) 
DMEM without 
phenol red for 
imaging 
-- -- 
Sigma-Aldrich 
(D1145) 
DMSO -- -- 
Sigma-Aldrich 
(D8418) 
Doxycycline 50 µg/mL PBS  
EDTA 0.5 M sterile ddH2O Roth (8043.4) 
EGF 100 µg/mL 
100 mM acetic acid, 
0.1% bovine serum 
albumin (BSA) 
Sigma-Aldrich 
(E9644) 
EGF (for E-Medium) 1 µg/mL 
in 10 mg/mL BSA in 
ddH2O, sterile filtered 
VWR (62405-786) 
EGTA -- -- Roth (3054.2) 
Fetal Calf Serum 
(FCS) 
-- -- Biochrom (50615) 
GMEM -- -- 
Invitrogen 
(11710-035) 
Heparin sodium salt 50 mg/mL 
PBS + 10 mM 
HEPES (pH 7.4) 
Sigma-Aldrich 
(H4784) 
HEPES -- -- Roth (9105.4) 
Hydrocortisone 0.4 mg/mL 
EtOH/1 M HEPES 
(pH 7.0) 
Sigma-Aldrich 
(H0888) 
Insulin 5 mg/mL sterile ddH2O Sigma-Aldrich (I1882) 
L-Glutamine 200 mM 0.9% NaCl PAA (M11-006) 
Lipofectamine2000 -- -- 
Life Technologies 
(11668019) 
Lipofectamine 
RNAiMAX 
-- -- 
Life Technologies 
(13778150) 
Mitomycin C 0.4 mg/mL PBS 
Enzo Life Sciences 
(BML-GR311) 
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Reagent Stock conc. Solvent Source 
Newborn Calf Serum 
(NCS) 
-- -- 
Life Technologies 
(16010-159) 
Nystatin 100x (10 000 U/mL) n.a.  
OptiMEM -- -- Invitrogen (11058-21) 
OptiPrep 60% -- 
Sigma-Aldrich 
(D1556) 
Penicillin/Streptomyc
in 
100x (10 000 U/ml) 0.9% NaCl PAA (P11-010) 
Puromycin 
  
Gibco (A11138-02) 
Rat tail type 1 
collagen 
5 mg/mL -- 
Enzo Life Sciences 
(ALX-522-435-0100) 
RPMI -- -- PAA (E15-039) 
Transferrin 5 mg/mL PBS 
Sigma-Aldrich 
(T1147) 
3,3,5-Triiodo-L-
thyronine (T3) 
20 nM 0.1 M NaOH/PBS Sigma (T6397) 
Trypsin/EDTA 0.5 g/L; 0.2 g/L -- 
Sigma-Aldrich 
(T3924) 
 
2.1.5 Plasmids 
Plasmid Reference 
pEGFP-CD151 G. Spoden/Dr. L. Florin (University Mainz) 
pEGFR-YFP (Klingner et al., 2014) 
p16sheLL (Buck et al., 2006) 
pClneo-EGFP (Buck and Thompson, 2007) 
pBSHPV16(114/B) (Kirnbauer et al., 1993) 
 
2.1.6 siRNA 
All siRNAs were used in with a concentration of 10 nM. Control siRNAs used were from 
Qiagen: GFP siRNA (SI04380467); Allstars Hs Cell Death Control siRNA (SI04381048), and 
Allstars Negative Control siRNA (SI03650318). 
  
34 Materials and methods 
Product name 
(Qiagen) 
NCBI gene symbol siRNA target sequence 
Hs_ANXA2_10 ANXA2 CACGGCCTGAGCGTCCAGAAA 
Hs_ANXA2_2 ANXA2 AAGTGTCGCTATTTAAGTTAA 
Hs_ANXA2_4 ANXA2 CTGGGACTGAGCTGTACAGTA 
Hs_CD151_2 CD151 CACCCTGTGCCATCACCATAA 
Hs_CD151_5 CD151 CACATACAGGTGCTCAATAAA 
Hs_CD151_6 CD151 CTGCCACATACAGGTGCTCAA 
Hs_DSC3_5 DSC3 AAGCGCCATTTGCTAGAGATA 
Hs_DSC3_6 DSC3 CAGAAGCACCTGGAGACGATA 
Hs_DSC3_7 DSC3 ACCATCCTTCAGCGTGAATTA 
Hs_DSG1_2 DSG1 ACCGAACAATTTGAACTCAAA 
Hs_DSG1_3 DSG1 CGGAATGTGAGTGCAACATTA 
Hs_DSG1_4 DSG1 CCCGTTGTTAGTGGACACCCA 
Hs_DSG3_5 DSG3 GACAGCGGTTATGGGATTGAA 
Hs_DSG3_6 DSG3 AACCACTTATACTAACGGTTA 
Hs_DSG3_7 DSG3 AACCGAGATTCTACTTTCATA 
Hs_EGFR_10 EGFR TACGAATATTAAACACTTCAA 
Hs_EGFR_11 EGFR ATAGGTATTGGTGAATTTAAA 
Hs_EGFR_12 EGFR CAGGAACTGGATATTCTGAAA 
Hs_ERBB2_14 ERBB2 AACAAAGAAATCTTAGACGAA 
Hs_ERBB2_15 ERBB2 CACGTTTGAGTCCATGCCCAA 
Hs_ERBB2_9 ERBB2 AAGTGTGCACCGGCACAGACA 
Hs_ERBB3_5 ERBB3 ACCACGGTATCTGGTCATAAA 
Hs_ERBB3_6 ERBB3 CTTCGTCATGTTGAACTATAA 
Hs_ERBB3_7 ERBB3 CCCAGTGAGAAGGCTAACAAA 
Hs_ERBB4_1 ERBB4 CCAGAACAAATTCCTTTGTTA 
Hs_ERBB4_5 ERBB4 CTACGTGTTAGTGGCTCTTAA 
Hs_ERBB4_6 ERBB4 TCGGGATTTGGCAGCCCGTAA 
Hs_FGFR2_12 FGFR2 CCCATCTGACAAGGGAAATTA 
Hs_FGFR2_13 FGFR2 CAGAATGGATAAGCCAGCCAA 
Hs_FGFR2_7 FGFR2 CAGCATATGTGTAAAGATTTA 
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Product name 
(Qiagen) 
NCBI gene symbol siRNA target sequence 
Hs_ITGA6_1 ITGA6 CACGCGGATCGAGTTTGATAA 
Hs_ITGA6_6 ITGA6 CAGGGTAATAAACTTAGGTAA 
Hs_ITGA6_7 ITGA6 CCGGCCTGTGATTAATATTCA 
Hs_S100A10_10 S100A10 CAGGACGGCCGGGTTCTTTGA 
Hs_S100A10_6 S100A10 CACCATTGCATGCAATGACTA 
Hs_S100A10_7 S100A10 CAGGACACTTAGCAAATGTAA 
 
2.1.7 Virus production and labeling reagents 
Reagent Source 
Alexa Fluor (AF) 488 / 594 / 647 carboxylic acid, succinimidyl 
ester 
Molecular Probes 
benzonase Roche 
illustra NAP-5 columns GE Healthcare 
Optiprep density gradient medium Sigma 
pHrodo Red, succinimidyl ester Molecular Probes 
plasmid safe DNase Epicentre Biotechnologies 
 
2.1.8 Virus stocks 
Virus Amount used for infection Reference 
FPC-HPV16-GFP 2.5-15 ng (Wang et al., 2014) 
HPV16-dsRed 10-30 ng (Buck et al., 2004) 
HPV16-GFP 2.5-15 ng (Buck et al., 2004) 
Raft-derived HPV16 MOI 5-15 
(McLaughlin-Drubin et al., 2004; 
Biryukov et al., 2015) 
Simian Virus 40 (SV40) MOI 10-40 (Pelkmans et al., 2001) 
VSV-GFP (Indiana) MOI 10 (Johannsdottir et al., 2009) 
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2.1.9 Inhibitors 
Inhibitor Target Solvent Stock conc. Source Reference 
aphidicolin 
DNA 
polymerase 
A+D 
DMSO 3 mM 
Sigma-Aldrich 
(A0781) 
(Spadari et 
al., 1982) 
cyclosporine A cyclophilins DMSO 50 mg/mL 
Calbiochem 
(239835) 
(Handschu
macher et 
al., 1984) 
cytochalasin D 
F-actin 
polymers 
DMSO 5 ng/ml 
Sigma-Aldrich 
(c8273) 
(Brown and 
Spudich, 
1979) 
dynasore dynamin 1/2 DMSO 10 mM 
Merck 
(324410) 
(Macia et 
al., 2006) 
EIPA 
Na+/H+ 
antiporters 
DMSO 50 µM 
Sigma-Aldrich 
(A3085) 
(L’Allemain 
et al., 1984) 
iressa EGFR DMSO 50 mM 
Tocris 
bioscience 
(1407) 
 (Ciardiello 
et al., 2000) 
jasplakinolide 
actin 
monomers 
DMSO 100 µM 
Calbiochem 
(420107) 
(Holzinger, 
2009) 
nilotinib bcr-Abl DMSO 50 mM 
LC laboratories 
(N-8207) 
(Weisberg 
et al., 2005) 
nystatin cholesterol  DMSO 5 mg/mL 
Sigma-Aldrich 
(N4014-50MG) 
(Holz, 
1974) 
progesterone cholesterol DMSO 5 mg/mL 
Sigma-Aldrich 
(P0130-25g) 
(Metherall 
et al., 1996) 
 
2.1.10 Antibodies 
2.1.10.1 Primary antibodies 
Antibody 
WB 
dilution 
IF 
dilution 
Neutraliz
ation  
Species Source 
CD151 (11G5a) -- 1:100/300 -- mouse AbD Serotec (MCA1856) 
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Antibody 
WB 
dilution 
IF 
dilution 
Neutraliz
ation  
Species Source 
AnxA2 (H47) 1:1000 -- -- mouse 
Prof. V. Gerke, IMB, 
ZMBE, Münster 
EGFR 1:1500 -- -- rabbit 
Cell Signaling Technology 
(#2232) 
Camvir-1 1:5000 1:200 -- mouse 
Santa Cruz 
Biotechnologies (sc-47699) 
PAB1605 -- 1:1000 -- mouse ETH Zürich 
Lam332 -- 1:500  rabbit Abcam (ab14509) 
α-tubulin 1:2500 -- -- mouse Sigma-Aldrich (T5168) 
H16.V5 -- -- 1:50000 mouse 
N. Christensen (PSU, 
Hershey, PA, USA) 
H16.U4 -- -- 1:500 mouse 
N. Christensen (PSU, 
Hershey, PA, USA) 
RG1 1:1000 -- 1:2500 mouse 
R. Roden (JHU, Baltimore, 
USA) 
K10 -- 1:1000 -- rabbit Covance (PRB-159P) 
K14 -- 1:2000 -- rabbit Covance (PRB-155P) 
Loricrin -- 1:1000 -- rabbit Covance (PRB-145P) 
S100A10  
(H21 03/13) 
1:125 -- -- mouse 
Prof. V. Gerke, IMB, 
ZMBE, Münster 
 
2.1.10.2 Secondary antibodies 
Antibody Dilution Species Source 
Alexa Fluor (AF) anti-
mouse IgG 
(488/594/647/700) 
1:2000/1:1500 
(IF/STORM) 
goat 
Molecular Probes (A-11029 / A-
11032 / A-21235 / A-21036) 
Alexa Fluor anti-rabbit 
IgG (488/594/647) 
1:2000 (IF) goat 
Molecular Probes (A11034 / A-11037 
/ A-21244) 
ECL anti-goat IgG 1:1000 (WB) donkey Santa Cruz Biotechnolgies (sc-2020) 
ECL anti-mouse IgG 1:5000 (WB) sheep 
GE Healthcare / Amersham 
(NA931) 
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Antibody Dilution Species Source 
ECL anti-rabbit IgG 1:1000 (WB) donkey GE Healthcare / Amerham (NA934) 
 
2.1.11 Primer 
Name Sequence Reference 
HPV16 E2 5’ 5’-ccatatagactattggaaacacatgcgcc-3’ 
(Conway et al., 
2009a) 
HPV16 E2 3’ 5’-cgttagttgcagttcaattgcttgtaatgc-3’ 
HPV16 E1^E4 5’ 5’-gctgatcctgcaagcaacgaagtatc-3’ 
HPV16 E1^E4 3’ 5’-ttcttcggtgcccaaggc-3’ 
TBP 5’ 5’-cacggcactgattttcagttct-3’ 
TBP 3’ 5’-ttcttgctgccagtctggact-3’ 
HPV16 E1^E4 probe 5’-6FAM-cccgccgcgacccataccaaagcc-BHQ1-3’ 
TBP Probe 5’-HEX-tgtgcacaggagccaagagtgaaga-BHQ1-3’ 
 
2.1.12 qRT-PCR kits 
Name Propose Source 
RNeasy Mini Kit RNA extraction Qiagen (74104) 
DNA clean&concentrator-5 DNA extraction/HPV genome extraction 
Zymo Research 
(D1014) 
QuantiTect Probe RT-PCR Kit 
Reverse transcription qPCR for detection 
of raft-derived HPV16 infection 
Qiagen (204443) 
Brilliant III Ultra-Fast SYBR 
Green QPCR Master Mix 
Virus titer raft-derived HPV16  
Agilent 
Technologies 
(600882) 
 
2.1.13 Staining reagents 
Name Source 
Atto 488-phalloidin Sigma-Aldrich (49409) 
Atto 647N-phalloidin Sigma-Aldrich (65906) 
Hoechst 33258, pentahydrate (bis-benzimide) Invitrogen (H3569) 
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Name Source 
phalloidin-tetramethylrhodamine B 
isothiocyanate (TRITC) 
Sigma-Aldrich (P1951) 
Red Dot 2 VWR/Biotium (BTIU-40061-1) 
 
2.1.14 Buffers and solutions 
Cell culture 
Name Composition 
CAPS buffer, high pH 0.1 mM CAPS in ddH2O, pH 10.5 
phosphate buffered saline 
1x (PBS) 
137 mM NaCl, 2.7 mM KCl, 9 mM Na2HPO4, 1.46 mM 
KH2PO4, pH 7.4 
HPV16 virion buffer 
1x PBS supplemented with 635 mM NaCl, 0.9 mM CaCl2, 0.5 mM 
MgCl2, 2.1 mM KCl 
 
Immunofluorescence and FACS buffers 
Name Composition 
Blocking solution 1-5% BSA dissolved in 1x PBS 
FACS buffer 
2% Fetal bovine serum (FBS), 20 mM EDTA, 0.02% NaN3 in 
PBS 
FACS perm FACS buffer + 0.1% saponin 
PHEM buffer 
60 mM PIPES, 10 mM EGTA, 2 mM MgCl2, 25 mM HEPES pH 
6.9 
Permabilization solution 10% (V/V) TritonX-100 in ddH2O 
STORM imaging buffer 
(Daniel Böning, PhD 
Thesis) 
500 mM PIPES (pH 7.1), 80% glucose, 2 mM EDTA, 0.8 mg/mL 
glucose oxidase, 0,08 mg/mL katalase, 150 mM 
mercaptoethylamine, 2 mM cyclooctatetraene 
 
Preparation of HPV16 and FPC-HPV16 pseudovirions 
Name Composition 
PBS/MgCl2 PBS (1x) supplemented with 9.5 mM MgCl2 
  
40 Materials and methods 
Name Composition 
HPV16 virion buffer 
PBS (1x) supplemented with 635 mM NaCl, 0.9 mM CaCl2, 0.5 
mM MgCl2, 2.1 mM KCl 
10% Brij-58 
10% (w/V) Brij-58 dissolved in HPV16 virion buffer, sterile 
filtered 
46% OptiPrep 
77% OptiPrep (60%), 10% PBS (10x), 12,5% 5 M NaCl, 0.045% 2 
M CaCl2, 0.025% 2 M MgCl2, 0.21 % 1 M KCl 
Furin convertase  
50 U, human, recombinant (ALX-201-002-U050, Enzo Life 
Sciences) 
 
Raft-derived HPV preparation 
Name Composition 
Reconstitution buffer, 10x 
2.2 g NaHCO3 and 4.77 g HEPES in 0.062 M NaOH (0.26 mM 
NaHCO3, 0.2 mM HEPES) 
DMEM, 10x 
Resuspend 10-fold amount of DMEM powder in 100 mL sterile 
ddH2O 
Homogenization buffer 0.05 M sodium phosphate buffer, pH 8.0 
HIRT DNA extraction 
buffer 
400 mM NaCl, 10 mM Tris-HCl pH 7.4, 10 mM EDTA, pH 8.0 
1 M MgCl2 in ddH2O, sterile filtered 
10 M NaOH in ddH2O, sterile filtered 
5 M NaCl in ddH2O, sterile filtered 
 
SDS-PAGE, Western Blotting and Coomassie staining 
Name Composition 
Blocking buffer (TBS-
TMP) 
TBS-T with 5% (w/V) non-fat milk powder 
Coomassie Brilliant Blue 
destaining solution 
30% methanol, 10% acetic acid in ddH2O 
Coomassie Brilliant Blue 
staining solution 
0.25% Coomassie Brilliant blue R-250, 45% methanol, 10% acetic 
acid in ddH2O 
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Name Composition 
Laemmlie SDS-PAGE 
running buffer 
0.1% SDS, 25 mM Tris,192 mM glycine 
SDS sample buffer, 5x 
10% SDS, 50% glycerol, 0.025% bromophenol blue, 250 mM Tris-
HCl pH 6.8 
Tris-buffered saline, 1x 
(TBS) 
150 mM NaCl, 50 mM Tris pH 7.5 
TBS-T TBS, 1x with 0.2% (V/V) Tween-20 
Transfer Buffer, 1x 192 mM glycine, 25 mM Tris, 10% or 20% Methanol 
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2.2 Methods 
2.2.1 Cell culture methods 
2.2.1.1 Cell line maintenance 
In general, cells were grown and expanded in 100 mm cell culture dishes in 10 mL of the 
appropriate growth medium as indicated in the materials section (2.1.2) at 37°C and 5% CO2. 
Cells were passaged twice per week when 80-95% confluence was reached. Cells were washed 
with 10 mL PBS, then incubated with 2 mL trypsin/EDTA solution for 5 min at 37°C and 
resuspended with 8 mL culture medium. Detached cells were distributed to new cell culture 
dishes. 
2.2.1.2 Freezing cell lines 
For long-term preservation, cells at a confluence of about 80% were passaged 1:3 the day before 
freezing to keep them in an exponential growth phase. Cells were incubated with 2 mL 
trypsin/EDTA for 5 min at 37°C until all cells were detached. The reaction was stopped with 8 
mL DMEM with 10% FCS, cell suspension was transferred into a 15 mL conical tube and cells 
were sedimented by differential centrifugation at 200 rcf for 5 min. Cells were resuspended in 1 
mL freezing medium, transferred into cryotubes and stored in a freezing container (Mr. Frosty, 
Nalgene, #5100-0001) at -80°C overnight prior to transfer to the liquid nitrogen storage. 
2.2.1.3 Thawing cell lines 
Cell were thawed in 100 mm cell culture dishes with 10 mL prewarmed DMEM + 20% FCS. To 
remove DMSO and dead cells, medium was exchange at 4-6 h post thawing when cells were 
found attached to the dish. 
2.2.1.4 DNA transfection 
Transient expression of genes of interest is achieved by transfection of expression plasmids with 
lipid-based transfection reagents. In general, 5x104 cells were seeded per well of a 12-well plate 
16-24 h prior to transfection. Per well 100 µL transfection mixture was prepared. For this 0.5 µL 
Lipofectamin2000 was added to 50 µL OptiMEM in one tube and of 0.5-1 µg DNA to 50 µL 
OptiMEM in a second tube. Lipofectamin mixture and DNA mixture were incubated separately 
at room temperature for 5 min before the DNA mixture was added to the Lipofectamin mixture. 
Transfection mixture was incubated for further 5 min at room temperature. Before addition to 
the cells, medium in each well was exchanged to 500 µL fresh growth medium. 100 µL 
transfection mixture was added dropwise to each well. To ensure expression of the transfected 
gene, cells were incubated for 12-24 h before used for further experiments.  
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2.2.1.5 RNAi transfection 
Transient knock downs of proteins of interest are mediated by transfection of siRNAs with lipid-
based transfection reagents.  
For transfections with 10 nM siRNA in 96-well plates, siRNAs were diluted to 67 nM in 96-
deepwell plates. Three siRNAs per target protein were prepared as 10 µM siRNA stocks on a 96-
well plate. For the dilution plate, 298 µL OptiMEM was added to each well of the deepwell plate 
before 2 µL of each siRNA stock was added to each well. Dilution plates were stored at -80°C 
and before thawed at 4°C for several hours before use. 
siRNA transfections in 96-well plates were performed as reverse transfection. To avoid plate 
effects, the outermost wells of each plate were filled with 100 µL PBS and not used for 
experimentation. Per well of the 96-well, 15 µL of OptiMEM containing 0.2 µL Lipofectamin 
RNAiMax were prepared in reaction tubes and incubated for 5 min at room temperature. After 
incubation, the Lipofectamin mixture was placed into the wells of the optical bottom 96-well 
plate and 15 µL siRNA from the dilution plate was added to each well. Next, HeLa Kyoto cells 
were detached, counted and diluted to a cell suspension containing 2000 cells per 70 µL growth 
medium. After 20 min of incubation of siRNA with Lipofectamin RNAiMax, 70 µL cell 
suspension was added to each well yielding a final siRNA concentration of 10 nM per well. Plates 
were incubated at 37°C, 5% CO2 for 48h before infection experiments with HPV16. 
2.2.2 Virus production and labelling 
2.2.2.1 HPV16 pseudovirion production 
Production of HPV16 pseudovirions containing reporter plasmids was performed as previously 
described by Buck et al.(Buck et al., 2005b, 2004) In brief, 1.4x107 HEK293TT producer cells 
were seeded on two 145 mm cell culture plates and each transfected with Lipofectamin2000 and 
30 µg of the plasmids p16sheLL and pClneo-EGFP. 48 h post transfection cells were harvested, 
sedimented and resuspended in PBS with 9.5 mM MgCl2 for virion maturation in presence of 
0.35% Brij-58, 25 mM Ammonium sulfate (pH 9), 0.2% Benzonase and 0.2% Plasmid-safe 
DNase. After maturation for 24 h at 37°C under overhead rotation, virus particles were purified 
via ultracentrifugation on a linear 25% - 39% OptiPrep gradient for 5h at 48000 rpm at 16°C in a 
SW60Ti rotor. The virus was recovered in 250 µL fractions from bottom to top and analysed for 
virus content by SDS-PAGE with a 10% polyacrylamide gel and subsequent coomassie staining. 
Virus-containing fractions were pooled and frozen at -80°C for long-term storage. 
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2.2.2.2 Furin-precleaved HPV16 pseudovirion production 
Production of furin-precleaved HPV16 pseudovirions containing an EGFP reporter plasmid was 
performed as previously described by (Wang et al., 2014). In brief, 1.4x107 HEK293TTF 
producer cells were seeded on two 145 mm cell culture plates and each transfected with 
Lipofectamin2000 and 30 µg of the plasmids p16sheLL and pClneo-EGFP. 48 h post 
transfection cells were harvested, sedimented and resuspended in PBS with 9.5 mM MgCl2 for 
furin cleavage and maturation. The cell lysate was incubated in presence of 0.35% Brij-58, 10 mM 
HEPES (pH 7.6), 2 mM CaCl2, 0.2% Benzonase and 0.2% Plasmid-safe DNase for 24 h at 37°C. 
After the first 24 h of maturation, 25 mM ammonium sulfate (pH 9.0) was added for further 24 h 
at 37°C under overhead rotation. Alternatively, FPC-HPV16 were produced in 293TT cells 
followed by addition of exogenous furin (10 U) prior to maturation of virus for 48 h as described 
(Day et al., 2008b). After 48h of maturation, virus particles were purified via ultracentrifugation 
on a linear 25% - 39% OptiPrep gradient for 5h at 48000 rpm at 16°C in a SW60Ti rotor. The 
linear gradient was prepared by rotation of 25% OptiPrep underlayed with 39% OptiPrep on the 
Gradient Master (Biocomp Instruments) for 1:50 min at an angle of 88° and 10 rpm. The virus 
was recovered in 250 µL fractions from bottom to top and analyzed for virus content by SDS-
PAGE and coomassie staining. Virus-containing fractions were pooled and frozen at -80°C for 
long-term storage. 
2.2.2.3 Labeling of HPV16 pseudovirions with AF dyes 
For visualization of single virus particles in microscopy-based experiments, HPV16 and FPC-
HPV16 particles were labeled with alexa fluor dyes as previously described (Schelhaas et al., 2008; 
Ewers and Schelhaas, 2012). Virus particles were diluted with virion buffer to 500 µL 0.5 mg/mL 
virus suspension and then supplemented with a 10-fold access over L1 amount of alexa fluor 
succimidyl ester. The virus-dye suspension was incubated for 1 h at room temperature on an 
overhead rotator. For purification, NAP-5 size exclusion columns (GE Healthcare) were first 
equilibrated with five column volumes virion buffer. Virus-dye suspension was loaded onto the 
column and flow-through was discarded. Virus particles were eluted in two fractions by first 
addition of 500 µL virion buffer and subsequent addition of 250 µL virion buffer for elution of 
the second fraction. Both fractions were tested for free dye by life microscopy and aliquots were 
frozen at -80°C. 
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2.2.3 Raft-derived HPV16 production 
2.2.3.1 Co-culture of J2 fibroblasts and HPV16-transduced keratinocytes 
J2 3T3 fibroblasts were grown in DMEM + 10% NCS until 95% confluence. Before thawing 
HPV16 114b WT3 keratinocytes, J2 fibroblasts were treated with 0.2 µg/mL mitomycin C in 5 
mL DMEM + 10% NCS for 1-2 h at 37°C, then washed once with DMEM + 10% NCS. 
Growth medium on J2 fibroblasts was exchanged to E-Medium, HPV16 114b WT3 
keratinocytes were added to the plate. Medium was exchanged after 5-6h. Mitomycin C-treated 
fibroblast can also be kept in DMEM + 10% NCS until next day.  
2.2.3.2 Organotypic raft culture 
Differentiating organotypic raft tissues were grown on a collagen-fibroblast-matrix at the air-
liquid interface supported by a metal grid. Raft-derived HPV16 particles were produced in 20-day 
differentiating organotypic raft cultures as described previously (McLaughlin-Drubin and Meyers, 
2005; McLaughlin-Drubin et al., 2004; Biryukov et al., 2015). 
To set up collagen-fibroblast matrix plugs, 6.25x105 J2 fibroblasts per plug were sedimented for 6 
min at 200 rcf and resuspended in 250 µL precooled 10x reconstitution buffer and kept on ice. 
Next, 250 µL precooled 10x DMEM was added and cell suspension was inverted five times. 
Finally, 2 mL rat tail collagen type 1 (5 mg/mL) was added to the cell suspension. The viscous 
suspension was mixed by careful pipetting to avoid formation of bubbles and kept on ice at all 
times to prevent polymerization. Polymerization was induced by addition of 6 µL 10 M NaOH 
(per 2.5 mL suspension), suspension was mixed by inversion and 2.5 mL collagen-fibroblasts 
suspension was transferred into each well of a 6-well plate. Plugs were left to solidify for 3-4 h at 
37°C. Before keratinocytes were added onto the collagen-fibroblast-matrix, the plugs were 
equilibrated by addition of 2 mL E-medium for at least 15 min. Meanwhile, HPV16 114b WT3 
keratinocytes were washed thoroughly with PBS to remove loosely attached J2 fibroblasts from 
the co-culture plates. When exclusively keratinocytes were left on the plates, cells were detached 
with trypsin, counted and sedimented. About 1x106 keratinocytes were resuspended in 1 mL E-
Medium, added onto one collagen-fibroblast plug and left for attachment over night at 37°C. The 
next day, medium was removed and collagen plugs were lifted onto the metal support grids in 
100 mm plates. E-Medium supplemented with 10 µM 1,2-Dioctanoyl-sn-glycerol (C8) was added 
beneath the support grids to prevent covering the upper surface of the raft tissues. Medium was 
exchanged every other day until raft tissues were harvested after 20 days in culture. Tissues were 
either used for immediate virus extraction or stored in low-binding tubes at -80°C or fixed for 
preparation of tissue sections. 
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For organotypic raft tissues with primary keratinocytes, keratinocytes were thawed in 
Keratinocyte Growth Medium 2 (Promocell). Collagen-fibroblast plugs were prepared as 
described above. After equilibration of the solidified plug with E-Medium + 5 µg/L EGF, 
primary keratinocytes were detached, counted, sedimented and 2x106 cells were resuspended in 1 
mL of E-Medium/EGF and added to the collagen-fibroblast matrix. Cells were left at 37°C for 4 
h for attachment; afterwards plugs were directly lifted onto metal support grids. Primary raft 
tissues were grown for 15 days with medium exchange every second day. Tissues were fixed and 
used for tissue sectioning. 
2.2.3.3 Virus extraction and virus titer determination 
Two HPV16-positive organotypic raft tissues were transferred into a glass homogenizer and 
supplemented with 500 µL homogenization buffer. Tissues were homogenized until no tissue 
fragments were visible anymore. Pistil and homogenizer were rinsed with further 250 µL 
homogenization buffer, before the suspension was transferred into a low-binding reaction tube. 
To remove non-encapsidated genomes from the preparation, 1.5 µL benzonase and 1.5 µL 1 M 
MgCl2 were added to the homogenate and the reaction was incubated for 1 h at 37°C on a 
rocking heat block. Afterwards, the salt concentration was adjusted by addition of 195 µL 5 M 
NaCl and the suspension was briefly vortexed. Remaining cellular debris was removed by 
differential centrifugation at 10500 x g at 4°C for 10 min. The supernatant contained the 
extracted virus particles and was taken off carefully. The virus preparation was stored at -20°C 
for short-term use or at -80°C for long-term storage.  
For each preparation virus titers were determined. Encapsidated genomes were extracted and 
subsequently quantified by qPCR. For genomes extractions, 10 µL of virus preparation were 
diluted in 176 µL HIRT buffer and supplemented with 4 µL proteinase K (10 mg/mL) and 10 µL 
10% SDS. The reaction mixture was incubated at 37°C for 2 h on a rocking heat block. Genomes 
were extracted from the lysates with the Clean&Concentrator-5 Kit (Zymo Research) according 
to the manufacturer’s protocol and eluted in 20 µL TE-buffer.  
Extracted genomes were quantified by quantitative real-time PCR. For a genome standard curve, 
the plasmid pBSHPV16(114b) was serially diluted to concentrations of 104-108 genomes per µL. 
qRT-PCR analysis was conducted using the Brilliant III Ultra-Fast SYBR QPCR Master Mix 
(Agilent Technologies #600882). The reaction master mix contained 12.5 µL SYBR green Mix, 
10.125 µL ddH2O, 0.75 µL of each 3’/5’ E2 primer (10 µM), and 0.375 µL ROX reference dye 
(1:500) per reaction. 1 µL of each DNA sample was added to 24 µL qPCR master mix on a 96-
well qPCR plate. The amplification program was run on a Stratagene Stratagene MX3005P PCR 
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cycler with the following thermal profile: hot-start 95°C, 15 min; 40 cycles: denaturation 94°C, 15 
sec; annealing 52°C, 30 sec; and elongation 72°C, 30 sec. Threshold cycle values (C(t) values) 
from this analysis were related to the plasmid genome standard curve and therefore provided the 
virus titer in genomes/µL preparation. 
2.2.3.4 Infection and detection of viral transcripts with qRT-PCR 
For infections with raft-derived HPV16 7.5x104 HaCaT or HeLa ATCC cells were seeded in 24-
well plates 24 h prior to infection. Typically, infections experiments were performed by addition 
MOI 7-10 raft-derived HPV16 to cells supplemented with 500 µL fresh growth medium. 
Medium was exchanged after 24 h and RNA was extracted 48 h post infection.  
As raft-derived HPV16 does not contain any reporter gene plasmid, infection was measured by 
quantification of the expression of the early viral splice transcript E1^E4 from the viral genome 
by quantitative reverse transcription PCR. RNAs were extracted with the RNeasy Plus extraction 
kit (Qiagen). Cells were washed once with PBS, then 350 µL RLT buffer was added directly into 
each well. Cells were incubated for 5 min. Cell lysates were added to reaction tubes containing 
200 µL 100% ethanol. Tubes were closed tightly and vortexed for 10 sec at maximum speed. Cell 
lysates were transferred into provided spin columns and spun for 1 min at 14000 rpm. Columns 
were washed with once RW1 buffer and twice with RPE buffer. After residual ethanol was 
removed, RNA was eluted with 50 µL ddH2O into fresh tubes. RNA samples were used 
immediately or frozen at -20°C. 
Extracted RNA was used in quantitative reverse transcription PCR. PCR analysis was conducted 
using the QuantiTect Probe RT-PCR Kit (Qiagen, #204443). Each sample was analyzed for two 
target RNAs: the viral E1^E4 transcript mRNA and the cellular control Tata-box Binding 
Protein (TBP) mRNA. The reaction master mix for E1^E4 contained 12.5 µL Master Mix, 7.25 
µL ddH2O, 0.5 µL FAM E1^E4 probe, 1 µL of each 3’/5’ E1^E4 primer (100 µM), and 0.25 µL 
RT-mix per reaction. The reaction master mix for TBP contained 12.5 µL Master Mix, 9 µL 
ddH2O, 0.5 µL HEX TBP probe, 0.125 µL of each 3’/5’ TBP primer (10 µM), and 0.25 µL RT-
mix per reaction. 2.5 µL of RNA samples was added to 22.5 µL master mix on a 96-well qPCR 
plate. The replication program was run on a Stratagene MX3005P PCR cycler with the following 
thermal profile: reverse transcription 50°C, 30 min; denaturation 95°C, 15 min; 42 cycles: 
denaturation 94°C, 15 sec; annealing/elongation 54.5°C, 1 min. Threshold cycle values (C(t) 
values) from this analysis were related to the cellular control mRNA as well as to a control 
infection with a previous virus preparation using the ΔΔC(t) method. 
  
48 Materials and methods 
2.2.3.5 Purification of raft-derived HPV16 particles 
To remove cellular material from crude raft-derived HPV16 preparations, cleared homogenates 
were separated on an OptiPrep step-gradient with 27%, 33% and 42% cushions (top to bottom). 
Separation was performed by ultracentrifugation at 48000 rpm at 16°C for 10 h in the SW60Ti 
rotor. After centrifugation, fractions were recovered from bottom to top in 250 or 500 µL steps 
using a peristaltic pump. HPV16 content of each fraction was determined by genome extraction 
and qPCR as described above (2.2.3.3). SDS-PAGE and subsequent coomassie brilliant blue 
staining was used to determine the amounts of cellular material within the fraction. Fractions 
with high HPV16 genomes to cellular material ratio were pooled, frozen in liquid nitrogen and 
stored at -80°C until further use. 
2.2.4 Infection assays and small molecule inhibitor treatments 
2.2.4.1 Standard HPV16/FPC-HPV16 infection 
About 5x104 HeLa or HaCaT cells were seeded 16 h prior to infection in each well of a 12-well 
plate. Prior to virus addition growth medium as removed and replace with 300 µL fresh growth 
medium. HPV16 or FPC-HPV16 PsVs were directly added to the growth medium and incubated 
for 2 h on a rocking platform at 37°C. At 2 h post infection, virus inoculum was removed and 
replaced by 500 µL fresh growth medium. Infected cells were fixed and analyzed by flow 
cytometry 48 h post infection. 
2.2.4.2 Infections with Vesicular Stomatitis Virus (VSV) 
About 1x105 HeLa ATCC cells were seeded 16 h prior to infection in each well of a 12-well plate. 
Before infection, growth medium was exchanged for 300 µL of VSV infection medium. VSV was 
directly added to each well and incubated for 1 h at 37°C on a rocking platform. The virus 
inoculum was removed 1 h p.i. and replaced with 1 mL growth medium. Cells were fixed at 5-6 h 
post infection and analyzed by flow cytometry. 
2.2.4.3 Infections with Simian Virus 40 (SV40) 
About 1x105 CV1 cells were seeded 16 h prior to infection in each well of a 12-well plate. Before 
infection, growth medium was exchanged for 300 µL of SV40 infection medium. SV40 was 
directly added to each well and incubated for 2 h at 37°C on a rocking platform. The virus 
inoculum was removed 2 h p.i. and replaced with 1 mL growth medium. Medium was replaced 
by growth medium with 5 mM DTT at 10 h post infection. Cells were fixed at 24 h post 
infection, stained for expression of the early protein SV40 large T-antigen and analyzed by flow 
cytometry. 
  
49 Materials and methods 
2.2.4.4 Infection in presence of small molecule inhibitors 
For infections in presence of small molecule inhibitors, cells were seeded as described for 
standard infections. Cells were pretreated with small molecule inhibitors at indicated 
concentrations for 30 min prior to infection. Inhibitors aphidicolin and nystatin/progesterone 
were added for preincubation already 16 h prior to infection. Infections were conducted as 
described above in growth medium supplemented with small molecule inhibitors. At 12 h post 
infection, growth medium was exchanged for fresh growth medium containing 
10 mM NH4Cl/10 mM HEPES, pH 7.6 to reduce cytotoxic effects of the small molecule 
inhibitors. At 8 h post infection, cells were fixed and analyzed by flow cytometry.  
2.2.4.5 HPV16/FPC-HPV16 preincubation with heparin 
HPV16 can be primed for infection and KLK8-cleavage by preincubation with heparin. HPV16 
pseudovirions were incubated with 10 mg/mL heparin in PBS in at total volume of 800 µL for 1 
h in low-binding reaction tubes at room temperature. Preincubated virus was then bound to 
extracellular matrix and incubated with conditioned medium. 
2.2.4.6 HPV16/FPC-HPV16 preincubation with antibodies 
For antibody neutralization experiments, HPV16 virions were incubated with different dilutions 
of L1 antibodies in a total volume of 100 µL growth medium for 2 h in low-binding reaction 
tubes at room temperature. Preincubated virus samples was then bound to extracellular matrix or 
directly added to cell in each well.  
2.2.4.7 Seed-over experiments and virus binding to ECM 
In seed-over experiments, the ability of HPV16 virions to bind to Laminin-332 in extracellular 
matrix (ECM) was exploited. HaCaT cells were seeded at confluence (5x105 cells/well) in a 12-
well plate and grown for 48 h to produce ECM for virus binding. HaCaT cells were removed 
from the ECM by incubation with 20 mM EDTA solution for 45 min and gentle tapping of the 
plates. Detached cells were removed and ECM was washed thrice with 2 mL PBS to remove 
remaining cells or cellular debris. FPC-HPV16 or HPV16 virions were bound to the ECM in 350 
µL growth medium per well for 1 h at 37°C on a rocking platform. Medium was removed and, 
for infection assays, 5x104 HeLa or HaCaT cells were added to each well. Cells were fixed at 48 h 
post infection and analyzed for the fraction of GFP-expressing cells by flow cytometry. 
2.2.4.8 Antibody neutralization assays 
About 16 h prior to experimentation, 5000 HeLa cells per well were seeded in optical bottom 96-
well plates. Prior to addition to cells, HPV16 and FPC-HPV16 were incubated with the L1 
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antibodies, H16.V5, H16.U4, and CAMVIR-1 (dilution range 1:500 to 1:500000), for 1 h at room 
temperature in DMEM. Cells were fixed with 4% PFA at 48 h post infection.  
For RG-1 neutralization, the RG-1 (1:2500) and PsV were added to 5000 HeLa ATCC cells per 
well of a 96 well plate. After 2 h, the inoculum was replaced by growth medium and cells were 
processed for infection analysis by automated microscopy at 48 h p.i..  
2.2.4.9 Double thymidine block for cell cycle synchronization  
Cultured cells can be accumulated in synchronous cell cycle progression by consecutive blocking 
and release with thymidine. Cells were seeded at approximately 50% confluence 16 h prior to the 
first thymidine treatment. To block cell cycle progression, growth medium was supplemented 
with 2 mM thymidine for 16 h. Cells were washed twice with prewarmed growth medium and 
supplemented with fresh growth medium to remove the drug and allow cell cycle progression for 
9 h. Cells were blocked for the second time by addition of 2 mM thymidine for another 16 h. 
Before experimentation, thymidine was washed out as described above. Cells were used in 
infection experiments about 2 h post release. 
2.2.4.10 Infectious internalization kinetics 
The kinetics of infectious internalization of FPC-HPV16 and HPV16 were analysed in seed-over 
or add-on experiments.  
For seed-over experiment, virus was bound to ECM as described above (2.2.4.7) prior to seeding 
of 5x104 target cells per well. At different time points after cell seeding, two wells infected with 
FPC-HPV16 or HPV16 were washed with a high pH buffer (0.1 M CAPS, pH 10.5) for 90 sec to 
destabilized extracellular virus particles. After the high pH wash, cells were washed thrice with 1 
mL PBS and subsequently supplemented with 1 mL growth medium. After 48 h, all samples were 
fixed and samples were analyzed by FACS for the fraction of infected cells.  
For add-on experiments, virus was directly added to wells containing 5x104 cells seeded 16 h 
prior to infection in cold growth medium supplemented with 10 mM HEPES pH 7.6. Cells were 
transferred to 4°C for 4 h to allow for binding of the virus particles without internalization. After 
binding, virus inoculum was removed and wells were supplemented with 1 mL of prewarmed 
growth medium. Plates were transferred to the cell culture incubator at 37°C. At different time 
points after transfer to 37°C, two wells infected with FPC-HPV16 or HPV16 were washed with a 
high pH buffer (0.1 M CAPS, pH 10.5) for 90 sec to destabilized extracellular virus particles, 
subsequently washed thrice with 1 mL PBS and supplemented with 1 mL growth medium. After 
48 h, all samples were fixed and samples were analyzed by FACS for the fraction of infected cells. 
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2.2.4.11 Fixation of cells for flow cytometry analysis 
Cells for analysis by flow cytometry were first detached from the wells with Trypsin/EDTA and 
subsequently fixed by addition of an equal volume of 8% Paraformaldehyde (PFA). Cell 
suspensions were incubated for 15 min at room temperature in the dark. Cells were then 
sedimented by differential centrifugation for 5 min at 600 rpm. Cell pellet were washed twice 
with PBS and resuspended in 300 µL FACS buffer for analysis. 
Cells infected with SV40 were similarly detached and fixed by addition of 8% PFA. After 
fixation, cells were stained with antibodies against the SV40 large T antigen to detect infected 
cells. Sedimented cells were resuspended in FACS perm buffer for 30 min at room temperature. 
Permeabilized cells were sedimented and subsequently resuspended in 100 µL antibody dilution 
in FACS perm buffer. Cells were incubated for 2h at room temperature in the dark. Afterwards, 
cells were sedimented and washed thrice in 500 µL FACS perm buffer. For staining with 
secondary antibodies cells were sedimented and resuspended in 100 µL anti-mouse-AF488 or 
anti-rabbit-AF488 antibody in FACS perm buffer and incubated for 1-2 h at room temperature. 
Afterwards, cells were sedimented, washed thrice in 500 µL FACS perm buffer and resuspended 
in 300 µL FACS buffer for analysis. 
For determination of infection levels by flow cytometry, uninfected control samples were 
measured and used to define the background levels of fluorescence. Infection efficiency was then 
deduced from the relative number of fluorescent cells above the background. 
2.2.4.12 Propidium iodide staining 
To determine cell cycle phases of cells treated with thymidine, DNA intercalating propidium 
iodide staining was used to analyse DNA content of the cell population. Cells were first detached 
from the wells with Trypsin/EDTA and subsequently sedimented by centrifugation at 300 rpm 
for 5 min. Cells were washed once with PBS and sedimented again before fixation with 1 mL 
cold 70% ethanol. Cells were left in ethanol at 4°C overnight. Fixed cells were sedimented at 
3000 rpm for 5 min and washed once with PBS. Before propidium iodide staining, RNA was 
removed by treatment with RNase for 5 min at room temperature. Meanwhile, propidium iodide 
was diluted to 50 µg/mL in PBS (1:200), added to the cells in RNase solution and incubated for 
30 min at room temperature. Cells were transferred into FACS tubes and analyzed at the FACS.  
Cells were first gated in a dot plot to exclude clumps and doublets, then cells were gated from the 
debris in a scatter plot and finally propidium iodide staining of the cells was analysed in a 
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histogram plot. From the histogram plot the fraction of cells in each G0/G1-, S- and G2/M-
phase was determined by fitting Gaussian distributions into the peaks using FlowJo. 
2.2.4.13 Infection analysis by microscopy 
96-well plates were fixed by addition of 100 µL 8% PFA to each well and incubation for 15 min 
at room temperature in the dark. Plates were washed five times with 100 µL PBS. For cell 
detection, nuclei were stained with RedDot2 (2.2.5.6).  
For analysis of cells on coverslips, cells were washed once with PBS and then subsequently fixed 
by addition of 1 mL 4% PFA in PBS. Cells were incubated for 15 min at room temperature in the 
dark and afterwards washed three times with 1 mL PBS. Nuclei were stained with Hoechst 
(2.2.5.5). Cover slips were mounted on a drop of AF1 mounting medium onto glass slides and 
sealed with clear nail polish. 
96-well plates were imaged with a Zeiss Axio Observer Z1 equipped with a Yokogawa CSU22 
spinning disc module and a CoolSnap HQ camera (Visitron Systems GmbH) with the 
appropriate excitation and emission filter sets. 16 fields of view were imaged per well (Schelhaas 
et al., 2012). 
Infection levels were determined using the MATLAB (MathWorks) script “infection counter” 
(Engel, 2011). First, cells were detected by the nuclear stain by an edge detection algorithm that 
recognizes the change in intensity of the picture smoothed by a Gaussian filter. The smoothing 
makes the segmentation less sensitive to changes in background. In the cases where the detected 
nuclei and the signal detected in the infection channel overlapped, the cell was counted as 
infected. The infection levels were then calculated on a well to well basis by averaging the 
infection index for each well (Snijder et al., 2012). 
2.2.4.14 Quantification of virus binding to ECM 
To assess virus binding to NaClO3-treated or untreated HeLa or HaCaT cells, 1-2.5 ng AF488-
labeled HPV16 or fcHPV16 was added to 0.75-1x105 cells. Samples were fixed with 4% PFA 1 h 
after virus addition, subjected to F-actin staining using Atto647N-phalloidin and analyzed by 
microscopy (Zeiss Axio Observer Z1 equipped with a Yokogawa CSU22 spinning disc module 
and a CoolSnap HQ camera; Visitron Systems GmbH).  For quantification of virus binding, z-
stacks were acquired using a 20x magnification. Maximum intensity projections were analyzed 
using CellProfiler v2.2.0 (Carpenter et al., 2006; Kamentsky et al., 2011). In brief, cell areas and 
virus particles were detected by image segmentation, and average virus intensities were 
  
53 Materials and methods 
normalized against cell area and depicted relative to virus intensities per cell area detected in 
untreated samples. More than 150 cells were analyzed per condition and independent experiment. 
2.2.5 Immunofluorescence staining and microscopic imaging of virus particles, raft tissues and 
cellular proteins  
2.2.5.1 Cryosectioning of organotypic raft tissue 
For immunofluorescence stainings of organotypic raft tissues, tissues were cut into pieces of 0.5 
cm side length. Tissue pieces were fixed in 2% PFA in PBS in a well of a 6-well plate for 90 min. 
Tissue were then transferred into another well containing PBS and cut into small pieces to be 
embedded into freezing medium (NEG-50, Richard-Allan Scientific). The freezing container was 
filled with freezing medium and tissue pieces were assembled in the freezing medium using 
forceps. Sections were incubated at 4°C overnight and frozen by carefully dipping into liquid 
nitrogen without submerging the plastic container. Samples were stored at -80°C before 
sectioning at the cryo-microtome. 
For immunofluorescence staining of tissue sections, cryosections were prepared at the Leica 
CM3500 cryo-microtome. The microtome was switched on 2 h before use and precooled to -
14°C chamber temperature and -15°C sample holder temperature. Samples were transferred to 
the precooled microtome 1-2 h prior to sectioning to allow adjusting of the sample temperature. 
Frozen tissues were mounted onto sample carriers with freezing medium and afterwards trimmed 
with a razor blade. On the sample holder, samples were moved close to the blade and trimmed 
carefully to produce an even surface. The thickness of the sections was adjusted to 8-10 µm. 
Sections were picked up with glass slides and stored at -20°C until further use. 
2.2.5.2 Paraffin embedding of organotypic raft tissue 
For histological stainings of organotypic raft tissues, tissues were cut into pieces of 0.5 cm side 
length. Tissue pieces were fixed in 4% PFA in PBS in a well of a 6-well plate for 90 min. Tissue 
were then transferred into another 35% isopropanol overnight to dehydrate the sample. The next 
day, dehydration was continued by incubation of tissue samples with solutions with increasing 
isopropanol concentration: twice in 70% isopropanol for 90 min, then 85% isopropanol for 90 
min, then twice with 96% isopropanol for 90 min, then twice 100% isopropanol for 15 min.  
Samples were soaked overnight in histol. As a last step followed the paraffin infiltration, samples 
were first soaked with Type 3 Paraffin for 90 min, second the samples were transferred into Type 
6 Paraffin for 3 h and finally samples were infiltrated with Type 9 Paraffin for 3 h or overnight or 
until embedding.  Sections arranged for embedding in Type 9 Paraffin in metal containers. 
Samples were stored at room temperature before sectioning at the microtome. 
  
54 Materials and methods 
The microtome was switched on 1 h before use and to allow prewarming. Samples were trimmed 
with a razor blade. On the sample holder, samples were moved close to the blade and trimmed 
carefully until an even surface was present. The thickness of the sections was adjusted to 8-10 
µm. Sections were picked up with glass slides and stored at room temperature until further use. 
2.2.5.3 Hematoxylin & Eosin staining (H&E staining) 
H&E staining is a classical histological staining method with which nuclei as well as cytoplasmic 
components are stained. Hematoxylin staining binds to DNA and leads to a blue nuclear stain. 
Intra- and extracellular proteins are stained with the red eosin staining. For H&E staining, 
paraffin was removed from tissue sections by incubation with histol for three times 3 min. Next, 
the samples were rehydrated by incubation with solutions with decreasing isopropanol 
concentration: twice 3 min 100% isopropanol, once 3 min 96% isopropanol, follow by 3 min in 
each 90%, 80%, 70% isopropanol and finally twice for 30 sec in H2O. After rehydration, nuclei 
were stained by incubation for 2.5 min in haematoxylin, followed by a 30 sec wash in H2O and 
incubation in bluing solution for 2 min. Samples were washed again for 30 sec in H2O. 
Afterwards, proteins were stained with 0.05% eosin solution for 3 min. Samples were washed in 
H2O for 30 sec and taken again for dehydration in solutions with increasing isopropanol 
concentration: 3 min 80% isopropanol, 3 min 96% isopropanol and twice 3 min 100% 
isopropanol. Before mounting, samples were soaked in histol twice for 3 min. Sections were 
covered with a glass cover slip on mounting medium. 
2.2.5.4 Immunofluorescence staining 
Previously PFA-fixed cells were permeabilized with 0.1% Triton-X-100 in PBS for 15 min and 
washed three times with PBS. Samples were blocked for at least 30 min at room temperature with 
3% BSA in PBS before antibody incubation to reduce unspecific binding. Primary antibodies 
were diluted in 3% BSA as indicated (2.1.10.1) and cells were incubated for 2 h on 50 µL drops 
of antibody dilution in a wet chamber at room temperature in the dark. After three washes with 
PBS, samples were incubated for one hour on 50 µL drops of secondary antibody dilution in a 
wet chamber. Samples were then counterstained with Hoechst or phalloidin. Coverslips were 
mounted on glass slides on drops of AF1 mounting medium, sealed with nail polish and stored at 
4°C in the dark. 
2.2.5.5 Hoechst staining 
Hoechst was used as a nuclear counterstain in some experiments and for tissue cryo-sections. 
The dye was diluted 1:10 000 in PBS and 0.5 ml were added to each coverslip in a 12 well plate or 
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50 µL were added to each spot with tissue section on a glass slide. Cells were incubated for 15 
min on a shaker at room temperature and subsequently washed with PBS three times for 5 min. 
2.2.5.6 RedDot2 staining 
RedDot2 is an alternative nuclear counterstain that allows detection in the far-red channel. It was 
mainly used for automated detection of cells on 96-well plates. Before staining, cells were 
permeabilized for 15 min with 0.1% Triton-X-100. Meanwhile, RedDot2 was diluted 1:500 in 
PBS. 40 µl of RedDot2 dilution was added per well on a 96-well plate. Cells were incubated for 
30 min at room temperature in the dark on the shaker and afterwards washed five times with 
PBS. 
2.2.5.7 Phalloidin staining 
Another counterstaining for cell outline detection was phalloidin, which stains filamentous actin 
in the cells. The dye was used in PHEM buffer, which allows a better preservation of actin 
structures. Phalloidin dyes were diluted to 2 µg/mL in PHEM buffer with 0.1% Triton-X-100. 
Coverslips were incubated on 50 µl drops of Phalliodin staining solution for 20 min in a wet 
chamber. Afterwards cells were washed three times for 5 min in PBS in the dark on a rocking 
platform. 
2.2.5.8 Electron microscopy 
About 1-5x106 PsV in PBS/0.8M NaCl were absorbed for 1 min on formvar coated, carbon 
sputtered grids. Particles were contrasted for 7 min with 1% phosphotungstic acid. Samples were 
analyzed directly after drying. The sample was analyzed at 80 kV on a FEI-Tecnai 12 electron 
microscope (FEI, Eindhoven, Netherlands). Images of selected areas were documented with 
Olympus Veleta 4k CCD camera. Electron microscopy was performed by L. Greune, Institute 
for Infectiology, Center for Molecular Biology of Inflammation, Münster, Germany. 
2.2.5.9 STORM imaging 
About 5x104 HeLa ATCC cells were seed on glass cover slips 24 h prior to infection. Cells were 
either pretreated for 30 min with 10 µg/mL cytochalasin D or left untreated. HPV16-AF647 was 
added to the cells for 6 h on a shaker at 37°C. Samples were fixed with 2% PFA for 15 min at 
4°C. Endogenous CD151 was stained with mouse anti-CD151 antibody (1:100) in 1% BSA/PBS 
for 2 h at room temperature in the dark and subsequently stained with anti-mouse IgG-AF700 
antibody (1:1500) in 1% BSA/PBS for 1 h at room temperature in the dark. After staining, the 
samples were again fixed with 4% PFA + 0.01% glutaraldehyde for 15 min at room temperature. 
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Samples were handed over to Daniel Böning (AG Klingauf, WWU Münster) and mounted on 
STORM imaging medium. Imaging was conducted as described by D. Böning (Böning, 2015). 
2.2.6 Biochemical methods 
2.2.6.1 Cell lysis 
Cells to be collected for SDS-Page or western blotting were harvested by addition of 2x or 5x 
SDS-Loading buffer with DTT to each well after washing cells once with PBS. To one well of a 
12-well plate usually 75 µL SDS-loading buffer was added, cells were detached with a cell scraper 
and transferred to safe-lock reaction tubes. For protein denaturation, samples were boiled for 5-
10 min at 95°C and frozen for storage at -20°C. 
2.2.6.2 SDS-PAGE 
Protein samples were separated by electrophoresis on polyacrylamide gels with a percentage 
suitable for size range of target proteins. In general, 5% stacking gels were used, whereas 
acrylamide percentage in separating gels ranged from 6% to 15% (see table below). Protein 
lysates were boiled for 5 min at 95°C before usually 10 – 20 µL lysate were loaded into each well. 
Samples were concentrated in the stacking gel by running the gel for 15 min at 110 V in 1x 
Laemmli buffer, then voltage was increased to 160 V and left constant until the loading buffer 
front reached the bottom of the gel (approx. 60 – 90 min). Gels were either taken for western 
blotting or directly stained with coomassie brilliant blue. 
Protein size range (kDa) Gel percentage  
200 – 60 6% 
100 – 40 8% 
70 – 20 10% 
60 – 20 12% 
40 – 10 15% 
 
2.2.6.3 Coomassie brilliant blue staining 
Coomassie brilliant blue is widely used as a dye to stain proteins after SDS-PAGE. Gels were 
stained with Coomassie staining solution for 30 min at room temperature. Afterwards gels were 
incubated with destaining solution until protein bands were visible. For quantification and 
documentations, gels were scanned on an Epson Perfection 4990 Photo scanner and bands were 
quantified with ImageJ. 
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2.2.6.4 Western blotting 
Proteins of interest can be detected through incubation with specific antibodies. Therefore, 
proteins separated by SDS-PAGE were transferred onto a nitrocellulose membrane by blotting 
for 50 min at 400 mA in precooled transfer buffer. Afterwards, membranes were blocked in 
blocking buffer (TBS-TMP) for at least 30 min.  
Membranes were incubated with 2.5 mL primary antibody in TBS-TMP (dilutions see 2.1.10) for 
2 h at room temperature or at 4°C overnight. Before secondary antibody incubation, membranes 
were washed three times with TBS-T. Secondary antibodies coupled to horseradish peroxidase 
(HRP) were diluted in TBS-TMP (dilutions see 2.1.10), before 2.5 mL dilution was added to each 
membrane and incubated for 1 h at room temperature. Membranes were then washed three times 
with TBS-T and twice with TBS before development with substrates for enhanced 
chemiluminescence (ECL, Pierce or ECL prime, GE Healthcare) on photographic films.  
2.2.6.5 Analysis of particle composition 
About 1 µg of HPV16 PsV were resuspended in SDS-loading buffer with 20 mM DTT and 
denatured at 95°C for 10 min. Proteins were separated on a 10% SDS-PAGE and stained with 
coomassie brilliant blue. As a protein standard, 250 ng, 500 ng and 1 µg BSA were used for linear 
regression fitting of signal intensity values from densitometry analysis by Fiji (Schindelin et al., 
2012). 
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3 Results 
3.1 Furin precleaved HPV16 is a valid tool to study HPV16 uptake kinetics 
To infect host cells, HPV initially binds to laminin-332 as a transient receptor in the extracellular 
matrix or to HSPGs as primary receptors on the cell surface or within the ECM (Joyce et al., 
1999; Giroglou et al., 2001; Shafti-Keramat et al., 2003; Johnson et al., 2009; Kines et al., 2009; 
Cerqueira et al., 2013; Richards et al., 2013; Culp et al., 2006b; Combita et al., 2001). The virus 
capsid undergoes a series of structural modifications upon HSPG binding, which comprise 
changes in capsid surface epitopes through HSPG interaction, L1 cleavage by KLK8, exposure of 
L2 N-terminus by cyclophilins and finally N-terminal L2 cleavage by furin (Cerqueira et al., 2013, 
2015; Bienkowska-Haba et al., 2009, 2012; Richards et al., 2006; Day et al., 2008b; Kines et al., 
2009; Wang et al., 2014). These structural modifications are likely required for engagement of an 
elusive internalization receptor (Selinka et al., 2007). 
Importantly, several HPV types internalize asynchronously over several hours, which is usual for 
viruses as long dwell times on the cell surface may result in detection by the immune system 
(Giroglou et al., 2001; Selinka et al., 2003; Buck et al., 2006; Smith et al., 2007; Selinka et al., 2007; 
Schelhaas et al., 2012). 
This study aimed to identify factors that contribute to the slow and asynchronous endocytosis to 
advance the understanding the novel endocytic pathway of HPV16. The current model suggests 
that the aforementioned structural modifications of the HPV capsid are rate-limiting factors as 
they occur sequentially or are limited by enzyme or internalization receptor abundance (Raff et 
al., 2013; Day and Schelhaas, 2014). Therefore, it was tested whether described structural 
modifications limited HPV16 entry singly or interdependently.  
According to the current knowledge, furin cleavage of the exposed L2 N-terminus of HPV 
capsids represents the final extracellular modification step. Therefore, HPV pseudoviruses were 
subjected to in vitro furin precleavage, which rendered them terminally restructured and would let 
them bypass all previous structural modification steps (Day et al., 2008b; Wang et al., 2014).  
To investigate the impact of furin cleavage on the slow and asynchronous internalization of 
HPV16, an additional step of furin cleavage was included during the maturation step of virus 
production, following the protocol described by Wang and colleagues (Wang et al., 2014). Briefly, 
HPV16 pseudovirus was produced by transfection of plasmids encoding the viral capsid protein 
L1 and L2 and a GFP reporter plasmid into producer cells. Cells were harvested and lysed 48 h 
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post transfection. The HPV capsid consists of L1 pentamers, which are stabililized by 
interpentameric disulfide bonds. Formation of these requires oxidizing condition and is achieved 
in vitro during maturation of the particles in the cell lysates, which was extended for efficient 
furin cleavage during furin-precleaved virus production (FPC-HPV). Virus particles were 
subsequently purified by density gradient centrifugation. 
A prerequisite for the analysis of infectious internalization kinetics using restructured FPC-
HPV16 particles was that it does not show assembly defects and uses the same endocytic 
pathway. Therefore, the morphology of the furin-precleaved HPV16 particles was compared to 
standard HPV16 PsV particles by negative staining electron microscopy, where the particles 
appeared indistinct (Figure 1A). HPV particles are composed of 360 L1 proteins forming 72 
pentamers (capsomers) and a variable number of up to 72 L2 proteins inside the particles (Buck 
et al., 2008). Next, the composition of HPV and FPC-HPV particles was analyzed to check the 
L2 cleavage and its incorporation into the capsids. Viral proteins from PsV particles were 
separated by SDS-PAGE and subsequently detected by coomassie brilliant blue staining. For 
FPC-HPV16 particles, the L2 protein band migrated faster than HPV16, which indicated an 
efficient furin processing. Densitometric analysis of FPC-HPV16 versus HPV16 protein 
composition revealed that about 42%±5% less L2 was incorporated in FPC-HPV16 particles. 
However, cellular histones were efficiently incorporated (about 16%±8% more than in HPV16), 
which suggested efficient DNA packaging in FPC-HPV16 particles despite furin treatment 
(Figure 1B). From this we concluded that FPC-HPV16 particles assembled correctly. 
Neutralizing HPV16 surface epitopes exists and contain a number of conformational epitopes 
(Christensen et al., 1996, 2001). Those can be used to assess viral structural features of different 
particles. Here, the exposure of two conformational epitopes on FPC-HPV16 were tested using 
neutralizing antibodies H16.V5 and H16.U4 and, as a control, the non-neutralizing antibody 
CAMVIR-1. H16.V5 was described to bind to several loops (FG and HI, as well as BC and HI) 
at the top of the pentamers and thereby induce conformational changes that lead to a 
hyperstabilization of the capsid (Christensen et al., 1996; Lee et al., 2015). H16.U4 binds a C-
terminal epitope located on the invading arm, which mediates the intercapsomeric anchorage 
(Carter et al., 2003; Modis et al., 2002). Recent data shows that binding of H16.U4 Fab fragments 
occurs only around pentavalent capsomers, possibly blocking interaction with HSPGs (Guan et 
al., 2015). CAMVIR-1, however, binds to a highly conserved linear L1 epitope at amino acids 
206-210 and has no neutralizating capacity (McLean et al., 1990; Roden et al., 1997). For 
neutralization, virus particles were incubated with antibodies for 1 h at 37°C, whereafter the 
inocula were used to infect HeLa ATCC cells. Both neutralizing antibodies reduced the infectivity 
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of HPV16 as well as FPC-HPV16 in a dose-dependent manner to a similar extent (Figure 1C  
H16.V5 and H16.U4). Upon incubation with the control antibody CAMVIR-1, no reduction of 
infection was observed with either virus, as expected (Figure 1C CAMVIR-1). This indicated that 
the neutralizing epitopes targeted by H16.V5 and H16.U4 were similarly accessible on HPV16 
and FPC-HPV16 particles, which supports correctly assembed FPC-HPV16.  
L2 from FPC-HPV16 was almost completely processed by furin, as no full-length L2 protein was 
visible on coomassie-stained SDS-PAGE gels (Figure 1B). To test, whether the furin-mediated 
L2 cleavage would be functional, we infected cells impaired in endogenous furin activitiy. For this 
furin was inhibited by irreversible, cell-permeable dec-RVKR-CMK, a peptidylchloroalkylketone, 
which has previously been shown to block HPV16 infection efficiently (Richards et al., 2006). 
HeLa ATCC cells were pretreated with dec-RVKR-CMK and subsequently infected with either 
HPV16 or FPC-HPV16. As expected, HPV16 infectivity was completely abolished upon furin 
inhibitor treatment, whereas FPC-HPV16 rescued infection to 97%±8% of the DMSO-treated 
control (Figure 1D).  
Processing of HPV16 particles upon HSPG binding eventually causes exposure of an L2 N-
terminal epitope buried in unprocessed viruses – the so-called RG-1 epitope, which is conserved 
among most HPV types (Gambhira et al., 2007; Day et al., 2008a). Here, the accessibility of this 
neutralizing epitope was analyzed using an RG-1 antibody for FPC-HPV16 and HPV16 
(Gambhira et al., 2007). The RG-1 antibody and virus particles were added simultaneously to 
HeLa ATCC cells and incubated for 2 h at 37°C. As expected, HPV16 infection remained 
unchanged in presence of RG-1 antibody. RG-1 treatment efficiently reduced FPC-HPV16 
infection to a residual infection of 21%±3% relative to mouse serum- treated controls (Figure 
1E), indicating a pre-exposure of the RG-1 epitope on FPC-HPV16 particles. In summary, these 
results suggested that L2 was efficiently processed by furin, which resulted in efficient exposure 
of the cross-neutralizing RG-1 epitope indicating that FPC-HPV16 particles resembled terminally 
restructured particles. 
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Figure 1 FPC-HPV16 assembly is similar to HPV16 and particles are structurally processed 
HPV16 and FPC-HPV16 particles were analyzed by negative staining electron microscopy. Depicted are 
representative images of virus particle. Scale bars represent 100 nm (A). HPV16 and FPC-HPV16 samples were 
denatured, separated by SDS-PAGE, and stained by coomassie brilliant blue to analyze the particle composition. 
Note the shift in the L2 size of furin cleaved protein (L2 cut) (B). Surface epitopes of HPV16-GFP (black) and 
FPC-HPV16-GFP (grey) particles were targeted with indicated dilutions of neutralizing antibodies H16.V5 (left), 
H16.U4 (middle) or non-neutralizing control antibody CAMVIR-1 (right). Preincubated viruses were used for 
infection of HeLa ATCC cells. Infected cells were determined by detection of GFP expression by automated 
immunofluorescence spinning disc microscopy at 48 h p.i. and analyzed with a MATLAB script scoring for 
infection. Presented are infection values relative to untreated controls in percent ± SD (C). For testing the 
dependence on furin during infection, 5x104 HeLa ATCC cells were pretreated with 10 µM furin inhibitor Dec-
RVKR-CMK or DMSO for 30 min. Cells were then infected with HPV16 (black bars) or FPC-HPV16 (white 
bars) in presence of the inhibitor for 2 h. Medium was exchanged to growth medium with 10 mM NH4Cl 12 h p.i. 
until harvest and analysis by flow cytometry at 48 h p.i.. Depicted are infection values relative to DMSO-treated 
controls in percent ± SD (D). To analyze structural processing, HPV16 or FPC-HPV16 and L2 neutralizing RG-1 
antibody were added to 5000 HeLa ATCC per well of optical bottom 96-well plates for 2 h incubation. Fraction 
of GFP-positive cells was evaluated after total 48 h by automated microscopy and analyzed as in C. Depicted are 
infection values relative to mouse serum-treated controls in percent ± SD (E). 
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3.2 FPC-HPV16 uses the same endocytic route as HPV16 
As FPC-HPV16 particles assembled correctly and were efficiently furin-precleaved, we aimed to 
analyze the endocytic route taken by the virus, which has not been shown to date.  HPV16 uses a 
novel endocytic pathway, which was defined by the requirement of actin but independence from 
clathrin, caveolin, flotillin, cholesterol, and dynamin (Schelhaas et al., 2012). Using FPC-HPV16 
as a tool to analyze altered internalization kinetics requires its uptake by the same endocytic 
mechanism. Here, small molecule inhibitors were employed to target cellular factors required 
during HPV16 endocytosis. 
Virus entry is a multistep process, which requires activation of cellular signaling pathways to 
induce endocytic uptake. During HPV16 endocytosis, epidermal growth factor receptor (EGFR) 
signaling as well as downstream effectors such as Abl, MEK/ERK, PLC, and PI3K/Akt/mTOR 
are activated (Schelhaas et al., 2012; Surviladze et al., 2012, 2013; Kühling, 2015; Bannach, 2014).  
The small molecule inhibitor iressa specifically blocks the tyrosine kinase domain members of the 
EGFR family. By this, it impairs HPV16 endocytosis (Schelhaas et al., 2012; Bannach, 2014). In 
presence of iressa, HPV16 and FPC-HPV16 infection was similarly reduced in a dose-dependent 
manner to a residual infection level of 12%±5% and 14%±10%, respectively (Fig. 2A). When 
activation of EGFR downstream signaling was analyzed, the kinase Abl within the mitogenic 
cascade was important for HPV16 infection (Plattner et al., 1999; Tanos and Pendergast, 2006; 
Bannach, 2014). To assess, whether FPC-HPV similarly required EGFR signaling via Abl, 
nilotinib, a specific inhibitor of Abl (Verstovsek et al., 2005), was used during infection. The 
treatment reduced infection with HPV16 to 34%±6% and FPC-HPV16 infection to 51%±11% 
in a dose-dependent manner (Fig. 2B). These results suggested that internalization of FPC-
HPV16 and HPV16 were equally dependent on EGFR signaling. However, FPC-HPV16 
infection was less affected by Abl inhibition than HPV16, which may indicate that signaling via 
Abl was involved during structural modifications. 
Further, HPV16 endocytosis depends on Na+/H+-exchangers (Schelhaas et al., 2012), which have 
been shown described as a hallmark of macropinocytosis (Mercer and Helenius, 2009; Mercer et 
al., 2010), where they locally lower the cytosolic pH and thereby activate GTPase function 
(Koivusalo et al., 2010). When we blocked Na+/H+-exchanger function with the amiloride 
derivative EIPA, HPV16 and FPC-HPV16 infections were completely blocked (Fig. 2C). Clearly, 
Na+/H+-exchangers were required for FPC-HPV16 internalization as well as for HPV16. 
The GTPase Dynamin-2 is a major scission factor involved, for example, clathrin mediated 
endocytosis (CME), caveolar endocytosis, the IL-2 pathway, and phagocytosis (Doherty and 
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McMahon, 2009; Mercer et al., 2010). In contrast, HPV16 endocytosis occurs independently of 
dynamin-2 function (Spoden et al., 2008; Schelhaas et al., 2012), which distinguishes it from other 
endocytic mechanisms. To corroborate that FPC-HPV16 endocytosis is also independent of 
dynamin function, cells were infected in presence of the dynamin inhibitor dynasore. Dynasore is 
a small-molecule inhibitor, which blocks GTPase activity to dynamins in a noncompetitive way 
(Macia et al., 2006). The efficiency of inhibition was tested using vesicular stomatitis virus (VSV) 
infection, which relies on clathrin-mediated endocytosis and therefore depends on dynamin 
(Johannsdottir et al., 2009). As expected, we observed a dose-dependent reduction of VSV 
infection (Fig. 2D, grey bars). In contrast, both, HPV16 and FPC-HPV16 infection were not 
affected by dynasore (Fig. 2D, black and white bars). In line with previous observations, the 
relative infectivity of HPV16 and FPC-HPV16 was increased upon dynasore treatment, a feature 
that has been attributed to upregulation of dynamin-independent pathways (Schelhaas et al., 
2012; Spoden et al., 2008). In conclusion, FPC-HPV16 as well as HPV16 were internalized by a 
dynamin-2 independent endocytic pathway.  
Perturbation of actin dynamics lead to formation of long membrane tubules containing HPV16 
particles. Hence, actin is likely involved in vesicle scission during HPV16 endocytosis (Schelhaas 
et al., 2012). Here, the actin depolymerizing agent cytochalasin D was used to analyze the 
involvement of actin dynamics in FPC-HPV16 uptake (Brown and Spudich, 1979). The relative 
infectivity of HPV16 and FPC-HPV16 was dose-dependently reduced to 30%±6% and 
21%±10%, respectively (Fig 2E). Moreover, treatment with jasplakinolide, an inhibitor of actin-
depolymerization (Holzinger, 2009), resulted in a similar reduction of infection to 12%±2% and 
19%±9%, for HPV16 and FPC-HPV16 respectively (Fig. 2F). Thus, the dynamic remodeling of 
the actin cytoskeleton was crucial for both both HPV16 and FPC-HPV16 endocytosis.  
After endocytic uptake, HPV16 particles traffic through the endo-lysosomal system, where 
endosomal acidification presumably triggers uncoating and enables separation of the L1 
capsomers from the L2 and viral DNA subviral complex (L2/vDNA) (Schelhaas et al., 2012; 
Bienkowska-Haba et al., 2012). To analyze, whether FPC-HPV16 also requires acid-activation 
within the endosomal pathway, the endosomal pH was neutralized with NH4Cl followed by 
infection with HPV16 and FPC-HPV16. Infection was similarly reduced for HPV16 and FPC-
HPV16 in a dose-dependent manner (Fig. 2G). Further, Bienkowska-Haba and colleagues 
(Bienkowska-Haba et al., 2012) showed that cyclophilins separate L1 capsomers from a subviral 
complex consisting of L2 and the chromatinized genome in early endosomes. Incidentally, 
cyclophilin activity is additionally required for the exposure the L2 N-terminus for subsequent 
cleavage by furin (Bienkowska-Haba et al., 2009). Cyclosporine A is a broad inhibitor of 
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cyclophilins (Handschumacher et al., 1984) and was used to analyze the requirement of 
cyclophilins during FPC-HPV16 infection. Infection with HPV16 and FPC-HPV16 was inhibited 
in a dose-dependent manner to 8%±1% and 12%±5%, respectively, in presence of cyclosporine 
A (Fig. 2H). Thus, FPC-HPV16 likely depended the same intracellular uncoating events mediated 
by cyclophilins as HPV16.  
Nuclear import of HPV16 depends on nuclear envelope breakdown (NEBD) for efficient 
genome delivery (Aydin et al., 2014). To test, whether FPC-HPV16 reached the nucleoplasm by 
the same import mechanism, cell cycle progression through S-phase was inhibited with 
aphidicolin (Spadari et al., 1982), which prevents the delivery of HPV16 viral DNA to the 
nucleus (Aydin et al., 2014). Inhibition of cell cycle progression with aphidicolin resulted in a 
dose-dependent reduction of infection to 14%±3% and 10%±2% for HPV16 and FPC-HPV16, 
respectively (Fig. 2I). This suggested that NEBD was also essential for nuclear import of FPC-
HPV16. 
Based on the inhibitor profile of this study, infectious entry of FPC-HPV16 likely occurs by the 
same entry pathway as HPV16. 
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Figure 2 FPC-HPV16 and HPV16 enter host cells by the same route 
HeLa ATCC cells were preincubated for 30 min with iressa (A), nilotinib (B), EIPA (C), dynasore (D), 
cytochalasin D (E), jasplakinolide (F), NH4Cl (G) or cyclosporine A (H) or overnight with aphidicolin (I) with the 
indicated concentration of each small molecule inhibitors. Cells were infected with HPV16 (black) or FPC-HPV16 
(grey) in the presence of the inhibitors. At 12 h p.i., medium was exchanged to growth medium with 10 mM 
NH4Cl until harvest and analysis by flow cytometry at 48 h p.i.. Depicted are infection values relative to DMSO-
treated controls in percent ± SD. 
  
66 Results 
3.3 Furin-precleavage of HPV16 particles is rate limiting for uptake 
According to the current model, furin cleavage of exposed L2 N-termini in HPV16 capsids is the 
final step within a cascade of structural modification after virus binding (Raff et al., 2013; Day 
and Schelhaas, 2014). It is proposed that terminal restructuring (by furin) enables particles to 
transfer from the primary receptor HSPGs to an elusive internalization receptor (Selinka, 2007; 
Day, 2008). If the structural modifications were the main rate-limiting factor for slow and 
asynchronous internalization of HPV16, terminally restructured particles would exhibit faster 
internalization kinetics. Hence internalization kinetics of HPV16 and FPC-HPV16 were 
compared. 
For this, our recently established assay to assess the internalization solely of infectious virions was 
used (Schelhaas et al., 2012). Briefly, virions were bound to cells in the cold. After binding, cells 
were shifted to 37°C to allow endocytosis for various times, before extracellular virus was 
rendered non-infectious by a high pH wash. At 48 h p.i., the infectivity of virus already 
internalized at the indicated times of the pH wash was scored. Consistent with previous results, 
the HPV16 infectious internalization followed a sigmoidal trend with a lag time of about 2 h (Fig. 
3A, dotted line). The half time of infectious internalization was determined to be about 9 h for 
HPV16 (Fig, 3A, dotted line), which was well within the time frame of 9-11 h of previous 
publications (Schelhaas et al., 2012; Cerqueira et al., 2013). FPC-HPV16 exhibited no visible lag 
phase and an almost linear internalization trend within in the first 10 h (Fig. 3A, solid line). In 
addition, the half time of infectious internalization was faster and estimated to about 7 h (Fig. 3A, 
solid line). In relative terms, this indicated that FPC-HPV16 internalized about 25% faster than 
HPV16 without a prominent lag phase. However, virus uptake still occurred asynchronously. 
This suggested that N-terminal cleavage of L2 by furin contributed to an initial lag phase, and 
thereby was a rate-limiting step for HPV16 internalization. However, the data also clearly 
indicated that additional factors for slow and asynchronous virus uptake existed.  
Instead of binding to HSPGs on cells, HPV16 can alternatively interact with laminin-332 or 
HSPGs in the extracellular matrix (Culp et al., 2006b), and likely undergoes the same structural 
modification bound to the ECM receptor that have been proposed for cell surface interactions 
(Day and Schelhaas, 2014; Cerqueira et al., 2015). Infectious internalization of ECM-bound 
HPV16 is even slower than cell surface bound virus with a half time of about 18 h (Cerqueira, 
2013; Schelhaas 2012), presumably because ECM-binding restricts diffusion of particles and 
sampling of the cell surface receptors for engagement of a secondary receptor (Schelhaas et al., 
2008; Raff et al., 2013). To corroborate our findings on the internalization kinetics of cell surface-
bound virus, we repeated infectious internalization experiments with ECM-bound virions. For 
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this, FPC-HPV16 and HPV16 were bound to ECM, cells were seeded onto the ECM-bound 
virus, and a high pH wash was performed at different times after seeding, which was followed by 
scoring the infectivity of internalized virus at 48 h post cell seeding as above. Again, HPV16 
infectious internalization followed a sigmoidal trend. However, the lag time was now about about 
6 h (Fig. 3B, dotted line). The half time of infectious internalization was estimated to about 
19 h for HPV16 (Fig, 3B, dotted line), which was in line with previous observations of 
approximately 16-18 h (Cerqueira et al., 2013). Under these conditions, FPC-HPV16 showed also 
a sigmoidal internalization trend with a reduced lag phase of about 4 h. The linear phase of 
increase in infection began about 8 h post infection, which was about 4-6 h earlier than for 
HPV16 (Fig. 3B, solid vs. dotted line). As for the add-on experiments, we found that the half 
time of infectious internalization was faster and estimated to about 13 h (Fig. 3B, solid line). 
Thus, FPC-HPV16 internalized about 30% faster than HPV16, but still asynchronously. Slower 
kinetics of infectious internalization after ECM-binding of HPV16 or FPC-HPV16 indicated that 
its ECM interaction introduced further rate-limiting factors. Those could either involve obscured 
accessibility of site on the capsid required for structural modification or might be due to limited 
availability of modifying factors required for virus release from the extracellular matrix (e.g. 
matrix metalloproteinases) and transfer to the internalization receptor. 
In summary, furin cleavage was likely a partially rate limiting step for HPV16 infectious 
internalization, and appeared to eliminate the lag phase before internalization started. However, 
more steps and factors clearly contributed to the protracted, asynchronous internalization of the 
viruses. In general, two aspects can be envisioned to contribute to the remaining asynchrony of 
internalization. Either the structural modifications occurred independently of one another as has 
been suggested recently (Bronnimann et al., 2016) and thus other structural modifications could 
be rate-limiting, or alternatively the availability of the putative secondary receptor (complex) may 
be limited. 
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Figure 3 Infectious internalization of FPC-HPV16 is faster and more synchronous 
In an add-on experiment, HPV16 (dotted) or FPC-HPV16 (solid) was bound to 5x104 HeLa ATCC cells per well 
in 12-well plates for 4 h at 4°C. Inoculum was exchanged and cells were transferred to 37°C. At indicated times 
post infection, cells were treated with pH 10.5 for 90 sec to inactivate extracellular virus. At 48 h p.i., GFP-
expressing cells were scored by flow cytometry (A). In seed-over experiments, HPV16 or FPC-HPV16 was bound 
to ECM derived from HaCaT cells for 2 h at 37°C. After binding, 5x104 HeLa ATCC cells were superseeded on 
the ECM-bound particles and at indicated times post infection extracellular virus was inactivated as described 
above. GFP-expressing cells were scored by flow cytometry after 48 h (B). Shown are infectious internalization 
values normalized to 48 h infection samples in percent ± SD for both experiments. 
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3.4 KLK8 cleavage of HPV16 is no rate-limiting step during HPV16 internalization 
Since internalization kinetics of HPV16 remain unchanged upon incubation with heparin, the 
interaction with HSPGs is not rate-limiting for virus uptake (Cerqueira et al., 2013). 
Therefore, we examined the role of structural modifications of HPV16 mediated by Kallikrein-8 
(KLK8) and cyclophilins in internalization kinetics, which supposedly occur upstream of furin 
cleavage and downstream of HSPG engagement (Bienkowska-Haba et al., 2009; Cerqueira et al., 
2015). KLK8 cleaves L1 in extracellular particles, and is required for efficient exposure of the L2 
RG-1 epitope and internalization of HPV16 (Cerqueira et al., 2015). KLK8 cleavage of virus is 
induced during incubation of heparin-pretreated, ECM-bound virus with conditioned medium, a 
cell supernatant that contains secreted KLK8 (Cerqueira et al., 2015). As a prerequisite for a rate-
limiting role in internalization, KLK8 cleavage would have to occur asynchronously to contribute 
to the protracted internalization of HPV16. Therefore, we analyzed the kinetics of L1 cleavage by 
KLK8 in conditioned medium after different times of incubation by Western blotting. The 
cleaved L1 showed a higher mobility of about 5 kDa compared to full length L1 (L1 A, Figure 
4A, (Cerqueira et al., 2015)). After 2 h, already 30% of L1 was cleaved and cleavage was maximal 
at 16 h (Fig. 4A). These results indicated that KLK8 cleavage occurred protractedly.  
Only about 30-50% of the L1 molecules were cleaved in vitro. Potentially, the cleavage site in L1 
may be obscured for KLK8 cleavage in the remaining L1 molecules of the virus particles. 
Alternatively, KLK8 cleavage efficiency may decline due to inactivation of the protease by self-
degradation over time (Eissa et al., 2011).  
To analyze if particles with maximal KLK8 cleavage increased the rate of HPV16 endocytosis, 
KLK-8 cleaved HPV16 and FPC-HPV16 were prepared and analyzed for the rate of infectious 
internalization in the seed-over experiment. However, the internalization rates of KLK8-
precleaved HPV16 and FPC-HPV16 remained unchanged if compared to uncleaved HPV16 and 
FPC-HPV16 (Fig. 4B). Both KLK8-precleaved and uncleaved FPC-HPV16 internalized faster 
than their HPV16 counterparts. Thus, KLK8 cleavage of L1 was not rate limiting for infectious 
internalization.  
Interestingly, while the internalization kinetics remained unchanged, the infectivity of virus 
particles was increased upon KLK8 pretreatment. When infection levels of ECM-bound, KLK8-
pretreated HPV16 and ECM-bound FPC-HPV16 were compared to untreated controls, both 
virus variants exhibited increased infectivity of about 50% after 6 h KLK8 pretreatment and 
about 100% upon maximal KLK8 cleavage after 16 h (Fig. 4C). Increased infectivity without any 
changes in the internalization kinetics indicated that the total number of available infectious 
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particles was increased, however, the rate of endocytosis of the single virus was not changed. 
This may indicate that single virions required to reach a threshold of KLK8 cleavage to be 
infectious, which is reached in more particles when the time for precleavage is extended. 
Alternatively, transfer of virus from the ECM to the cell surface may be limited by proteolytic 
remodeling of the ECM. Therefore, extended preincubation with conditioned medium could 
allow for more particles to be ready for release from the ECM than in untreated ECM. 
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Figure 4 KLK8 cleavage is not rate limiting during HPV16 infectious internalization 
For the analysis of the kinetics of L1 cleavage by KLK8, HPV16 or FPC-HPV16 PsVs were incubated with 10 
mg/mL Heparin for 2 h at room temperature. The viruses were subsequently bound to ECM for 1 h at 37°C and 
then incubated with conditioned medium or DMEM. Samples were taken at indicated times, lysed and subjected 
to SDS-PAGE and Western blotting using L1-specific CAMVIR-1 antibody. L1 cleavage bands were quantified 
by densitometry using Fiji. Shown is relative abundance of the L1 A band normalized to maximal cleavage at 16 h 
post incubation in percent ± SD (A). HPV16 (left) or FPC-HPV16 (right), preincubated Heparin as in A), was 
bound to ECM from HaCaT cells for 2 h at 37°C. Bound PsV were incubated with growth medium (black) or 
conditioned medium (grey) for 16 h at 37°C. Subsequently, 5x104 HeLa ATCC cells were seeded for seed-over 
experiments as in Fig. 3B. Depicted are relative infectious internalization values normalized to 48 h infection 
samples in percent ± SD (B). Absolute infection levels after 48 h upon preincubation with conditioned medium 
for 6 h or 16 h were normalized to DMEM preincubated infection samples. Relative infection values of 3 
independent experiments were depicted in percent ± SD (C). 
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3.6 Cyclophilin activity has only minor impact on the kinetics of HPV16 uptake 
L2 cleavage by furin is facilitated by the peptidyl-prolyl isomerase function of cyclophilins 
presumably by the externalization of the L2 N-terminus (Bienkowska-Haba, 2009 and 2012). 
Mutations in L2 that render the molecule more flexible (Fig. 5A) lead to a cyclophilin-
independent RG-1 exposure of the resulting virus particles (L2-GP-N HPV16) (Bienkowska-
Haba, 2009). However, cyclophilins are as well involved in intracellular uncoating of HPV16, 
where they mediate the separation of L1 from the L2/vDNA complex during endosomal 
trafficking (Bienkowska-Haba, 2012). Therefore, L2-GP-N HPV16 particles should still be 
sensitive to cyclosporine A treatment. Moreover, L2 N-terminal exposure likely precedes furin 
cleavage, therefore L2-GP-N mutant HPV16 should still be sensitive to furin inhibition. As a 
quality control, L2-GP-N mutant virus particle assembly and integrity were tested indirectly by 
infection in presence of cyclosporine A and furin inhibitor (Fig. 5B). As expected, L2-GP-N 
HPV16 and FPC-HPV16 were still sensitive to CsA treatment, due to the intracellular cyclophilin 
activity involved in separation of L1 and L2/vDNA subviral complex. Furthermore, L2-GP-N 
FPC-HPV16 particles retained their infectivity in the presence of furin inhibitor (Fig. 5B), 
indicating efficient furin precleavage during virus production as seen before (Fig. 1E). Therefore, 
L2-GP-N mutant HPV16 and FPC-HPV16 particles likely were similar to published particles and 
therefore suitable for our studies. 
The internalization kinetics of HPV16 and L2-GP-N HPV16 particles were compared in the 
infectious internalization assay. The internalization rates of L2-GP-N HPV16 were slightly but 
significantly increased at early time points after virus binding to cells as compared to normal 
HPV16 (Fig. 5C). At 4 h p.i., internalization of L2-GP-N HPV16 was increased about 3.6 fold 
over HPV16, and at 10 h p.i. a 1.5-fold higher internalization of L2-GP-N HPV16 was observed.  
Similarly, a significantly increased internalization at 16 h p.i. was observed when both viruses 
were compared in seed-over experiments (Fig. 5D). However, the observed effects were generally 
lower and resulted only in a 1.7 fold and 1.3-fold increase in L2-GP-N HPV16 internalization 
over HPV16 at 16 h and at 24 h p.i., respectively.  
These results suggested that exposure of the L2 N-terminus contributed slightly to asynchronous 
internalization at early time points post binding of standard HPV16 particles. So far only single 
time points were tested, from which significantly different trends in infectious internalization 
kinetics were expected based on the previous experiments with HPV16 and FPC-HPV16. 
Therefore, the half time of infectious internalization for L2-GP-N HPV16 was only roughly 
estimated and showed that L2-GP-N HPV16 internalized 10% faster than HPV16. This indicated 
that N-terminal exposure was rate limiting and that increased flexibility of the L2 protein was not 
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sufficient for a more pronounced increase in internalization. This may be due to the subsequent 
dependence on furin cleavage, which appears to be more strongly limiting and therefore could 
mask part of the cyclophilin effect. Alternatively, this may hint at still inefficient L2 N-terminal 
exposure, which may be obscured by only partial structural preprocessing as seen for KLK8 
cleavage. 
To test, whether the effect seen for the L2-GP-N mutant virus could be attributed to cyclophilin-
mediated L2 N-terminal exposure and therefore increased furin cleavage efficiency, L2-GP-N 
FPC-HPV16 particles were compared to FPC-HPV16. Surprisingly, the internalization rates were 
statistically indistinct for FPC-HPV16 and L2-GP-N FPC-HPV16 at all time points (Fig. 5E and 
F). However, it is likely that faster internalization of L2-GP-N HPV16 were the result of a 
modest increase efficiency of L2 N-terminus exposure. Possibly, using in vitro preprocessed furin-
cleaved virus, N-terminal exposure of the L2 N-terminus does no longer affect infectious 
internalization. To address the effect of more available N-termini on the efficiency of furin-
cleavage, experiments in presence of an excess of active furin would be helpful. This suggests 
that once furin cleavage has occurred as in L2-GP-N FPC-HPV16, cyclophilins likely played no 
further role in the rate of internalization.  
Taken together, our results indicated that furin cleavage was the main rate-limiting step of the 
conformational changes in HPV16 for infectious internalization. However, our results also 
suggested that further changes in the cellular state or the accessibility of the secondary receptor 
(complex) dictated the rate of virus internalization. 
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3.7 Towards raft-derived HPV16 as a tool to study HPV16 endocytosis 
This study suggested that structural modifications only partially contributed to slow and 
asynchronous HPV16 internalization. Therefore, it is likely that in additional cellular factors were 
rate limiting during HPV16 internalization. Previous studies suggested that virus particles derived 
Figure 5 CyPB activity slightly contributes to asynchronous internalization of HPV16 
Schematic depiction of the amino acid sequence of a putative CyPB binding motif in HPV16 L2 and of mutated 
HPV16 L2-GP-N (A). Furin and cyclophilin dependence during infection was tested by infection of 5x104 HeLa 
ATCC cells pretreated with 10 µM furin inhibitor Dec-RVKR-CMK or 10 µM cyclosporine A (CsA) or DMSO 
for 30 min. Cells were then infected with HPV16 (black), L2-GP-N HPV16 (dark grey), FPC-HPV16 (white), or 
L2-GP-N FPC-HPV16 (light grey) in presence of the respective inhibitor for 2 h. Medium was exchanged to 
growth medium with 10 mM NH4Cl at 12 h p.i. until harvest and analysis by flow cytometry at 48 h p.i.. Depicted 
are infection values relative to DMSO-treated controls in percent ± SD. Experiments with L2-GP-N mutant 
HPV16 or FPC-HPV16 were only conducted once, experiments with normal HPV16 and FPC-HPV were 
conducted twice (B). The infectious internalization kinetics of HPV16 (black) and HPV16 L2-GP-N (dark grey) 
were compared in add-on experiments as in Fig. 3A (C). Infectious internalization of HPV16 HPV16 (black) and 
HPV16 L2-GP-N (dark grey) were analyzed in seed-over experiments as in Fig. 3B (D). The infectious 
internalization kinetics of FPC-HPV16 (white) and FPC-HPV16 L2-GP-N (light grey) were compared in add-on 
experiments as in Fig. 3A (E). Infectious internalization of FPC-HPV16 HPV16 (white) and HPV16 L2-GP-N 
(light grey) were analyzed in seed-over experiments as in Fig. 3B (F). Shown are relative infectious internalization 
values normalized to 48 h infection samples in percent ± SD for all experiments. 
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from infected tissues are structurally preprocessed and associated with unknown cellular factors, 
due to the long residence time within the differentiating tissue and the virus shedding with 
cornified cells (Doorbar et al., 2012; Biryukov and Meyers, 2015; Cruz et al., 2015; Cruz and 
Meyers, 2013). 
To date, most of the studies on papillomavirus entry rely on recombinant particles extracted after 
transfection of monolayer producer cells, pseudovirion (PsVs), virus-like particles (VLPs) or 
quasivirus. In host cell tissues, however, virus assembly only occurs within the uppermost 
granular layers where the expression of structural proteins, L1 and L2, is upregulated due to its 
differential promoter activation with the tissue (Doorbar et al., 2012). To achieve resembling 
conditions, close to the in vivo situation, virus production within a differentiating organotypic raft 
tissue has been established (McLaughlin-Drubin and Meyers, 2005; Biryukov et al., 2015). This 
yields raft-derived HPV16 particles, which were produced in a multilayered, differentiated 
epithelium. However, due to its production within an in-vitro tissue, raft-derived particles come 
in a suspension with usually low titer and large amounts of cellular debris, which is therefore not 
directly comparable to HPV16 PsVs purified on OptiPrep gradients. This likely gave rise to 
conflicting reports concerning host cell factors required for HPV16 endocytosis. HPV16 PsVs 
and raft-derived particles are morphologically indistinct and similarly neutralized by L1 
neutralizing antibodies, raft-derived HPV16 particles are neutralized by the cross-neutralizing 
RG-1 antibody against L2 (Conway et al., 2009b). This suggests that raft-derived HPV16 particles 
come in a structurally preprocessed conformation. So far, no studies have directly compared 
endocytosis and infectious internalization dynamics of raft-derived HPV16 and HPV16 PsVs, 
which would provide valuable information on possible structural priming of virus particles or 
host cell factors required. During this study, HPV16 production in organotypic raft culture was 
established, raft tissues were characterized and raft-derived HPV16 was purified for future 
comparative studies. 
Raft-derived virus production was set up in 20-day organotypic raft cultures. In brief, HPV16-
transduced keratinocytes were grown on the air-liquid interface for 20-days on a collagen-
fibroblast support matrix. After 20 days, differentiated tissues were harvested, homogenized and 
benzonase treated. Extracted virus particles were separated from the bulk cellular material by 
differential centrifugation, which yielded a crude virus extract. The extracted crude raft-derived 
HPV16 was tested for infectivity and neutralization by qRT-PCR on the relative amount of early 
splice transcript E1^E4 after infection in presence or absence of neutralizing L1 antibody 
H16.V5. We found that infection was efficiently reduced by about 88%±12% as expected (Fig. 
6A). From this we concluded that our raft-derived HPV16 particles were assembled correctly.  
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Organotypic raft-tissue based virus production yields low viral titers, which make the virus 
production time consuming and costly (Biryukov and Meyers, 2015). Optimization of the tissue 
differentiation may be a way to improve virus yields. Organotypic raft tissues were, therefore, 
characterized for tissue morphology and differentiation. Mature 20-day tissues were embedded in 
paraffin and stained with H&E staining after thin sectioning. The tissues formed thin-layered 
epithelia including pronounced stratified layers (Fig. 6B #1), comparable to previous studies 
(Conway et al., 2009b). This suggested that in vitro differentiation of the tissues was successful. 
Interestingly, some thicker regions within the epithelium showed tumor-like growth within upper 
layers of the tissue interspersing the stratified layers (Fig. 6B #2). This phenotype coincided with 
low virus titers derived from the tissues and indicated, that the episomal viral genome was 
incorporated into the host cell genome, which led to a tumor-like cell growth and a concurrent 
loss of virus production as observed for malignant lesions (Doorbar, 2005).  
To test whether raft-derived HPV16 depended on the same host cell factors during endocytosis, 
infections with crude raft-derived HPV16 were performed in presence of selected small molecule 
inhibitors as for FPC-HPV16 before. When HaCaT cells were pretreated with aphidicolin, which 
blocked cells in S-phase and therefore nuclear import of HPV16 (Aydin et al., 2014), infection 
with HPV16 PsV was reduced in presence of 0.2 µM aphidicolin to 36%±20% as compared to 
solvent-treated control. Surprisingly, raft-derived HPV16 infection increased dose-dependently, 
when the inhibitor concentration was increased to completely abolish infection (Fig. 6C; compare 
Fig. 2I). To exclude that this was specific for block of cell cycle progression with aphidicolin, 
HaCaT cells were incubated with actin depolymerizing agent cytochalasin D and infected with 
raft-derived HPV16. Similarly, after treatment with low concentrations of cytochalasin D 
infection was reduced to maximally 32%±8%. Higher inhibitor concentrations, however, 
increased infection to levels above DMSO control (Fig. 6D). Analysis of the raw data from qRT-
PCRs revealed high variability among the C(t) values of the cellular control transcript Tata-box 
binding protein (TBP) upon inhibitor treatment. This likely reflects different tolerances for small 
molecule compounds when crude raft-derived HPV16 was present. This may be a combined 
effect resulting from cytotoxicity of the chemical itself and the presence of huge amounts of 
cellular fragments in the crude virus preparation with may induce changes in transcription. These 
results suggested that analysis of the raft-derived HPV16 infection levels in presence of small 
chemical inhibitors and cellular debris from the virus preparations by qRT-PCR using the ΔΔC(t) 
method caused artefacts in the analysis. Consequently, raft-derived virus particles would have to 
be purified to limit the effects disturbing the analysis. 
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Nonetheless, we also wanted to analyze whether raft-derived HPV16 depended on structural 
modifications such as KLK8 cleavage of L1 upon binding to the cells with the available material. 
Therefore, KLK8 expression was transiently disrupted by siRNA-mediated KLK8 knock downs 
in HeLa ATCC cells. Transfected cells were infected with crude raft-derived HPV16. Knock 
down of KLK8 with two different siRNAs affected infectivity of raft-derived HPV16 only mildly 
with a maximal reduction by about 40% for one siRNA (Fig. 6E), whereas infection with HPV16 
PsVs was efficiently reduced under similar conditions (compare (Cerqueira et al., 2015); Fig. 
4A/B). Still, a trend towards reduction of infection was observable, which suggested that KLK8 
cleavage may be required for infection with raft-derived HPV16. This would argue against a 
structural preprocessing on raft-derived HPV16 particles during their production. 
In summary, infection experiments with non-purified raft-derived HPV16 particles were 
inconclusive and induced artifacts in the analysis. Consequently, density gradient purification of 
virus particles would be a prerequisite for further studies with raft-derived HPV16, which may 
reduce side effects introduced by cytotoxicity. Crude raft-derived HPV16 was added on top of an 
OptiPrep step-gradient of 27%, 33% and 42% and separated by ultracentrifugation for 10 h at 
48000 rpm. Subsequently, fractions were taken from bottom to top. The distribution of viral 
genomes within the gradient was analyzed by SYBRgreen-based qPCR after lysis of the capsids. 
The majority of virus particles resided in the upper fractions (Fig. 6F #8-#10). Fractions with 
highest genome contents were subjected to negative staining EM. Single virus particles were 
detected in the tested fractions (Fig. 6G F#9/F#10), which was impossible before separation by 
ultracentrifugation. Surprisingly, virus particles still appeared to be associated with cellular 
material, which also was found in respective fractions (Fig. 6G F#10; SDS-PAGE with 
coomassie staining, data not shown). The virus yield was assessed after purification relative to the 
input material: only about 20-30% of input material was recovered after purification. In summary, 
we concluded, that purification of raft-derived HPV16 was partially achieved by 
ultracentrifugation on an OptiPrep step gradient; however, conditions still required optimization 
due to only partial removal of cellular material and relatively low recovery. 
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In addition to its application in virus production, organotypic raft culture could be used as an in 
vitro tissue infection model to study questions like superinfection of HPV positive cells or to 
investigate the HPV cell tropism within a differentiated tissue. 
The differentiation state of HPV16-transduced and primary tissues was analyzed by cryo-
sectioning and immunofluorescence staining. Immunofluorescence staining with tissue 
differentiation markers K10 for suprabasal cells and Loricrin for the cornified layers showed that 
HPV16-positive and -negative tissues efficiently differentiated in layered epithelia after 20-day or 
 
Figure 6 Purification of raft-derived HPV16 is essential for host cell entry studies 
Tissues from 20-day organotypic raft cultures were paraffin-embedded, sectioned, and H&E stained. Depicted are 
two sections from different parts of the tissue (A). 7.5x104 HaCaT cells were infected with raft-derived HPV16 at 
MOI 10 or raft-derived HPV16 preincubated for 60 min with H16.V5 neutralizing antibody. At 48 h p.i., cells 
were harvested, lysed, and total RNA was extracted for subsequent analysis of expression of E1^E4 early splice 
transcript by reverse transcription qPCR (qRT-PCR). Threshold cycle values were related to the cellular control 
TBP and normalized using the ΔΔC(t) method. Shown are results of three independent experiments ± SD (B). 
HaCaT cells were preincubated with aphidicolin overnight (C) or with cytochalasin D for 30 min (D) with the 
indicated concentration of each small molecule inhibitors. Cells were infected with raft-derived HPV16 in the 
presence of the inhibitors as in A). At 12 h p.i., medium was exchanged to growth medium with 10 mM NH4Cl 
until harvest and analysis by qRT-PCR after 48 h p.i.. Depicted are infection values relative to DMSO-treated 
controls in percent ± SD. HeLa ATCC cells were reverse transfected with 10 nM siRNAs directed against KLK8 
or non-targeting control siRNA (AllNeg). Cells were infected with raft-derived HPV16 at 48 h post transfection. 
Infection was determined at 48 h p.i. by RNA extraction and qRT-PCR as above. Depicted is the expression of 
E1^E4 in infected cells relative to the number of negative-control cells. Values are the means of three 
independent experiments with standard deviations (E). Raft-derived HPV16 was separated from cellular material 
on an OptiPrep step-gradient (27%, 33%, and 42%) by ultracentrifugation. Fractions were collected from bottom 
to top. Genome distribution within the fractions was analysed by lysis of capsids and subsequent SYBRgreen-
qPCR on viral genomes. Genome distribution was plotted relative to the sum of total genomes recovered from 
the gradient. Values are averaged from two independent experiments with standard deviations (F). Raft-derived 
HPV16 particles from respective fractions were analyzed by negative staining electron microscopy. Depicted are 
representative images of virus particle. Scale bars represent 100 nm (E).  
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15-day raft culture, respectively (Figure 7). Basal cell staining K14, however, was difficult possibly 
due to an old antibody and will be repeated in future experiments. Comparison of the Hoechst 
staining of HPV16-transduced tissue and primary tissues revealed that HPV16-positive tissues 
possessed a more densely packed phenotype, as judged by more nuclei per area. This suggested 
that tissues in presence of HPV16 genomes showed a stronger proliferation phenotype, as it 
would be expected in the presence of viral oncoproteins E6 and E7 and reflect the life cycle of 
HPVs (Doorbar, 2012). 
In conclusion, organotypic raft culture yielded likely fully differentiated tissues, which could serve 
as a future model system for in-vitro 3D tissue infections and superinfections. 
 
Figure 7 Organotypic raft-tissues are fully differentiated 
15-day primary organotypic raft tissue (left) and 20-day HPV16-positive organotypic raft tissues (right) were 
trimmed, embedded in cryo-freezing medium, and flash frozen with liquid nitrogen. 6-10 µm thick sections were 
cut on a Leica CM 3050 cryomicrotome at -15°C, transferred to glass slides and stored at -20°C. 
Immunofluorescence stainings were performed with K10 (suprabasal marker), or Loricrin (cornified layer marker) 
and co-stained with Hoechst (nuclei). Tissues were covered with mounting medium and sealed with cover slips. 
Confocal images were taken with a Zeiss LSM 780 confocal laser-scanning microscope. Presented are maximum 
intensity projections of 3 confocal slices.  
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3.8 Internalization of ECM-bound FPC-HPV16 is faster and more synchronous after 
cell cycle synchronization 
As structural modifications of the virus particle only accounted partially for slow and 
asynchronous infectious internalization of HPV16, possibly cellular factors were responsible for 
the remaining part of the asynchrony. Cells are strongly remodeled while they progress through 
the cell cycle. Possibly HPV16 endocytosis is dependent on cell cycle progression.  
In line with that, HPV16 import into the nucleus is linked to cell cycle progression, as it requires 
nuclear envelope breakdown (NEBD) to access the nuclear space (Aydin et al., 2014). Moreover, 
in a recent study cell cycle synchronization results in a more synchronous overall entry and leads 
to a reduction of the time until reporter gene expression by 50% as compared to unsynchronized 
cells (Broniarczyk et al., 2015). To assess, whether certain cell cycle stages would facilitate 
endocytosis of HPV16, the infectious internalization rates of HPV16 and FPC-HPV16 were 
tested in synchronized cells in comparison to non-synchronized cells. Cells were synchronized by 
a double thymidine S-phase arrest (Fig. 8A). The distribution of the cell populations within the 
cell cycle phases was analyzed by propidium iodide staining. The DNA intercalating dye is used 
to distinguish cells by their DNA content, which is increased due to DNA synthesis during S-
phase and reaches its peak in G2 phase (Krishan, 1975). Following the cells over several hours 
after release of the thymidine block revealed that the cells showed a synchronized mitotic activity 
around 8-10 h after the release (Fig. 8D). Cells majorly in G1/S phase transition were infected 2 
h post thymidine release with HPV16 and FPC-HPV16 either in seed-over or add-on conditions. 
Interestingly, we found that the half time of FPC-HPV16 internalization was reduced by about 
5 h or 40% upon cell cycle synchronization in seed-over experiments, (Fig. 8B), whereas there 
was no significant difference observable in the add-on experiments with FPC-HPV16 (Fig. 8C). 
Furthermore, the internalization rates of HPV16 remained unchanged irrespective of cell 
synchronization (data not shown). 
While this indicated that cell cycle synchronization did not reduce the asynchrony of virus 
internalization in general, internalization of ECM-bound FPC-HPV16 appeared to be strongly 
affected. This indicated that rate-limiting factors, which slowed down the release of ECM-bound 
terminally restructured particles, were reduced by cell cycle synchronization. This could either be 
due to enhanced secretion of matrix remodeling factors which may be required for faster release 
of FPC-HPV16 from the extracellular matrix, or due to increased availability of interaction with 
the internalization receptor due to remodeling of the plasma membrane during cell cycle 
progression. Since this effect was only observed in the seed-over experiment, the data may point 
towards a faster transfer from the ECM to the cell surface in synchronized cells. However,  
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further experiments are required to validate either of these possibilities.  
Figure 8 ECM-bound FPC-HPV16 internalizes faster upon cell cycle synchronization  
Schematic depiction of cell cycle synchronization by double thymidine block; HeLa ATCC cells were seeded 8 h 
prior to 16 h thymidine treatment. Cell cycle arrest was released by wash out of thymidine. Cells were left 
untreated for 9 h, before a second treatment with thymidine for 16 h. Thymidine was washed out and cells were 
used for infectious internalization experiments about 2.5 h post release (A). Infectious internalization of FPC-
HPV16 with synchronized (black) and non-synchronized (grey) cells were performed in seed-over experiments as 
in Fig. 3B (B). Infectious internalization kinetics of FPC-HPV16 (black) with synchronized (black) and non-
synchronized (grey) were performed in add-on experiments as in Fig. 3A (C). Relative infectious internalization 
values were normalized to 48 h infection samples in percent ± SD. Non-synchronized or synchronized HeLa 
ATCC cells were fixed with ethanol at indicated times and stained with propidium iodide for analysis of their 
DNA content. Cells were analyzed by flow cytometry and cell cycle phases were quantitated by Gaussian fitting of 
the cell populations with FlowJo. Sum of cell populations at each time point was used for normalization. Shown 
are the values from a single experiment (D). 
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3.9 The accessibility of the secondary receptor for virus interaction is limited 
As mentioned above, previous results indicated a transfer from HSPGs to a secondary receptor 
necessary for infectious endocytosis (Selinka et al., 2007). The available data suggested that these 
were facilitated by conformational changes in the virion (Day et al., 2007; Selinka et al., 2007; Day 
et al., 2008b; Cerqueira et al., 2013; Raff et al., 2013; Day and Schelhaas, 2014). Hence, terminally 
modified particles should be able to engage this receptor directly. Binding to HSPG-deficient 
cells has been observed with HPV16 and FPC-HPV16 particles, however, their affinities have 
not been directly tested in comparison to binding to HSPGs (Selinka et al., 2007; Day et al., 
2008b; Raff et al., 2013). To test the availability of the secondary receptor for infectious 
internalization, FPC-HPV16 particles were used to infect cells with severely reduced sulfation of 
glycosaminoglycans (GAGs). For this, cells were pretreated with NaClO3, which results in 
undersulfation of GAGs (Humphries and Silbert, 1988; Safaiyan et al., 1999), before infection 
with HPV16 and FPC-HPV16. As expected, HPV16 were unable to infect NaClO3-treated cells 
(Fig. 9A, B, HPV16, (Cerqueira et al., 2013)). Infection was reduced to 25%±3% and to 5%±2% 
in seed-over and add-on experiments, respectively (Fig. 9A, B, HPV16). In contrast, FPC-HPV16 
efficiently infected NaClO3-treated cells, when previously bound to ECM to 70%±15% 
infectivity of the untreated controls (Fig. 9A, FPC-HPV16). This indicated that structural priming 
of the capsid enabled FPC-HPV16 to infect HSPG-deficient cells after attachment to ECM. 
To our surprise, infection of FPC-HPV16 was not restored, when the particles were directly 
added to NaClO3-treated cells (Fig. 9B, FPC-HPV16), which was indicative of the inability to 
bind to these cells. This suggested that, despite structural priming of FPC-HPV16, the affinity to 
the internalization receptor remained low. 
To verify that virus binding to cell surface receptors was perturbed, we quantified the amount of 
HPV16 and FPC-HPV16 binding to NaClO3-treated cells using particles that were covalently 
labeled with fluorophores. Microscopy showed that HPV16 and FPC-HPV16 readily bound to 
untreated HeLa and HaCaT cells (Fig. 9C, virus grey and green, actin red). However, binding of 
HPV16 and FPC-HPV16 was lost almost completely in cells pretreated with NaClO3 (Fig. 9C, 
HPV16 black, FPC-HPV16 white). Quantification virus signal detected per area occupied by cells 
in random fields of view confirmed this observation, as relative binding to treated HeLa ATCC 
cells was reduced to 2%±2% or 4%±2% (HaCaT 5%±1% and 9%±4%) for HPV16 and FPC-
HPV16, respectively. Despite the low overall binding, the data suggest a slightly more efficient  
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Figure 9 FPC-HPV16 fails to directly interact with the secondary receptor 
HPV16 (black) or FPC-HPV16 (white) was bound to ECM derived from HaCaT cells as in Fig. 3B. HeLa ATCC 
or HaCaT cells were treated with 50 mM NaClO3 for 2 days or left untreated and used for seed-over infection 
experiments. Cells were harvested and analyzed by flow cytometry for GFP-expression (A). HeLa ATCC or 
HaCaT cells were treated with 50 mM NaClO3 for 2 days and subsequently infected with HPV16 (black) or FPC-
HPV16 (white) in add-on experiments as in Fig. 2 (B). Relative infection values were normalized to 48 h infection 
samples of untreated cells in percent ± SD. AF488-labeled HPV16 (grey/green, upper panel) or FPC-HPV16 
(grey/green, lower panel) particles were added to untreated or NaClO3-treated HeLa ATCC (C) or HaCaT (D) 
cells for 1 h for binding. Cells were fixed and stained for F-actin with Atto-647-phalloidin (red). Image stacks 
through the whole cells were acquired on a spinning disc confocal microscope. Shown are maximum intensity 
projections of representative cells from one of at least 3 independent experiments. For quantification, the virus 
signal was overlayed with a cell mask from the phalloidin channel; virus intensities were measured with a cell 
profiler pipeline, related to the cell area and normalized to the virus signal/cell area of untreated cells. For each 
condition, more than 150 cells were analyzed (C/D). 
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binding trend for FPC-HPV16, which could hint at a minimal advantage for internalization 
receptor binding upon structural priming. 
Treatment with NaClO3 globally reduces O-sulfation of heparin sulfates to about 30% of the 
levels in untreated controls (Safaiyan et al., 1999). To abolish residual effects due to the reversible 
treatment, binding and infection experiments were validated using CHO cells and pgsA-745 cells, 
which completely lacked GAGs due to a mutation in the xylosyltransferase gene (Esko et al., 
1985).  
When similar virus amounts were used for binding and infection in parental CHO and pgsA-745 
cells, no significant binding to pgsA-745 cells was seen as compared to the parental control (Fig. 
11A, HPV16 and FPC-HPV16 left panels). When ten times more virus was used, large aggregates 
were present on CHO cells, which may be induced by hydrophobic interaction of the 
fluorophores attached to the virus particles or indicate clustering of virus in certain membrane 
regions. However, still very few virus particles associated with the surface of pgsA-745 cells using 
similar amounts of HPV16 and FPC-HPV16 (Fig. 10A, HPV16 and FPC-HPV16 right panels). 
This is in line with the results from NaClO3-treated cells and strengthens the notion of low 
affinity binding to the internalization receptor in absence of HSPGs. 
To check, whether minimal binding to pgsA cells resulted in a rescue of infection, virus amounts 
were adjusted to an infection level of 20% for parental CHO. Infection of pgsA cells with that 
same amount did result baseline level of infection – even when the virus amount was increased 
ten times, infection of pgsA cells was not rescued (Fig. 10B). However, even though the 
differences in the infection levels of HPV16 and FPC-HPV16 were not significant, a slight trend 
towards higher infection by FPC-HPV16 was seen, which indicated that structurally processed 
virus is internalized slightly better, but still inefficiently. Day and colleagues reported similar 
observations (Day et al., 2008b), where FPC-HPV16 bound and infected pgsA and chlorate-
treated cells more efficiently. However, in our hands these effects were not statistically 
significant. 
In conclusion, these experiments suggested that FPC-HPV16 infection was independent from 
HSPG interaction. However, the loss of binding and infection upon direct addition to NaClO3-
treated or GAG-deficient cells indicated either that the affinity for the internalization receptor 
was low or the internalization receptor was not readily available for binding on the cell surface. 
Therefore, receptor availability could be rate limiting during HPV16 endocytosis. 
  
85 Results 
3.10 RNAi confirms the importance of potential secondary receptor candidates 
To explore the potential limited availability of the HPV16 internalization receptor, previously 
described receptor candidates were analyzed for their importance for HPV16 infection. 
To date, the internalization receptor for HPV16 endocytosis is still under debate. Several receptor 
candidates have been described previously: α6-integrin, epidermal growth factor receptors, 
tetraspanin CD151, and annexin A2 heterotetramer have been put forward based on their 
requirement for HPV16 entry (Schelhaas et al., 2012; Surviladze et al., 2012; Evander et al., 1997; 
Yoon et al., 2001; Spoden et al., 2008; Scheffer et al., 2013; Dziduszko and Ozbun, 2013; 
Woodham et al., 2012; McMillan et al., 1999; Woodham et al., 2015). Desmosomal cadherin 
DSG1 was identified in pull down experiments with FPC-HPV16 on pgsA cells (P. Day, personal 
communication). Potential receptor candidates were tested on a targeted siRNA screen, which 
 
Figure 10 Low affinity binding of FPC-HPV16 to secondary receptor on HSPG-negative cells 
Different amounts of AF488-labeled HPV16 (grey/green, left panel) or FPC-HPV16 (grey/green, right panel) 
particles were bound to parental CHO cells (upper panel) or HSPG-negative pgsA-745 cells (lower panel) for 1 h. 
Cells were fixed and stained for F-actin with Atto-647-phalloidin (red). Image stacks through the whole cells were 
acquired on a spinning disc confocal microscope. Shown are maximum intensity projections of representative cells 
from one of at least 3 independent experiments (A). Parental CHO cells or pgsA-745 cells were infected with 
HPV16 (black) or FPC-HPV16 (white) in add-on experiments as in Fig. 3B. Virus amounts were adjusted yield 
20% absolute infection in parental CHO cells in standard experiments (B, left bars). Infectivity on pgsA cells was 
further tested with the 10x virus amount of the previous standard experiment (B, right bars). Relative infection 
values were normalized to 48 h infection samples of untreated cells in percent ± SD (n≥3). 
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was designed based on literature, previous results on interactions and a previous RNAi screen 
(Blattmann, 2008). 
We aimed to confirm the receptor candidates in a 96-well based unified experimental setup, 
where each protein was targeted with three different siRNA nucleotides. A factor was considered 
a hit, when two or more siRNAs reduced infection with HPV16 by more than 50% relative to 
infection levels in allstar negative siRNA treated control cells. Further, the experiments were 
controlled for transfection and silencing efficiency with allstar death siRNA and anti-GFP 
siRNA, which leads to the death of the cells or reduces the GFP expression from the HPV 
pseudogenome, respectively. HeLa Kyoto cells were targeted with the siRNAs by reverse 
transfection and subsequently infected with HPV16 at 48 h post transfection. Cells were fixed 
and analyzed for nuclear signal and GFP expression by automated microscopy. Images analysis 
was performed using MATLAB (MathWorks) script “infection counter” (Engel et al., 2011) to 
score for cell numbers and infected cells. Cytotoxic siRNAs were excluded from the analysis, 
when they reduced the cell numbers more than 90% as compared to allstar negative siRNA 
treated control. 
Receptor candidates CD151, ITGa6, DSC3, DSG1 and DSG3 were tested, which have been 
described to be involved in cell-ECM and cell-cell contact formation. Tetraspanin CD151 is 
involved in dynamic microdomain formation in the plasma membrane, where it associates with 
other tetraspanins or integrins in tetraspanin-enriched microdomains (TEMs). Laminin-binding 
integrin α6 is found with integrin β4 and laminin-332 in hemidesmosomal structures, where it 
also associates with CD151. Desmosomal cadherins DSC3, DSG1, and DSG3 are building 
blocks of desmosomes, which mediate cell-cell adhesion.  
RNAi experiments validated three receptor candidates, which strongly influenced infection. For 
tetraspanin CD151 knock down, all three different siRNAs reduced infection to below 50% (Fig. 
11A), while cell numbers were not strongly affected by the treatment. Moreover, we found that 
desmosomal cadherins DSC3 and DSG3 were of importance for HPV16 infection as knock 
down of either protein reduced infection by more than 50% for at least two siRNAs. However, 
desmosomal cadherin DSG1 did not influence infection in a comparable manner as none of the 
siRNAs reduced HPV16 infection to below 50% compared to control treatment (Fig. 11A). 
However, desmosomal cadherin DSG1 did not influence infection in a comparable manner as 
none of the siRNAs reduced HPV16 infection to below 50% compared to control treatment 
(Fig. 11A). Cells numbers remained mostly unaffected or only slightly affected by siRNA 
treatment, indicating that siRNA treatment did not cause off-target effects or affected cell 
  
87 Results 
viability. Only siRNA3 against DSG1 showed reproducibly high cytotoxicity, which reduced cell 
numbers below 10% of the Allstar negative control and was therefore excluded from the analysis 
(Fig. 11B). 
CD151 was previously described to co-internalize with HPV16, where its association with 
integrins was required (Scheffer et al., 2013). Our data support the importance of CD151 for 
HPV16 infection. Desmosomal cadherins DSC3 and DSG3 are novel receptor candidates, which 
indicate that interaction with cell-cell contacts is involved HPV16 endocytosis.  
Interestingly, knock down of integrin α6 did not match the criteria for hit selection; none of the 
three siRNAs reduced infection by more than 50% and one siRNA even increased infection to 
over 100% (Fig. 11A). This suggested that either ITGα6 was not required for HPV16 infection 
or that knock down conditions in these experiments were not sufficient to reduce protein levels 
to critical levels. Therefore, future validation of protein knock down levels is essential for final 
conclusions. ITGα6 has been a long-standing candidate as HPV16 receptor as binding of HPV 
VLPs was efficiently blocked with ITGa6 antibodies and VLP binding correlated with high 
expression levels of ITGα6 ((Evander et al., 1997; Yoon et al., 2001), respectively) – however, 
direct binding data was never shown. Furthermore, it was shown for HPV11 that infection of 
cells devoid of ITGα6β4 was possible and that ITGα6 was not essential for HPV16 infection in 
vivo (Shafti-Keramat et al., 2003; Huang and Lambert, 2012). Therefore, the role of ITGα6 in 
HPV16 endocytosis is questionable and remains to be clarified. 
EGFR signaling has been shown to be involved during internalization of HPV16 particles 
((Schelhaas et al., 2012; Bannach, 2014). Initial virus binding likely activates EGFR signaling due 
to clustering of HPSGs and EGFR underneath the virus particles. Furthermore, EGFR is 
activated later during HPV16 internalization, where it is important for pit formation (Kühling, 
2015). 
Therefore, all EGFR family members were analyzed by siRNA knock down for their 
involvement in infection. Surprisingly, knock down of several EGFR isoforms strongly reduced 
infection in all targets by more than 50% (Fig. 11C). Cells numbers were reduced by siRNAs 
against ERBB2, ERBB3 and ERBB4, which could be the result of less cell proliferation due to 
knock down of compared to allstar negative control siRNA treated cells (Fig. 11D). This 
suggested that maybe these EGFRs affect HPV16 infection indirectly, possibly by reduced cell 
proliferation, which is required for HPV infection (Pyeon et al., 2009). Taken together, these 
results indicated that EGFR was involved in HPV infection. However, it is likely that different 
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EGFR isoforms have indirect effects on HPV infection, as they may be involved in different 
cellular processes, which are required during HPV16 infection.  
AnnexinA2 (AnxA2) is a Ca2+-dependent membrane-binding protein, which is involved in 
endocytic and exocytic processes (Rescher and Gerke, 2008). AnxA2 forms a heterotetrameric 
complex (A2t) with S100A10 (p11), which enables it to interact with two membranes 
simultaneously (Lambert et al., 1997). During HPV16 entry, it was proposed that extracellular 
A2t associates with HPV16 particles, where it is part of an internalization receptor complex and 
mediates membrane bending (Raff et al., 2013; Woodham et al., 2012; Dziduszko and Ozbun, 
2013). 
Here, AnxA2 and S100A10 siRNAs did not clearly validate the proposed role of A2t in HPV16 
internalization. Only one of 3 siRNAs against AnxA2 clearly reduced infection below 50% of the 
control. For S100A10 all three siRNAs reduced infection slightly but only one of the three 
reduced infection below 50% (Fig. 11E). Cell numbers remained largely unaffected by RNAi 
treatment, except for siRNA1 against AnxA2, which reduced cells numbers about 50% but also 
showed a very variable effect on HPV16 infection (Fig. 11G). This indicated that the siRNA 
treatment did not have cytotoxic side effects. Validation of the protein knock down levels 
revealed that reduction in protein did not correlate with observed reduction of infection (Fig. 
11F). This suggested that side effects of AnxA2 and S100A10 knock down rather than 
requirement for the proteins themselves reduced HPV16 infection. Additionally, two HeLa cell 
lines with an inducible shRNA expression against AnxA2 were tested for HPV16 infection 
(Woodham et al., 2012). Surprisingly, similar reduction of infection was observed in cell lines 
expressing in AnxA2 knock down cells as well as in cells expressing a non-targeting control 
shRNA (data not shown, n=1), whereas infection of parental HeLa cells was possible. Taken 
together these results suggested that A2t was not directly required during internalization of 
HPV16. 
All internalization receptor candidates had at least a partial effect on HPV16 infection, which 
made it difficult to exclude possible candidates. Most likely, from these results and the literature, 
tetraspanin CD151, EGFRs and possibly desmosomal cadherins play an important role during 
internalization. On the other hand, our results indicate that AnxA2 and S100A10 are not essential 
for HPV16 infection. However, due to the high throughput setup of these RNAi experiments, 
results still have to be validated in follow up experiments to determine knock down efficiencies 
and correlation between knock down and reduction of infection. 
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3.11 Low incidence of co-localization of HPV16 with CD151 and EGFR  
The most prominent internalization receptor candidates were CD151 and EGFR. CD151 has 
previously been described to co-localize and co-internalize with HPV16, however most 
experiments have been carried out when CD151 was overexpressed. Terminally restructured 
particles are thought to transfer to the secondary receptor and would therefore co-localize at 
some point. Due to the asynchronous internalization we figured that at any time HPV16 should 
be found co-localizing with receptor candidates, however in low incidence. We examined 
whether co-localization of HPV16 with CD151 and EGFR could be detected separately or in 
combination. For this AlexaFluor-labeled HPV16 particles were bound for 2-6 h to HeLa ATCC 
 
Figure 11 Internalization receptor candidates are validated in targeted siRNA experiments 
HeLa Kyoto cells were reverse transfected with 10 nM of the indicated siRNAs. Cells were subsequently infected 
with HPV16 at 48 h post transfection and fixed at 48h p.i.. Nuclei were stained with RedDot2 and images were 
acquired by automated microscopy. Infection levels were determined using Matlab Infection counter and 
normalized to infection levels in Allstar negative transfected control cells. Depicted are average infection values 
and cell numbers relative to allstar negative transfected controls and standard deviations from three independent 
experiments (A-E/H). Western blot analysis of protein knock down levels for AnxA2 and S100A10 after siRNA 
transfection, α-tubulin was used as a loading control (F/G). 
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cells and subsequently cells were stained for endogenous CD151. The membranous staining 
resembled signal from expression of CD151-GFP, which was used as a control for the antibody 
staining, and endogenous staining as seen in by Spoden and colleagues (Spoden et al., 2008). 
CD151 was highly abundant all over the basolateral surface and also formed localized patches, 
which possibly represented tetraspanin-enriched microdomains (TEMs). HPV16 particles 
partially co-localized with CD151 patches (Fig. 12A).  
Next, co-localization of HPV16 particles with EGFR was analyzed, however, antibody staining 
was challenging concerning its reliability and reproducibility. This may be due to inaccessible 
EGFR epitopes in presence of HPV16 as the virus may block binding of the antibody. This was 
supported by the observation that EGFR signal was rather excluded from spots where HPV16 
was bound (data not shown). Therefore, transient transfections with EGFR-YFP were used for 
subsequent HPV16 binding experiments. HPV16 bound to the cell surface always overlapped 
with the very abundant EGFR-YFP distributed all over the cell surface. Occasionally, EGFR-
YFP signal showed localized maxima hinting at clustering of EGFR receptors, which also in part 
co-localized with bound HPV16 (Fig. 12B). 
Finally, AF-labeled HPV16 was bound to EGFR-YFP transfected cells and stained for CD151 
after fixation. Several virus particles bound to the cell surface of transfected or untransfected 
cells. We noticed that CD151 and EGFR patches only occasionally overlapped. Accordingly, co-
localization of CD151, EGFR and HPV16 occurred only rarely (Fig. 12C).  
These results suggested that co-localization studies were challenging due to asynchronous 
interaction of single HPV16 with the internalization receptor. As internalization itself has been 
shown to be rather quick (Schelhaas et al., 2012), interaction of HPV16 with the internalization 
receptor might also only occur briefly or only be briefly visible on the cell surface. We concluded 
that synchronization of HPV16 internalization would be essential for further studies. 
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Figure 12 Potential secondary receptor interaction of HPV16 occurs at low incidence 
Fluorescently labeled HPV16 was bound to HeLa ATCC cells for 6 h before cells were fixed and were 
immunostained with a CD151 antibody without permeabilization (A). Fluorescently labeled HPV16 was bound for 6 
h to HeLa ATCC cells, which were transfected with EGFR-YFP 24 h prior to experimentantion. Subsequently, cells 
were fixed and mounted without permeabilization (B). For triple co-localization experiments, HeLa ATCC cells were 
transfected with EGFR-YFP 24 h prior to experimentantion. Labeled HPV16 was bound to transfected cells for 4-6 
h. Cells were fixed and stained for CD151 as in A). Z-stacks were acquired with a Zeiss LSM 780 confocal laser-
scanning microscope. Presented are maximum intensity projections of confocal slices though the whole cell. 
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3.12 Super resolution imaging reveals localization of HPV16 to CD151 patches 
Co-localization of internalization receptor candidates with virus particles was challenging and 
occurred only at very low incidence. It was previously shown that destabilization of the actin 
cytoskeleton perturbs HPV16 internalization and leads to the formation of long membrane 
tubules, which contain high amounts of virus particles (Schelhaas et al., 2012; Kühling, 2015). 
According to our current model, these membrane tubules arise from endocytic pits, which failed 
be released from the plasma membrane. In that case, it would be likely that these tubular 
structures are enriched in virus particles, which are associated with their internalization receptor. 
To identify the receptor components and possibly the arrangement of an internalization platform 
within the plasma membrane, co-localization of HPV16 and receptor candidate CD151 was 
assessed using super resolution microscopy.  
Stochastic optical reconstruction microscopy (STORM) relies on repeated imaging of 
photoswitchable fluorophores on a sample. By sparse activation of fluorophores single point-
spread functions (PSF) can be determined and used for calculation of precise localization of the 
fluorophore by Gaussian fitting. In conventional microscopy, this is impossible as activation of 
all present fluorophores leads to overlapping and interfering PSFs. To reach higher resolutions, 
we used an experimental 3D STORM setup by Daniel Böning (Böning, 2015), which reached a 
voxel size of 12-15 nm in direct dual color experiments.  
We bound fluorophore-labeled HPV16 to cytochalasin D treated or untreated HeLa ATCC cells 
and subsequently stained the cells with CD151 antibody for STORM measurement of single 
cells.In untreated cells, single HPV16 particles were found to locate in or above small CD151 
patches (Fig. 13). Only few large virus aggregates were visible on the cell surface. However, a 
large fraction of virus particles did not co-localize with CD151 patches, which possibly 
represented particles still bound to the primary heparan sulfate receptor. Co-localization, 
estimated from a single experiment (2-3 cells per condition), of HPV16 with CD151 spots was in 
untreated cells only about 5-10%. Upon treatment with cytochalasin D, however, it was roughly 
doubled to about 15-20%. 
When we compared cytochalasin D treated with untreated cells, we observed that the CD151 
signal formed larger patches and even aggregates, which was likely due to cell contraction in the 
periphery upon actin depolymerization (Fig. 14). However, upon visual analysis of single confocal 
slices, we found that single CD151 patches appeared to be bigger than in control conditions. 
Moreover, virus signals on the cell surface also appeared to form more and larger aggregates as 
compared to untreated cells. In some regions HPV16 signals formed elongated (tubular) 
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aggregates associated with CD151 patches. It is tempting to speculate that these resembled virus-
induced tubules as previously seen in electron micrographs (Schelhaas et al., 2012). However, 
non-aggregated virus as well as large aggregates were found, which did not associate with CD151 
at all.  In summary this indicated, that 3D STORM was indeed feasible to visualize potential 
membrane tubules, which were formed upon virus binding and block of internalization. As 
before complete binding to CD151 or accumulation in tubules was not observable due to 
asynchronous virus processing and internalization.  
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Figure 13 Single virus particles localize to CD151 patches 
AF-647 labeled HPV16 was bound to HeLa ATCC cells on cover slips for 6 h before cells were fixed and were 
immunostained with an CD151 antibody without permeabilization. CD151 was visualized with an AF-700 
coupled secondary antibody. Cover slips were mounted on STORM mounting medium and single cells were 
measured on an experimental direct dual color 3D STORM setup by Daniel Böning (AG Klingauf, WWU 
Münster). Acquired images had dimensions of 41 µm x 41 µm x 1 µm with a voxel size of 15 nm. Depicted is an 
inset of a maximum intensity projection of an imaged single cell (top row) showing a merged image and the single 
channels for CD151 (red) and HPV16 (green). CD151 and HPV16 surface renderings (bottom rows) were 
performed using the surpass fuction of Imaris 8.1.2 (Bitplane). Shown are side and top views of representative 
virus particles, which localized to CD151 patches. 
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Figure 14 STORM imaging reveals virus associated tubular structures upon cytochalasin D treatment 
HeLa cells were pretreated with 10 µM cytochalasin D for 30 min. AF-647 labeled HPV16 was bound to HeLa 
ATCC cells on cover slips for 6 h before cells were fixed and were immunostained with an CD151 antibody without 
permeabilization. STORM imaging was performed as in Fig. 14. Depicted is an inset from a maximum intensity 
projection of a single cytochalasin D treated cell (top row) showing a merged image and the single channels for 
CD151 (red) and HPV16 (green). Two distinct regions of interest are shown in the insets below, numbered 1 and 2 
(second row). CD151 and HPV16 surface renderings (bottom rows) were performed with the surpass function of 
Imaris (Bitplane, Version 8.1.2). Shown are side and top views of representative aggregates of virus particles, which 
co-localized with CD151 patches. 
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4 Discussion 
HPV16 endocytosis occurs over a protracted period of time by a novel endocytic pathway 
(Schelhaas et al., 2012). Upon binding, the virus particle undergoes a series of structural 
modifications, which are essential for infection and are thought to prime the virus for 
engagement of the secondary receptor and subsequent endocytosis (Raff et al., 2013). Structural 
alterations in the virus capsid have been hypothesized to be the reason for the asynchronous 
uptake of viruses by endocytosis. The results presented here, however, suggested that structural 
modifications only account for a part of slow and asynchronous infectious internalization. L2 
exposure by cyclophilins and cleavage of the L2 N-terminus by furin were found to speed up 
infectious internalization by 30%, whereas HSPGs and KLK8 cleavage did not increase uptake 
kinetics. This indicated further rate-limiting steps downstream of these initial structural 
modifications. Structurally processed HPVs rely on an internalization receptor for infectious 
uptake into the host cells, of which several candidates have been previously described. Here, 
RNAi experiments partially validated the receptor candidates. In follow-up co-localization with 
HPV, prime receptor candidates CD151 and EGFR, however, showed low incidence of co-
localization, which indicated rate limited interaction with the internalization receptor.  
In more detail, our current model for HPV16 entry presents as such: Upon virus binding to the 
cells or ECM, a cascade of structural modifications is required for infectious internalization of 
HPV. Importantly, entry of HPVs is very slow and asynchronous as compared to other viruses 
(e.g. VSV) with half times of 14 h for infectious internalization. As HSPGs are abundantly 
expressed on the cell surface, this interaction was not rate limiting (Cerqueira et al., 2013). 
HSPG-dependent cleavage of the L1 proteins by the secreted protease KLK8 occurred upon the 
initial structural changes brought by glycan engagement without any apparent rate limitation. 
Exposure of the L2 N-terminus by cyclophilin isomerases and its cleavage by proprotein 
convertase furin were rate-limiting steps, which caused 30% of the half time of infectious 
internalization. Terminally restructured virus particles are subsequently transferred to an essential 
internalization receptor. Consequently, interaction with the internalization receptor was likely 
responsible for the remaining slow and asynchronous entry as a result of its limited availability. 
Several receptor candidates have been described in the literature; therefore, it is unlikely that 
HPVs only interacts with a single receptor. Possibly, tetraspanin CD151 regulates a dynamic 
rearrangement of the plasma membrane receptors including HSPGs, EGFR and Integrin a6, 
which leads to an increased EGFR signaling and endocytic uptake of the virus engaged with the 
receptors platform by a novel endocytic pathway (Schelhaas et al., 2012).  
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4.1 The role of structural modifications on infectious internalization of HPV16 
This study addressed the contribution of structural modifications to the kinetics of infectious 
internalization upon initial binding of HPV16 to host cells. For this HPV16 pseudovirus particles 
were compared to structurally primed HPV16 pseudovirus, furin-precleaved HPV16. According 
to the current model, furin cleavage represents the final step of the extracellular processing of 
HPV16 during host cell entry (Day and Schelhaas, 2014). Structural modification of HPV16 
particles are essential for infectious uptake into host cells. Block of any of the modifications leads 
to loss of infectivity despite endocytic uptake of the particles. Virus particles, which cannot 
dissociate from HSPG due to chemical crosslinking, are internalized non-infectiously (Selinka et 
al., 2007). Similarly, blocking KLK8 cleavage, cyclophilin activity, or furin cleavage leads to non-
infectious internalization of HPV16 (Cerqueira et al., 2015; Bienkowska-Haba et al., 2009; 
Richards et al., 2006). Furin cleavage appears to be especially important for infectious 
internalization and nuclear targeting of the viral genome (Richards et al., 2006; Day et al., 2008a; 
b). Inhibition of furin cleavage results in localization of HPV16 particles in endosomes, however, 
no endosomal escape is possible (Richards et al., 2006). This indicates that L2 cleavage may be 
necessary to allow for interactions with cellular proteins, which are required for trafficking of 
L2/vDNA to the nucleus. Moreover, binding of the L2 N-terminus by L2 antibodies on the cell 
surface leads to the loss of virus from the cell surface. This indicates that the exposure of a 
binding site for internalization receptor engagement may be dependent on extracellular furin 
cleavage. This suggests that only terminally restructured virus particles are primed for infectious 
endocytic uptake.  
4.2 Interaction with HSPGs is not limited 
Primary binding of HPVs occurs to HSPGs on the cell surface or within the extracellular matrix 
(Joyce et al., 1999; Johnson et al., 2009; Kines et al., 2009; Combita et al., 2001). A previous study 
from our lab shows that interaction of HPV with heparin activates the virus for infection and 
induces changes in the epitope exposure on the viral capsid as detected by enhanced binding of a 
conformational antibody (Cerqueira et al., 2013). However, this initial interaction does not 
influence the kinetics of infectious internalization, which remains slow and asynchronous upon 
heparin preincubation as compared to untreated virus (Cerqueira et al., 2013). 
Glycosaminoglycans serve as attachment factors for many viruses. They are generally considered 
to tether and thereby concentrate viruses on or close to target cells (Jolly and Sattentau, 2006; 
Marsh and Helenius, 2006). Examples for this are HSV1, respiratory syncytial virus (RSV) and 
dengue virus attachment before entry, which can be blocked by heparin preincubation (WuDunn 
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and Spear, 1989; Krusat and Streckert, 1997; Chen et al., 1997). Conceptually, it is therefore 
plausible that initial attachment to abundant HSPGs is not rate limiting for infectious 
internalization. However, in case of HPV, HSPGs do not solely serve as bona fide attachment 
factors but are also involved in initial structural rearrangement (Dasgupta et al., 2011; Cerqueira 
et al., 2013). To induce the structural rearrangement that leads to exposure of a buried epitope of 
HPV16, a sequential engagement of different heparin binding epitopes has been proposed 
(Richards et al., 2013). Initial attachment to HSPGs occurs via epitopes located at the top of the 
pentamers involving BC-, EF-, FG- and/or HI-loops (Dasgupta et al., 2011). Subsequent 
interaction of long heparin sulfate molecules with a binding site at the side of the pentamers 
(alpha 4-loop) may then induce a strain that leads to the exposure of a formerly poorly accessible 
epitope located at amino acids 396-415 bound by H16.B20 antibody (Christensen et al., 1996; 
Dasgupta et al., 2011; Cerqueira et al., 2013). AAV-2 infection also involves structural changes 
upon HPSG engagement for interaction with a co-receptor (Summerford and Samulski, 1998; 
Levy et al., 2009). Due to the high abundance of HSPGs, it is likely that neither binding nor 
induction of initial structural rearrangement by HSPGs was a rate-limiting process during HPV16 
endocytosis.  
4.3 KLK8 cleavage is not rate limiting for infectious internalization 
The major capsid protein L1 is proteolytically processed by the secreted protease KLK8 in a 
HSPG-dependent manner, as the efficiency of KLK8 cleavage is significantly enhanced upon 
preincubation with heparin (Cerqueira et al., 2015). 
When HPV16 and terminally restructured FPC-HPV16 particles were pretreated with heparin, 
bound to ECM and incubated with medium containing secreted cellular material (conditioned 
medium) for different times, cleavage of maximally 50% of all L1 was observed after 16 h. 
Pretreatment with heparin likely covers the complete particle, which would make KLK8 cleavage 
sites similarly accessible by structural activation. This posed the questions as to why not all KLK-
8 cleavage sites were processed and whether this had any effects on the uptake kinetics of 
preprocessed particles.  
One possible reason for partial cleavage is that cleavage efficiency of KLK8 may be lost over 
time, due to self-degradation of the protease itself (Eissa et al., 2011). Alternatively, it is possible, 
that KLK8 cleavage within N-terminus of the L1 protein, which is located in the canyon between 
neighboring L1 pentamers (Cerqueira et al., 2015; Modis et al., 2002), induces further structural 
rearrangements. Single cleavages, in turn, could then translate into an extended effect, which 
would obscure the accessibility of further potential KLK8 cleavage sites. Moreover, it is possible 
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that only one half of the virus particle is processed efficiently by KLK8, while the other side of 
the particles is not accessible due to embedding of the virus in ECM. Accordingly, ECM binding 
of HPV16 during preincubation with conditioned medium could affect the efficiency of KLK8 
cleavage. To clarify whether these inhibitory effects existed during KLK8-preincubation, future 
experiments could be performed in suspension in absence of ECM. 
Maximal KLK8-precleavage of HPV16, however, did not affect slow and asynchronous 
infectious internalization of these pretreated particles. This indicated that KLK8 cleavage was not 
rate-limited and that extended cleavage of L1 by KLK8 clearly did not increase the uptake-rate of 
HPV16 particles. 
Interestingly, exposure to conditioned medium increased infectivity of both HPV16 particles and 
FPC-HPV16 particles proportional to the duration of the pretreatment. An increased infectivity 
but unchanged infectious internalization kinetics indicated that more particles were rendered 
infectious but internalized at the same slow and asynchronous rate. One underlying reason could 
be that the proteolytic processing by KLK8 was limited by the amount of active protease present 
in the conditioned medium. The activity of the secreted proteases was possibly affected by non-
optimal conditions within the medium, which then affected cleavage efficiency. This would lead 
to only a fraction of virus particles that reached a cleavage threshold required for infectious 
internalization. Longer incubation with conditioned medium (6 h or 16 h) would, thus, lead to 
overall more infectious particles.  
Alternatively, restructured HPV16 particles may not be released efficiently from the extracellular 
matrix. KLK8 and other proteases in the conditioned medium could be involved in remodeling 
of the ECM, which may result in an efficient transfer of more terminally processed particles to 
the cell surface. Several proteases are secreted by cells and are therefore potentially active in 
conditioned medium (Lu et al., 2011; Cawston and Young, 2010; Page-McCaw et al., 2007). 
Remodeling of the extracellular matrix is an important process during wound healing and 
involves several secreted matrix metalloproteases (Gill and Parks, 2008; Caley et al., 2015). 
Therefore, is reasonable that extended matrix remodeling may be required to allow for more 
virus particles to detach from extracellular matrix and infect cells. Whether ECM remodeling 
influenced the efficiency of virus release, which led to the increased infectivity, could be tested in 
future experiments by pretreatment of virus particles in suspension. The virus would then be 
directly added to target cells and ECM binding and release steps would be omitted.  
Another possible reason for higher infectivity may be that extended KLK8 cleavage enhanced 
initial extracellular uncoating, which may be advantageous for later uncoating within the 
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endosomal compartments after internalization. This would mean that a higher degree of KLK8-
processing destabilized or opened the particle, so that (late-)endosomal proteases and cyclophilin 
more efficiently mediated separation of L1 and the L2/vDNA subviral complex. This possible 
mechanism could be tested by determination of the fraction of virus, which was internalized in a 
non-infectiously by staining and co-localization of the vDNA with L1 and lysosomes versus co-
localization of vDNA with the nucleus. 
Despite the higher infectivity observed after extended incubation with KLK8-containing 
conditioned medium, no significantly faster internalization was observed for the pretreated virus 
particles. This indicated that the extent of KLK8 processing of the virus particles was not rate-
limiting for infectious internalization. Restructured FPC-HPV particles similarly did not show 
changed internalization kinetics. This suggested that no further proteolytic processing by KLK8 
or other secreted proteases was required for infection after furin cleavage. Hence, this finding 
supported the notion that FPC-HPV particles were indeed terminally restructured.  
4.4 L2 N-terminal exposure is rate limited 
Structural rearrangements of the L1 capsid shell by HSPGs and KLK8 lead to an increased 
accessibility of the L2 N-terminus (Cerqueira et al., 2015). Previous studies showed the 
involvement of cyclophilin isomerases during exposure of the N-terminal sequence (Bienkowska-
Haba et al., 2009, 2012). When a mutant L2 with increased flexibility was incorporated into 
HPV16 particles, infectious internalization was slightly faster than with HPV16 particles. 
However, the actual extent of this effect may be masked due to the downstream requirement for 
furin cleavage for infectious internalization. 
When furin precleavage of HPV16 was combined with mutant L2, infectious internalization 
kinetics were not affected as compared to FPC-HPV16 only. This suggested that higher flexibility 
of the L2 N-terminus was only relevant for the kinetics prior to furin cleavage. This is in line with 
the model, that KLK8 cleavage opens the interpentameric canyon and enables L2 exposure 
(Cerqueira et al., 2015). L2 is an inherently unstructured protein with many described functional 
domains (Wang and Roden, 2013). Due to this feature, so far no crystal structure of the L2 
protein is available. However, the putative cyclophilin binding site within the L2 protein is a 
proline rich region. Proline is an unusual amino acid, which due to its pyrrolidine ring has limited 
flexibility for the conformation of the peptide chain and induces turns of the backbone in cis 
configuration (Li et al., 1996). Cis – trans isomerization is slow (Brandts et al., 1975) and could 
therefore hinder efficiency of L2 N-terminal exposure during HPV16 infection. In line with our 
observations, the introduction of higher flexibility within the L2 backbone, as naturally seen in L2 
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proteins from for example BPV1, possibly favors exposure of the N-terminus, which may make 
cyclophilin activity dispensible (Bienkowska-Haba et al., 2009).  
Cyclophilins are peptidyl-prolyl isomerases, which are important chaperones during protein 
folding (Schönbrunner and Schmid, 1992; Kruse et al., 1995). During HPV infection cyclophilins 
are required for exposure of the cross-neutralizing RG-1 epitope of L2 (Bienkowska-Haba et al., 
2009). As HPV16 requires further cyclophilin activity for L1 and L2 separation during uncoating 
after internalization (Bienkowska-Haba et al., 2012), targeting cyclophilins with cyclosporine A 
does not allow conclusions for each function separately. A recent publication shows that furin 
cleavage of HPV16 containing an N-terminally tagged L2 protein was not blocked in presence of 
cyclosporine A (Bronnimann et al., 2016), which indicates that exposure of the L2 N-terminus is 
facilitated by cyclophilin activity but does not completely depend on cyclophilins. 
While on the one hand the N-terminal tag could induce permanent or increased exposure of this 
L2 region due to problems during packaging, the study suggests that cyclophilins may not be 
involved in N-terminal exposure at all. HPV virions undergo a maturation process that leads to 
the formation of intercapsomeric disulfide bonds (Buck et al., 2005b). During this process the 
capsid diameter shrinks by about 3 nm (Cardone et al., 2014). It is likely, that this structural 
compaction could lead to the buildup of a spring-like energy within the L2 protein due to forced 
interaction of protein domains. These forces would then be release upon partial uncoating of the 
virus capsid by KLK8 and could in turn drive the exposure of the L2 N-terminus without any 
assistance. Extreme examples for this mechanism are certainly HSV1 and bacteriophages, which 
contain strongly compressed genomes within the virus capsid ready to be ejected upon uncoating 
(Bauer et al., 2015; Tzlil et al., 2003). Introduction of an N-terminal tag on the L2 protein would 
increase the spring-like force within the capsid, as larger L2 proteins have to be more compacted 
and are thus under higher strain. This would than explain why tagged L2 N-termini are readily 
exposed and cleaved upon partial uncoating by HSPG interaction and KLK8 cleavage without 
requirement of cyclophilin activity. This effect would then be less pronounced in case of a 
smaller tag, e.g. a HA-tag, as seen by Bronnimann and colleagues (Bronnimann et al., 2016). In 
HPV16 particles with untagged L2 proteins, L2 N-terminal exposure could require cyclophilin 
activity to substitute for a lower spring force generation. This could be due to the optimal size of 
the L2 protein, which could lead to lower or variable force generation that would depend on the 
number of L2 proteins incorporated in the particles (Buck et al., 2008; Buck and Trus, 2012). 
Concluding from this, it is tempting to speculate, that only the fraction of virus particles that 
contained the L2 amount necessary to reach a threshold of spring force, would be efficiently 
processed and therefore infectious. 
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Further studies using non-cell-permeable cyclophilin inhibitors, like MM284 (Malešević et al., 
2010; Balsley et al., 2010; Heinzmann et al., 2015), could help to elucidate the involvement of 
cyclophilins for extracellular structural changes without affecting the separation of L2/vDNA 
from L1 during endosomal trafficking.  
4.5 L2 N-terminal cleavage by furin is rate limiting 
Furin cleavage is considered to be the final modification step before HPV16 internalization. 
When furin-precleaved HPV16 and standard HPV16 particles were compared in infectious 
internalization kinetics, half times of internalization were reduced by 25-30%. Thus furin cleavage 
was the major rate-limiting step during extracellular structural rearrangement. In vitro treatment of 
HPV16 with furin yielded complete cleavage of L2 proteins, therefore infectious internalization 
kinetics showed the maximal effect observable due to furin processing.  
One underlying reason for the slower uptake of unprocessed HPV16 could be the efficiency of 
cleavage by furin, which is influenced by furin activity and/or abundance. Infectivity of HPVs is 
increased under furin overexpression conditions (Day et al., 2008b), which indicates that furin 
abundance can be rate limiting for infection. Moreover, furin can be shed and still mediate 
cleavage (Denault et al., 2002). For HPV16 it is unknown whether the membrane-bound or the 
shed form of furin mediates the cleavage. Therefore, it may be that the activity of furin is not 
optimal for fast and immediate cleavage. Alternatively, the furin cleavage site in L2 may be not 
optimal for furin processing, as it has been shown for HIV precursor protein gp160 that one 
cleavage site is preferred over a second one (REKR’A vs KAKR’R) (Brakch et al., 1995). Even 
though, the HPV16 cleavage site (RVKR’R) rather matches the preferred motif in HIV gp160, it 
is not clear whether the fifth position in the motif may influence the cleavage efficiency 
(Matthews et al., 1994). Furthermore, it is unknown how the protease is recruited to the exposed 
N-terminus of L2. A stochastical encounter of virus and protease due to diffusion may be rate 
limiting, if the abundance of active furin is low. Alternatively, accessibility of the exposed HPV16 
N-terminus for furin might be hindered for untreated viruses as the particles may be embedded 
in the ECM or entangled in interactions on the cell surface due to their initial attachment. 
The kinetics of HPV16 infectious internalization describes a sigmoidal curve with a characteristic 
lag phase within the first hours after binding. In general terms, a lag phase could indicate that an 
initial sequence of structural changes is required before terminally restructured virus particles can 
enter the host cells. For FPC-HPV16, the lag phase reduced to a minimum in add-on 
experiments. This indicated that structural changes leading to terminally restructured particles are 
no longer required. The slope of the infectious internalization curve of FPC-HPV16 remained 
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unchanged. This suggested that terminally restructured particles are not readily taken up into the 
cells, which leads to synchronous internalization. Intriguingly, infectious internalization of ECM-
bound HPV and FPC-HPV was even slower than internalization upon direct cell binding. Again 
the lag-phase was reduced when FPC-HPV16 was used instead of untreated HPV16, but it was 
not abolished as in add-on experiments. This prolonged lag-phase could indicate that additional 
factors are involved in processing the virus before its asynchronous uptake into the cell, when 
bound to ECM. Matrix metalloproteinases are required for HPV16 entry (Cerqueira et al., 2015; 
Surviladze et al., 2012). MMPs are involved in the remodeling of extracellular matrix and could 
therefore aid in the release of virus particles bound to ECM. This remodeling could be further 
limiting for the transfer to the internalization receptor.  
In conclusion, this strongly indicates that further rate-limiting steps are involved downstream of 
structural modification, which account for the remaining rate-limitation. 
4.6 What are possible additional rate-limiting steps during HPV16 entry? 
An obvious possibility is that the engagement of the internalization receptor is limited. We bound 
FPC-HPV16 to cells with perturbed HSPG sulfation or to HSPG negative cells. In this study, 
binding of FPC-HPV16 to HSPG-negative cells was very inefficient. Moreover, when we 
analyzed co-localization of HPV16 internalization receptor candidates CD151 and EGFR with 
HPV16 particles, we found that co-localization only occurred at very low incidence. The low 
amount of FPC-HPV16 binding to cells with perturbed sulfation of HSPGs suggested that 
interaction with the internalization receptor was limited and, thus, may be the reason for the 
remaining asynchrony of HPV16 entry. This poses the following questions: 1) Is FPC-HPV16 
terminal restructured and ready for secondary receptor engagement? 2) Did the NaClO3-
treatment affect the internalization receptor engagement? 3) Is the internalization receptor itself 
not available for binding? 
Furin cleavage of the L2 N-terminus and transfer from HSPGs to an internalization receptor are 
reportedly required essential for infectious internalization of HPV16 (Richards et al., 2006; 
Selinka et al., 2007). Thus, likely only terminal structurally rearranged particles are able to transfer 
to the internalization receptor that targets the virus into an infectious endocytic pathway. Low 
affinity interaction with the internalization receptor could indicate, that FPC-HPV16 particles 
were not terminally restructured and required yet another so far unknown structural modification. 
This would then lead to another rearrangement, which allows for direct and high affinity 
engagement of the internalization receptor. To date, there is no indication for further structural 
modifications on the HPV16 virion. In line with that, we showed here that extended 
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preincubation with cellular supernatant containing secreted proteases and cellular material 
(conditioned medium) did not improve infectious internalization of FPC-HPV16. Therefore, it 
was rather unlikely that FPC-HPV was not terminally restructured. 
Internalization receptor binding was primarily analyzed by binding to NaClO3-treated cells. 
Treatment of cells with NaClO3 leads to a transient loss of O-sulfation of HSPGs on the cell 
surface (Safaiyan et al., 1999). It may be that NaClO3-treatment directly or indirectly affected the 
localization or function of other plasma membrane proteins, which may be involved in HPV16 
internalization. This cannot be ruled out completely as the internalization receptor of HPV16 is 
still elusive. Transient drug treatment itself, however, did likely not affect internalization receptor 
engagement, as HSPG-negative pgsA cells were bound with similarly low efficacy. However, 
sulfated HPSGs associated with growth factors have been proposed to mediate clustering and 
activation of EGFR during HPV endocytosis (Surviladze et al., 2012; Kühling, 2015). One could 
speculate that sulfated HSPGs are involved in that formation of an internalization receptor 
complex for HPV16. In that case, absence of HSPGs would certainly perturb internalization 
receptor engagement. 
On the other hand, the internalization receptor itself may be limited for virus engagement. One 
possible mechanism triggered after virus binding and its terminal structural rearrangement may be 
that the receptor has to be recruited into a functional complex. Several internalization receptor 
candidates of HPV16 have previously been described and proposed to form a functional entry 
platform during HPV16 entry (Raff et al., 2013). In line with this, receptor clustering and co-
migration has been previously described for several other viruses, including murine leukemia 
virus (MLV), which clusters its receptor mCAT-1 upon binding to filopodia (Lehmann et al., 
2005). Hence, receptor complex formation could be a valid mechanism for HPV16 endocytosis.  
One possibility limitation to receptor engagement may be that a low affinity but high avidity 
receptor complex has to form around the bound virus particles. The tetraspanin CD151 may 
provide the platform for this. In our hands, CD151 was required for HPV16 infection. 
Moreover, CD151 has been previously described to co-localize with HPV16 during entry and 
endocytosis (Spoden et al., 2008; Scheffer et al., 2013). Tetraspanins are abundant proteins 
known for their ability to dynamically restructure the membranes, as they interact with surface 
receptors and other tetraspanins to form nano- and microdomains, so-called tetraspanin enriched 
areas (TEA) and tetraspanin enriched microdomains (TEMs) (Espenel et al., 2008; Yáñez-Mó et 
al., 2009). Tetraspanins have a large extracellular loop (LEL) with which specific interactions with 
non-tetraspanin proteins are mediated (Stipp et al., 2003). Tetraspanin-tetraspanin interaction is 
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likely mediated through the hydrophobic interactions between the transmembrane domains and 
may be dependent on palmitylation (Berditchevski, 2001; Yang et al., 2002). 
The ability of CD151 to form a network of interactions with other tetraspanins and their 
interaction partners would make CD151 an optimal candidate for the formation of internalization 
receptor complex. Interestingly, CD151 interacts with laminin-binding integrins, mainly α3β1 and 
α6β1/β4 via a QRD motif within the LEL, which have been described to be involved in HPV16 
endocytosis (Berditchevski, 2001; Stipp, 2010). CD151 has also been linked to modulation of 
EGFR signaling mainly in cancer cells (Novitskaya et al., 2014; Sadej et al., 2013). Therefore, it 
may be that HPV16 binding induces the formation or restructuring of TEMs, which would bring 
integrins and EGFR in close proximity. This in turn could lead to enhanced EGFR signaling, 
which has been shown to be important for internalization (Bannach, 2014). A similar entry 
platform was suggested previously (Raff et al., 2013; Scheffer et al., 2014) and formation of such 
an entry platform would likely be asynchronous and in line with the rate-limitation observed 
during infectious internalization. In line with the observed kinetics during HPV entry is the 
observation that prototype tetraspanin CD9 exhibits different dynamics within the plasma 
membrane depending on its localization to smaller or larger TEA (Espenel et al., 2008). Larger 
domains show frequent association and dissociation of CD9 molecules in single molecule 
tracking by total internal reflection fluorescence microscopy (TIRFM), whereas very small 
domains appeared to be static and confined over several minutes. Further, CD151 and CD82 
have been shown to confine movement of their interaction partner ITGα6β4 and EGFR, 
respectively (Zhang et al., 2002; Danglot et al., 2010). After HPV16 binding, particles show a 
phase of random motion until they are eventually confined and rapidly internalized (Schelhaas et 
al., 2008). Thus, CD151 may serve as a hub for the recruitment and confinement of receptor 
components during HPV16 endocytosis.  
Another well-studied example for a complex engagement of different receptors during infection 
is hepatitis C virus (HCV) (Lindenbach and Rice, 2013). During HCV entry, the virus particles 
first engage with LDLR and HSPGs as primary attachment factors (Agnello et al., 1999; Germi et 
al., 2002; Monazahian et al., 1999). HCV interaction with SRB1 provides specificity for 
hepatocytes and mediates structural rearrangement, which allows for subsequent direct 
interaction with tetraspanin CD81 (Bankwitz et al., 2010). CD81 interaction is promoted by 
EGFR-dependent HRAS activation and induces lateral movement of the HCV-receptor complex 
via activation of actin remodeling RHO GTPases (Zona et al., 2013; Brazzoli et al., 2008). 
Further, tetraspanin interaction may induce structural changes in the virion for acid dependent 
uncoating (Sharma et al., 2011). Signaling of PKA and EGFR (and EPHA2) then promote 
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interaction with tight junction protein CLDN1, which is essential for clathrin-mediated uptake 
(Farquhar et al., 2008, 2012; Lupberger et al., 2011).  
Similarly, during HPV16 entry CD151 could recruit other tetraspanins and interacting proteins 
(i.e. integrins and EGFR) to a small stable platform, where EGFR signaling would be induced. 
Recruitment of different receptor components could provide a low affinity but high avidity entry 
platform for HPV16 by a novel endocytic pathway.  
A different possibility is that slow and asynchronous HPV16 endocytosis may involve 
disassembly and endocytosis of a preexisting plasma membrane complex. Interestingly, HPV16 
transient binding receptor laminin-332 and internalization receptor candidates CD151 and 
ITGα6 are involved in forming hemidesmosomes. Hemidesmosomes mediate the attachment of 
cells, like basal keratinocytes, to the ECM. Plasma membrane proteins ITGα6β4 and BPAG2 
connect extracellularly to laminin-332 in the ECM, whereas they are linked to intermediate 
filaments via intracellular adaptor proteins BPAG1e and Plectin 1a (Walko et al., 2015). 
Hemidesmosomes are formed in stratified and pseudostratified epithelia, where they mediate 
tissue integrity and stability (Borradori and Sonnenberg, 1999). However, hemidesmosomes are 
dynamically regulated upon cell differentiation, migration and wound healing. Hemidesmosomes 
within tissues are large, stable structure with a core domain and some dynamics at the borders 
(Borradori and Sonnenberg, 1999; Owaribe et al., 1990; Tsuruta et al., 2003). In cultured cells 
only hemidesmosome-enriched protein complexes (HPC) are found at the basal surface of the 
attached cells (Ozawa et al., 2010; Carter et al., 1990). These complexes appear more dynamic and 
are remodeled during cell migration (Tsuruta et al., 2003; Ozawa et al., 2010; Geuijen and 
Sonnenberg, 2002). CD151 localizes to hemidesmosomal structures (Sterk et al., 2000), where it 
is likely involved in their formation and turn over. In cultured cells the absence of CD151 
stabilizes the hemidesmosome-like complexes (Li et al., 2013), whereas its overexpression is 
associated with increases migratory behavior in cancers (Kohno et al., 2002; Yang et al., 2008). 
Hemidesmosome disassembly occurs during wound healing within a tissue and is regulated by 
activation of receptor tyrosine kinases (e.g. PKCa by EGFR activation) leading to integrin 
phosphorylation and subsequent dissociation from its intracellular adaptor plakin (Margadant et 
al., 2008; Alt et al., 2001; Kitajima et al., 1992, 1999). Further, an increased Ca2+ concentration 
during terminal differentiation of keratinocytes was found to lead to disappearance of HPC in 
cultured cells (Kostan et al., 2009). Intriguingly, many of these processes are similarly involved in 
HPV16 entry and may point to a role of hemidesmosomal disassembly during HPV16 
endocytosis. A possible model for HPV16 internalization could be that HPV16-induced EGFR 
signaling leads to an increased disassembly of hemidesmosomal structures, which would enable 
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the virus to bind to integrins and/or CD151. Disassembled hemidesmosomes may then be either 
relocated or internalized. In addition to the HPV16 internalization receptor candidates involved, 
EGFR, PKC, and Ca2+-dependent signaling, all of which promote hemidesmosomal disassembly, 
are also important during HPV16 endocytosis (Schelhaas et al., 2012; Surviladze et al., 2012; 
Bannach, 2014). Therefore, it is tempting to speculate that the virus particles are specifically 
internalized in migrating keratinocytes using inherent hemidesmosomal dynamics, which would 
fit nicely to the epithelial tropism of the HPVs. This notion is supported by in vivo data, where 
binding of HPV16 to the vaginal epithelium in a mouse vaginal challenge model shows a 
preferential binding to the basement membrane (Kines et al., 2009). Similarly, SV40 endocytosis 
serves as an example for the transient recruitment of integrin, which is important for its 
internalization (Stergiou et al., 2013). However, HCV entry involves recruitment of tight 
junctional protein CLDN1 mediated by a tetraspanin CD81 (Harris et al., 2010; Krieger et al., 
2010), which could indicate a similar mechanism. Future experiments could aim at stalling 
hemidesmosomal disassembly or dynamic rearrangement of hemidesmosomal components. 
Another reason for a limited interaction of HPV16 with the internalization receptor may be that 
its availability on the cell surface is restricted. In that case, primary virus binding to HPSGs would 
induce increase receptor expression or secretion to the cell surface. As HSPGs themselves do not 
induce intracellular signaling but act as co-receptors for several kinases (Sarrazin et al., 2011), 
transcriptional activity may be induced by EGFR signaling, which is triggered upon HPV16 
binding. EGFR activation leads to induction of several downstream pathways, which typically 
results in changes in transcriptional activities (Hackel et al., 1999; Lemmon and Schlessinger, 
2010). HSPG-dependent EGFR stimulation can occur by interaction of heparin-bound EGF 
(HB-EGF) in the extracellular matrix or on the cell surface (Aviezer and Yayon, 1994; Prince et 
al., 2010). HPV16 initially interacts with HSPGs potentially with sufficient binding sites to induce 
clustering of HSPGs and EGFRs (Dasgupta et al., 2011; Richards et al., 2013), which would 
induce a change in translational activity. Moreover, it has been reported that ITGα6β4 in cancer 
cells mediates increased expression of VEGF via PI3K signaling (Chung et al., 2002), which is 
also important for HPV16 endocytosis (Schelhaas et al., 2012; Bannach, 2014). Increased 
abundance of growth factors could then in turn again activate EGFR signaling as above. 
Heparin-pretreatment of HPV16 rescues infection of cells with perturbed HSPG sulfation 
(Cerqueira et al., 2013). In line with this model, heparin-covered particles may recruit growth 
factors from the surrounding medium and thus similarly induce EGFR signaling. However, this 
hypothesis is rather unlikely as described receptor candidates for HPV16 are abundant proteins in 
the plasma membrane.  
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4.7 Why does HPV16 enter host cells by a slow and asynchronous mechanism? 
As HPVs are epitheliotropic and depend on cell division for host cell entry, they need to access 
basal stem cells in the epithelium (Pyeon et al., 2009; Schmitt et al., 1996). For access, it has been 
proposed that HPVs infect upon wounding of the host issue, which is backed by in vitro and in 
vivo studies showing that HPVs bind to extracellular matrix and infect exclusively upon tissue 
disruption in mice (Culp et al., 2006a; Kines et al., 2009; Johnson et al., 2009). Residing on the 
basement membrane, HPVs profit from wound healing as mitotically active stem cells migrate in. 
Migrating cells show increased dynamics in their membrane composition, e.g. due to disassembly 
and reassembly of adhesion complexes (Ozawa et al., 2010).  Moreover, wound areas undergo 
extensive restructuring by secreted proteases and therefore provide factors required for virus 
priming for infection, e.g. KLK8 and MMPs (Kishibe et al., 2012; Moses et al., 1996). 
Attachment to the basement membrane may involve extended dwell times until cells actually 
reach the virus particles ((Grando et al., 1993); migration of keratinocytes 24 µm/h; (Kim et al., 
2009); fibroblast max. 40 µm/h). Therefore, slow and stepwise uncoating could be of advantage 
for at least two reasons: Firstly, the requirement of multiple structural rearrangements could 
increase overall (long-term) particle stability within the proteinase rich environment. However, to 
date, there are no comparative data on the stability of standard HPV particles and structurally 
primed particles like FPC-HPV.  
Slow stepwise processing of HPV capsids could provide a mechanism for immune escape. It has 
been shown, that the RG1 epitope is broadly cross-neutralizing for different HPV types 
(Gambhira et al., 2007; Day et al., 2008a). Therefore, this epitope may be hidden as long as 
possible to avoid detection by immune cells or neutralization. Therefore, HPVs may have 
evolved this mechanism to ensure the survival of the species in the constant struggle with the 
host cell defenses. However, both, stability and immune detection, would speak against general 
priming of the virus particle during maturation during tissue differentiation as proposed 
previously for raft-derived HPVs (Cruz and Meyers, 2013; Cruz et al., 2015). Results of this study 
were obtained from in vitro experiments, which do not reflect an in vivo wound-healing scenario 
and therefore may reflect not all relevant. However, in vivo studies, which use a murine vaginal 
challenge model, support prolonged dwell times on the basement membrane and slow 
repopulation of wounded areas (Kines et al., 2009; Roberts et al., 2007). 
Future studies in vitro and in vivo with differentially primed HPV particles could further our 
understanding of the processes involved in early steps of HPV infections. 
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4.8 Concluding remarks 
The findings presented here expand our knowledge on the importance of structural remodeling 
of HPV16 prior to endocytosis. Structural modifications by cyclophilins and furin were found to 
be rate limiting for infectious internalization. However, they accounted only for a part of the slow 
and asynchronous internalization kinetics of HPV16. This work provides evidence that 
engagement of the secondary receptor may contribute to slow and asynchronous internalization.  
Since primary binding and efficient structural modification is essential to establish virus infection 
and likely determines internalization receptor interactions, these results are important for the 
characterization of the novel endocytic pathway used by HPV16 and the determination of its 
cellular function. Furthermore, knowledge of structural rearrangements and receptor engagement 
may help to understand and prevent HPV infections in vivo. 
This study explored rate-limiting steps during structural processing of HPV16 and suggested the 
existence of additional rate limitations probably caused by receptor availability on the target cell 
itself. However, there are several open questions remaining. Does binding affinity of the virus to 
HSPGs change upon structural processing? Does such a change in affinity induce efficient 
transfer to the secondary receptor? Which proteins participate in internalization receptor binding? 
What is the underlying mechanism of asynchronous receptor engagement? Answering these 
questions would significantly advance the understanding of the cellular function of the novel 
endocytic pathway of HPV16.  
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6 Abbreviations 
A2t annexin A2 heterotetramer 
AAV adeno-associated virus 
AF Alexa Fluor 
AKT proteinkinase B (aka PKB) 
AP-2 adaptor protein 2 
ARF6 ADP-ribosylation factor 6 
ATCC American Type Culture Collection 
BCA bicinchoninic acid 
CAR coxsackievirus and adenovirus receptor 
CHO chinese hamster ovary  
CLIC clathrin-independent carriers 
CLDN1 claudin-1 
CME clathrin-mediated endocytosis 
CsA cyclosporine A 
CyP cyclophilin 
DMEM Dulbecco's Modified Eagle Medium 
DMSO Dimethyl sulfoxide 
DN dominant negative 
DNA desoxyribonucleic acid 
DSG desmoglein 
ECM extracellular matrix 
EDTA ethylene diamine tetraacetic acid 
EE early endosome 
EEA1 early endosomal antigen 1 
EGFR epidermal growth factor receptor 
EGTA ethylene glycol tetraacetic acid 
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EM electron microscopy 
ER endoplasmic reticulum 
ERK extracellular signal-regulated kinase 
FACS fluorescence-activated cell sorting 
FAK focal adhesion kinase 
FCS fetal calf serum 
FPC-HPV furin-precleaved HPV 
GAG glucosaminoglycan 
GEEC GPI-AP-enriched endosomal compartment 
GF growth factor 
GFP green fluorescent protein 
GMEM Glasgow Minimum Essential Medium 
GPI-AP glycophosphatidyl-anchored proteins 
GTP guanosine triphosphate 
HA hemagglutinin 
HPV human papillomavirus 
HSPG heparan sulfate proteoglycan 
HSV1 herpes simplex virus 1 
IAV Influenza A virus 
IgG immunoglobulin G 
IL-2 interleukin-2 
ITGα6 integrin alpha 6 
KD knockdown 
KLK8 kallikrein-8 
LAMP1 lysosomal-associated membrane protein 1 
LCMV lymphocytic choriomeningitis virus 
LDLR low density lipoprotein receptor 
LE late endosome 
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MCV Merkel cell polyomavirus 
MLV murine leukemia virus 
MMP matrix metalloproteinase 
MOI multiplicity of infection 
mTOR mammalian target of rapamycin 
NCS newborn calf serum 
ND10 nuclear domain 10 
NEBD nuclear envelope breakdown 
NLS nuclear localization signal 
NPC nuclear pore complex 
OCLN occludin 
PAK1 p21 (Cdc42/Rac)-activated kinase 1 
PBS phosphate buffered saline 
PFA paraformaldehyde 
PIC pre-integration complex 
PI3P phosphatidyl-inositol 3 phosphate 
PI3K phophatidyl-inositol-(4,5)-bisphosphate 3-kinase 
PKC protein kinase C 
PLC phospholipase C 
PML promyelocytic leukemia protein 
pRb retinoblastomaprotein 
PV papillomavirus 
PsV pseudovirions 
QV quasivirus 
RE recycling endosome 
RFP red fluorescent protein 
RNA ribonucleic acid 
RNAi ribonucleic acid interference 
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ROI region of interest 
RPMI Roswell Park Memorial Institute 
RTK receptor-tyrosine kinase 
SDS sodium dodecyl sulfate 
SFV Semliki forest virus 
siRNA small interfering RNA 
SNX sorting nexin 
STORM stochastic optical reconstruction microscopy 
SV40 Simian virus 40 
TBS Tris buffered saline 
TEA tetraspanin enriched area 
TEM tetraspanin enriched microdomain 
TGN trans-Golgi network 
TRITC tetramethylrhodamine B isothiocyanate 
VLP virus-like particle 
vRNP viral ribonucleoprotein 
VSV vesicular stomatitis virus 
YFP yellow fluorescent protein 
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